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Cornelia de Lange Syndrome (CdLS) is a multisystem genetic disorder caused by 
mutations in the cohesin complex.  It is believed that cohesin is able to regulate gene 
expression with CTCF by holding chromatin in topological complexes, such as 
active chromatin hubs, and that CdLS is caused by loss of these complexes causing 
aberrant gene expression. 
In order to determine if loss of these complexes in CdLS resulted in a general 
change in the compaction of chromatin, I undertook a series of analyses of the 
nucleus in CdLS patient lymphoblastoid cell lines (LCLs), compared to wildtype, 
and later in RNAi knockdown models of CdLS.  By fluorescent in situ hybridisation 
(FISH) I studied the chromatin compaction of different regions of the genome, and 
found that in some, but not all, CdLS cell lines, gene-rich regions have less compact 
chromatin compared to wildtype.  RNAi knockdown of two proteins that are mutated 
in CdLS, NIPBL and SMC1, also resulted in decompaction of regions of the genome, 
however these were different regions than in the patient LCLs, perhaps due to 
variation between cell lines.  This change was not due to the interaction between 
cohesin and CTCF, as I found that knockdown of CTCF did not result in changes in 
chromatin compaction.  I have also looked at the published data for gene expression 
in CdLS, and in mouse and Drosophila models of CdLS, and have found no 
correlation between the genes misexpressed in CdLS in the three species, nor 
between three cell lines of the same species. 
These data suggest that the variation in chromatin compaction observed in CdLS 
may not be due to an interaction between cohesin and CTCF, and that cohesin can 
act independently of CTCF to regulate gene expression.   
1 Introduction 
 
The cohesin complex holds sister chromatids together before separation at 
metaphase.  Mutations in cohesin proteins or cohesin-associated proteins are known 
to cause Cornelia de Lange Syndrome (CdLS).  It is now believed that cohesin is also 
able to regulate gene expression through tethering of promoter-enhancer interactions, 
through interaction with other proteins, and it is disruption of these interactions that 
causes misexpression of genes and the phenotypes of CdLS. 
I speculated that alteration in the tethering of intra-chromosome interactions 
would result in altered organisation of DNA in the nucleus, and altered chromatin 
compaction.  My aim, in this thesis, was to examine the ways in which chromatin 
compaction was affected by CdLS, and to consider the molecular causes of any such 
changes. 
 
1.1 The cohesinopathies 
1.1.1 Symptoms of the cohesinopathies 
Cornelia de Lange Syndrome (OMIM 122470) is a genetic disorder that affects 
around 1 in 10,000 people, and results in a variety of developmental defects, 
including growth retardation, gastrointestinal problems, microcephaly, mental 
retardation, autistic-like behavioural problems, characteristic faces and hirsuitism, 
oro-dental problems, upper limb abnormalities, ophthalmic problems, seizures and 
cardiac problems (Figure 1.1A and B).  There is a wide spectrum of severity in 
CdLS.  The limb abnormalities range from severe deformities including monodactyly 
and complete absence of the radii (Figure 1.1A), to minor deformities such as small 
hands (Figure 1.1B).  Variation can also be seen in the mental retardation phenotype 
of patients, as some patients are completely non-verbal, whilst others are capable of 
independent living. 
Many similarities can be seen between CdLS and Roberts Syndrome (RBS; 
OMIM 268300).  Similarly to CdLS, patients with RBS suffer from deformities of 
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A
Figure 1.1 – Cohesinopathy patients.
A, a patient with mild CdLS (Gillis et al 2004).  B, a patient with severe CdLS 




the limbs (however in RBS these defects occur in both the upper and lower limbs), 
cleft palates, microcephaly and growth retardation (Figure 1.1C).  Unlike CdLS, cells 
from RBS patients display altered metaphase chromosomes, with splaying out of the 
pairs of sister chromatids.  RBS is generally more severe than CdLS. 
In both syndromes, patients may show combinations of these defects at a whole 
spectrum of severity from classical or severe to mild.  These diverse phenotypes are 
indicative of a developmental disorder in which the underlying molecular aetiology 
is aberrant gene expression in a variety of tissues. 
 
1.1.2 Genetics of CdLS 
CdLS mutations are mostly sporadic, with cases occurring in families with no 
known history.  However there are families of multiple affected siblings, presumably 
due to parental germline mosaicism.  Milder forms can be inherited from affected 
parents, but severely affected individuals will not have children, due to physical and 
mental disability, so these forms are never inherited (OMIM 122470). 
CdLS was thought to be due to autosomal dominant mutations, which occurred 
spontaneously in most cases.  Studies found that NIPBL was mutated in around half 
of all cases of CdLS (Krantz et al, 2004; Tonkin et al, 2004).  Tonkin et al (2004) 
studied the breakpoints in previously identified CdLS patients with de novo 
translocations and compared them to other kinds of chromosome aberrations in these 
regions in other CdLS patients.  A translocation between 5p13.1 and 13q12.1 in one 
CdLS patient corresponded to a deletion in another patient at 5p13.1-5p14.2.  They 
mapped the breakpoint on chromosome 5 using fluorescent in situ hybridisation 
(FISH) and found that it mapped to a previously uncharacterised gene, which they 
named NIPBL, or Nipped-B-like, due to its sequence similarity to the fly Nipped-B 
(Figure 1.2).  Krantz et al (2004) used a genome-wide linkage analysis and identified 
four candidate regions for a gene mutated in CdLS.  The highest lod score, of 2.7, 
was also found at 5p13.1.  Mutational analysis by conformation-sensitive 
electrophoresis identified NIPBL. 
NIPBL is a large gene, and comprises 249,561 bp in 47 exons (Figure 1.3).  The 
gene encodes a 2804 aa protein with a mass of 316 kDa.  The NIPBL protein 
3
Figure 1.2 – NIPBL sequence alignment.  
The sequence of NIPBL protein in humans (top) compared to the orthologous proteins in (from second from top to 
the bottom) mouse, zebrafish, Drosophila, S. pombe and S. cerevisiae.  Bases are coloured blue to indicate 
identity between the species, with darker colour indicating higher identity.  The PxVxL domain is highlighted in 











































































































Figure 1.3 – CdLS mutations in NIPBL.
Track showing a number of NIPBL mutations identified in CdLS patients, created using the UCSC genome 
browser (GRCh37/h19 assembly; Kent et al, 2002; http://genome.ucsc.edu/).  Mutations occur across the 
whole gene, and represent all possible mutation types.  Exon 10, which encodes the PxVxL domain is 










contains a PxVxL domain that interacts with chromoshadow domains (Lechner et al, 
2005), and glutamine-rich HEAT repeats near the C-terminus, which are thought to 
act as a scaffold for other proteins to assemble (Neuwald and Hirano, 2000). 
NIPBL mutations were then identified by sequencing the gene in a variety of 
patients, and they included insertions, deletions, splice-site mutations, missense, 
nonsense and altered start codons (Figure 1.3), across the whole of the gene, with 
symptoms varying from mild to classical.  All of these patients were heterozygotes, 
consistent with the dominant inheritance of the disorder, and this wide range of 
genotypes is indicative of haploinsufficiency.  Patient cohorts have been studied to 
determine if there is a correlation between the type of NIPBL mutation and the 
severity of the clinical phenotype.  Patient phenotypes were categorised as mild, 
moderate or severe, whilst genotypes were categorised as truncating, splice site or 
missense.  A statistical correlation was found between patients with truncating  
mutations and severe phenotypes, whilst patients classified as mild or moderate were 
more likely to have missense or splice site mutations (Gillis et al, 2004; Bhuiyan et 
al, 2006; Selicorni et al, 2007). 
NIPBL is mutated in only around half of all CdLS cases and mutations in other 
genes have since been implicated.  Musio et al (2006) identified cases of CdLS with 
in-frame deletions and missense mutations in SMC1L1 (OMIM 300590).  Deardorff 
et al (2007) identified a single patient with a mild form of CdLS with an in-frame 
deletion in SMC3 (OMIM 610759) and Zhang et al (2009) have identified a family 
with multiple affected siblings, all with a missense mutation in PDS5B.  Both 
SMC1L1 and SMC3 mutations have only been reported in mild cases of CdLS.  As 
these are all mild missense or in-frame mutations, this may indicate that more severe 
mutations of these genes are lethal.  In the family affected by PDS5B mutations, a 
missense mutation was identified in two affected siblings, and the unaffected father 
and one unaffected sibling.  The two affected siblings inherited a different maternal 
allele than their unaffected sibling, suggesting that the mother also carries a recessive 
allele that was not picked up in the screen and was passed on to her two affected 
offspring. 
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SMC1L1 is located on the X-chromosome but escapes X-inactivation and its 
effects are dominant.  There are instances of maternal inheritance of SMC1L1 
mutation since some affected females can have children, possibly due to ratio of 
normal-to-mutated protein giving them only a mild phenotype.  Males with SMC1L1 
mutation survive, however there are not sufficient numbers of SMC1L1 mutants to 
statistically compare its incidence between the sexes.  SMC3 mutation is 
heterozygous in the one known affected individual, so its inheritance is assumed to 
be dominant.  SMC3 is found on chromosome 10.  PDS5B mutation shows recessive 
inheritance and is on chromosome 13. 
A large percentage of CdLS patients do not yet have a known gene mutation.  
NIPBL is implicated in around half of all cases, SMC1L1 in less than 5%, SMC3 
mutation has only been reported once and PDS5B in only one family.  It is clear that 
there is still much research to be done to find the rest of the genes that can be 
mutated to cause CdLS.  Advent of whole exome sequencing should rapidly reveal 
this/these missing genetic component(s) (reviewed in Ng et al, 2010). 
Complete heterozygous deletion of NIPBL appears to give a different phenotype 
to CdLS.  A patient was born with a deletion at 5p13.2, encompassing the whole of 
NIPBL and no other known genes, but was not identified as a CdLS patient due to a 
complete lack of the facial phenotypes associated with CdLS.  However, similarly to 
CdLS, this patient suffers from retardation of growth and development, limb defects, 
cardiac defects, cleft lip and palate and gastrointestinal reflux (Reeves et al, in 
preparation).  NIPBL or SMC1A duplication gives a different phenotype to both 
CdLS and NIPBL deletion.  Some features appear to completely contrast CdLS, 
including long philtrums and large hands with long fingers; other features are similar 
to CdLS, such as high palates, low set ears, low hairlines, mental retardation, 
developmental delay and sleep disturbances; however most features of CdLS are 
absent and it is clear that this is a distinct disorder (Yan et al, 2009). 
 
1.1.3 Genetics of RBS 
RBS (OMIM 268300) is caused by a mutation in establishment of cohesion 1 
homologue 2 (ESCO2).  Unlike CdLS, RBS is autosomal recessive.  Linkage analysis 
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in four families who shared a common ancestor in isolated villages near Bogotá, 
Colombia identified 8p12-21.1 as a locus for RBS.  This interval was then narrowed 
down using more families and fine mapping, identifying a transcript which was later 
determined to be ESCO2.  Mutations have been found in ESCO2 in all studied RBS 
patients, and include frameshift, nonsense and missense mutations. 
 
1.2 The cohesin complex 
All of the genes currently known to be mutated in CdLS and RBS are involved in 
the function of the so-called cohesin complex, implicated in mitosis.  SMC1L1 and 
SMC3 are subunits of the complex itself, NIPBL is the complex loader, and ESCO2 
and PDS5 are required for the establishment of sister chromatid cohesion. 
 
1.2.1 Subunits of cohesin are a members of the SMC family 
The SMC family is a family of protein complexes consisting of cohesin, 
condensin and SMC5/6 in eukaryotes and bacterial bsSMC in Bacillus subtilis, RecN 
in Deinococcus radiodurans and MukBEF in Escherichia coli, with similar proteins 
in other bacterial species (Figure 1.4).  In eukaryotes, these complexes are made up 
of a heterodimer of two structural maintenance of chromosomes (SMC) proteins; in 
cohesin these are SMC1L1 and SMC3, in condensin SMC2 and SMC4 and SMC5/6 
is made up of SMC5 and SMC6.  However B. subtilis, D. radiodurans and E. coli 
have only one SMC protein in each species, BsSMC, RecN and MukB respectively, 
all of which form homodimers.  SMC proteins have anti-parallel coiled-coil domains 
and are around 50nm long, with globular head and hinge domains at either end of the 
coils.  In the heterodimers of SMC proteins, the dimerisation interface of the two 
coiled-coils is the hinge domain.  All SMC proteins have both their N and C termini 
at their head domains, and different proteins bind at this domain to complete the 
proposed ring structure of each complex (Losada and Hirano, 2005; Strunnikov, 
2006; Lim and Oh, 2009).  The kleisin protein family is closely associated with the 
SMC protein family, as they have been identified as closing protein rings (Schleiffer 




















Figure 1.4 – SMC proteins and complexes.
A, scematic of the domains of SMC proteins.  B, cartoons of SMC complexes.  Adapted from Losada 
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The cohesin complex is made up of four subunits; two SMC proteins, SMC1L1 
and SMC3, and three kleisin proteins, Rad21 and SA1 or SA2 (stromal antigen; for 
ease I will always use the name of the human orthologue unless otherwise stated; 
Table 1.1; Figure 1.5).  The complex is composed of two SMC protein arms, joined 
at the hinge region, and secured together at the head region by kleisin proteins.  In 
cohesin, the gap between the SMC heads is bridged by Rad21.  Either SA1 or SA2 
binds to Rad21; all current evidence suggests functional homology of the two 
proteins.  The resulting tripartite ring is 35nm in diameter.  In meiotic cohesin, 
SMC1L1 is replaced by SMC1B and Rad21 is replaced by Rec8.  The cohesin 
complex is loaded onto chromatin via a complex of NIPBL (Nipped-B in Drosophila 
melanogaster, Mis4 in Schizosaccharomyces pombe and Scc2 in Saccharomyces 




The protein complex condensin is related to cohesin and is involved in the 
compaction of chromosomes into their mitotic structure.  Like cohesin, condensin 
consists of two SMC proteins, SMC2 and SMC4, forming a head-coiled-coil-hinge 
structure.  A ring is formed by kleisin proteins, the chromosome associated proteins, 
CAP-G, CAP-H and CAP-D2 in condensin I and CAP-G2, CAP-H2 and CAP-D3 in 
condensin II, associating with the hinge domains of the SMC proteins (Figure 1.4).  
Compaction is speculated to occur by the formation of loops along the chromosome, 
held within the ring (Hagstrom and Meyer, 2003).  Condensin II associates with the 
chromosomes in prophase and partially condenses the chromosomes by hierarchical 
folding, and is followed by condensin I in prometaphase, which then fully condenses 
the chromosomes by forming an axial glue structure.  The two condensins appear to 
alternate along the axis of the metaphase chromatids (Losada and Hirano, 2005). 
The condensin complex was first discovered and named in Xenopus laevis, as 
XCAP-C and XCAP-E (orthologues of SMC4 and SMC2 respectively) were found to 


















































































































































































































































































































































































































































































































































































Figure 1.5 – The cohesin complex.
The human cohesin complex is made up of SMC1, SMC3, Scc1 and SA1/SA2.  A, in the ring model a 
single cohesin ring encircles two strands of DNA (Haering et al, 2008).  B, in the handcuff model, two 
rings each encircle a single strand of DNA and are held together by a single molecule of SA1 or SA2 
(Zhang et al, 2008).
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of the Drosophila Barren protein, which is now known to be an orthologue of CAP-
H.  The condensin complex was shown to be necessary for the condensation of 
chromatin at mitosis, independently of topoisomerase IIα (Hirano et al, 1997).  
Continuing to work with X. laevis, Kimura et al (1999) found that condensin is able 
to condense chromosomes by introducing positive supercoils, positive trefoil knots 
and an ordered global positive writhe.  These actions require the presence of ATP, 
type I and type II topoisomerases and condensin phosphorylation. 
In Caenorhabditis elegans and Drosophila melanogaster, condensin was also 
shown to be important in meiosis, promoting chromosome condensation after 
crossover and resolving linkages between sister chromatids.  In flies, it is condensin 
II that is responsible for preventing transvection; similarly condensin II is responsible 
for this role in C. elegans too (Chan et al, 2004; Hartl et al, 2008). 
The phenotypes of condensin mutants and knockdowns suggest various roles and 
actions of condensin.  In C. elegans, depletion of SMC4 and MIX-1 (SMC-2 
orthologue) results in aberrant chromosome structure and segregation at mitosis, and 
disrupted segregation at meiosis II but not meiosis I.  However this depletion does 
not result in decondensation at metaphase, suggesting a complex role for condensin 
in chromosome architecture (Hagstrom et al, 2002).  Similarly, the structural 
integrity of chicken chromosomes is lost upon conditional knockdown of SMC2, as 
is the localisation of non-histone proteins, such as topoisomerase II and INCENP in 
DT40 cells.  In these cells, loss of SMC2 results in delayed, but eventually 
apparently normal but non-functional chromosome condensation (Hudson et al, 
2003).  In mouse ES cells, an RNAi screen found that knockdown of SMC2 and 
SMC4 results in metaphase arrest and enlarged interphase nuclei, without any change 
in DNA content (Fazzio and Panning, 2010). 
Loss of condensin has also been shown to result in phenotypes that are unrelated 
to the cell cycle or chromatin condensation.  In Drosophila, Barren (CAP-H) 
colocalises with Polycomb and is necessary for Fab-7-regulated homeotic gene 
expression (Lupo et al, 2001).  Mice with a homozygous mutation in kleisin β (CAP-
H2) have defects in T lymphocyte development, such that circulating T-cell numbers 






thymocytes and their precursors are decreased.  These mice are otherwise fertile, 
viable and have no cell cycle defects (Gosling et al, 2007).  There is a strong 
enhancement of position effect variegation in Drosophila upon various condensin 
mutations, suggesting a role for condensins in interphase (Cobbe et al, 2006).  
In C. elegans, a condensin homologue is important for dosage compensation of 
the X-chromosome in the hermaphrodite.  The condensin in the DCC differs from 
normal C. elegans condensin by only one subunit, SMC4 is replaced with the 
specialised protein DPY-27.  DCC is proposed to condense both X-chromosomes 
together into higher order structures, which reduce transcription from the two copies 
to a similar level as that in the XO males (Csankovszki et al, 2009). 
Condensin-binding sites have been mapped in yeast and these colocalise with 
binding sites for the Scc2/Scc4 complex.  Mutation of scc2 or scc4 decreased 
condensin-chromatin association and resultant chromosome condensation, indicating 
that Scc2/Scc4 promotes binding of condensin to chromatin, though it is not 
essential.  A stable interaction between Scc2/Scc4 and condensin, however, could not 
be detected, so it is not impossible that Scc2/Scc4 is able to condense chromatin 
independently (D’Ambrosio et al, 2008). 
 
1.2.1.3 The SMC 5/6 complex 
The precise role of the SMC5/6 complex, the final member of the eukaryotic 
SMC family, is yet to be elucidated, though it appears to be involved in the DNA 
damage response, at double strand breaks, at recombination and replication forks and 
for the replication and stability of rDNA (De Piccoli et al, 2009).  Other than the two 
SMC proteins, SMC5 and SMC6, the SMC5/6 complex also contain six non-SMC 
elements, Nse1-6, in yeasts.  Nse1 has a RING finger motif and is suggested to be a 
ubiquitin ligase; Nse2 has a characteristic SUMO-ligase RING finger motif, which is 
able to sumolate some SMC5/6 complex subunits; Nse3 is a melanoma antigen 
encoding protein (MAGE), which are widely expressed in cancers (it is impossible to 
determine which of the 55 human MAGE proteins is orthologous to Nse3); the 
function of Nse4 is unknown; Nse5 and Nse6 form a heterodimer and interact with 
the hinge region of SMC5/6 (Figure 1.4; Duan et al, 2009).  SMC5/6 is known to be 
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related to the DNA damage response and mutants of the complex are radiosensitive, 
and it has a role in the segregation of repetitive chromosome regions, such as rDNA 
repeat regions (Losada and Hirano, 2005).  It is also required to dissolve DNA-
mediated sister chromatid linkages prior to mitosis (Bermúdez-López et al, 2010).  
Scc2 is necessary for the localisation of the SMC5/6 complex on undamaged 
chromosomes, however in G2/M the complex relocates to double strand breaks 
(DSBs) where SMC6 aids repair of collapsed replication forks; this relocation occurs 
independently of Scc2 (Lindroos  et al, 2006). 
 
1.2.1.4 Bacterial SMC complexes 
BsSMC is not essential for survival of B. subtilis, however mutants have defects 
in chromosome segregation and condensation, suggesting the complex is functionally 
homologous to condensin.  The bridge between the two head domains is made up of 
ScpA, similar to Rad21, and ScpB (Figure 1.4), which suggests that the complex is 
more structurally similar to cohesin.  The structural similarity of the bacterial SMC 
complex to cohesin, but functional similarity to condensin suggests that both 
eukaryotic complexes may have evolved from duplications of the bacterial complex 
(Strunnikov, 2006). 
Like BsSMC, the MukBEF complex in E. coli consists of a homodimer of an 
SMC protein, MukB, held in a ring by non-SMC subunits, MukE and MukF, which 
appear to be structurally homologous to ScpB and ScpA respectively.  Unlike other 
SMC protein dimers, the MukB homodimer does not have a hole in its hinge domain.  
It is thought that MukBEF is able to condense the bacterial chromosome through the 
detachment of MukB head domains from MukF, entrapping DNA within the ring.  
MukBEF is found to from foci, colocalising with the oriC of the E. coli chromosome 
and forming distinctive clusters at the ¼ and ¾ positions in the cells (Lim and Oh, 
2009). 
RecN is a bacterial double strand break repair protein.  Sequence analysis has 
identified it as related to the SMC proteins and biochemical analysis has found that 
homodimers of this protein bind duplex DNA, hydrolysing ATP.  RecN is shown to 
stimulate intermolecular ligation of DNA molecules in the presence of DNA ligase, 
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presumably by holding the two ends of the DNA together.  Little is known about its 
structure (Reyes et al, 2010). 
 
1.2.2 The discovery of the cohesin complex 
SMC1L1 was first identified in a screen in S. cerevisiae, which found that smc1
+/-
 
mutants had an elevated rate of minichromosome non-disjunction (Strunikov et al, 
1993).  Meiotic studies found that smc1
-
 haploid spores did not survive.  Linear 
chromosomes were then studied and non-disjunction, similar to that seen with the 
artificial minichromosomes, was again observed.  Whilst smc1 expression was 
observed throughout the cell cycle, budded smc1 mutant cells showed clumping of 
the DNA at the bud neck and did not divide.  Association of sister chromatids was 
one of the possible functions suggested for SMC1.  The name “cohesins” was coined 
in a yeast screen for proteins involved in holding the sister chromatids together.  
Mutants were identified that lost chromosomes at high frequency during proliferation 
at 25˚C, and that could separate sister chromatids in the absence of APC/C function 
(the anaphase promoting complex) at 37˚C.  The APC/C is a ubiquitin E3 ligase 
which marks numerous proteins for degradation to allow progression into mitosis, 
including cyclins and securin.  Four complementation groups of mutants were 
identified in the screen; smc1, smc3, scc1 (sister chromatid cohesion; the Rad21 
orthologue) and scc2 (the NIPBL orthologue).  Scc1 protein was most abundant and 
associated with chromosomes on entry into S-phase, but degraded during mitosis; 
this was dependant on the presence of Smc1 protein.  The cohesins, SMC1, SMC3 
and Scc1, were suggested to bind to sister chromatids as they replicate during S-
phase before synchronous cleavage of the complex at mitosis allowing separation.  
The cleavage of the cohesin complex at anaphase was thought to be dependant on 
APC/C, as it was found to be necessary for dissociation of Scc1 from chromatin 
(Michaelis et al, 1997).  Indeed, immunodepletion of SMC1 and SMC3 in Xenopus 
laevis results in normal nuclear envelope assembly and DNA replication but causes 
defects in the separation of sister chromatids in mitosis; these data reinforce the idea 
that these proteins have a role in cohesion (Losada et al, 1998).  Synchronous 
separation of the chromosomes occurs as a result of cleavage of the Rad21 subunit of 
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cohesin by separase, a cysteine protease related to caspases (Uhlmann et al, 2000).  
Separase is inhibited throughout the cell cycle by Securin, however at anaphase 
Securin is ubiquitinated and targeted for degradation by the APC/C complex (Cohen-
Fix et al, 1996).  This releases Separase, which cleaves all the cohesin complexes 
associated with the kinetochores.  Cohesin dissociates from the chromatids, the 
sisters are pulled to the opposite poles and the cell divides (Zou et al, 1999). 
The role of the cohesin loader, NIPBL, was first identified by studying its S. 
pombe homologue, Mis4.  Mis4 was initially identified as necessary for stable 
maintenance of minichromosomes in fission yeast, and mutations in this protein 
result in misegregation and premature separation of chromosomes.  Missegregation 
was found to be due to a much earlier event than mitosis itself, since viability was 
lost during S-phase (Furuya et al, 2008).  Later, the Mis4/NIPBL budding yeast 
homologue, Scc2, was found to complex with Scc4 (MAU-2 in humans) and 
mutation of either protein resulted in failure of cohesin complexes in binding DNA.  
Temperature sensitive mutants of scc2 suffered from precocious sister chromatid 
separation (PSCS) at the restrictive temperature, and the resultant drop in cell 
viability occurred at the time of DNA replication.  Loss of Scc2 at any later point in 
the cell cycle did not give a phenotype until the following cell cycle.  Cohesin 
complexes were found in scc2
-/-
 cells, but they were not able to associate with DNA, 
either at the centromeres or on the chromosome arms.  This suggested that the 
protein was only involved in the establishment of cohesion and not in cohesion itself 
(Ciosk et al, 2000).  Scc2/Mis4/NIPBL and Scc4/MAU-2 were dubbed “adherins” 
due to their role in cohesion, without being a member of the cohesin complex itself. 
 
1.2.3 Models of sister chromatid cohesion by cohesin 
Various models of cohesin structure and sister chromatid cohesion have been 
proposed (reviewed in Nasmyth and Haering, 2009).  Most are variations on two 
basic models, one where the SMC1L1 and SMC3 head regions bind to the DNA in 
various conformations, and the other where the cohesin complex forms a ring 
encircling the DNA (Figure 1.5).  Variations have been proposed for both of these 
basic models where cohesin acts as either a monomer or a dimer.  Rings models have 
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long been favoured as these demonstrate how cleavage of the complex can result in 
both dissociation from the DNA and destruction of the complex. 
Some in vitro evidence supports the encircling model (Figure 1.5A; Haering et 
al, 2008).  Working on S. cerevisiae proteins, the group covalently linked the cohesin 
ring together; SMC3 and SMC1 were linked together at the hinge region by mutating 
adjacent side chains in the two proteins to cysteines, and the same was done at the 
head region of SMC1 and the C-terminus of Scc1.  Upon incubation with 
dibromobimane (dBBr) or bis-malemidoethane, thiol linkages were formed between 
the cysteine residues of the proteins, holding the complex covalently together.  A 
covalent link was made between SMC3 and Scc1 by creating a TEV-fusion protein, 
genetically fusing the two proteins together with a TEV cleavage site in between 
them; this link could then be cleaved using TEV protease, opening up the cohesin 
ring.  The group had previously shown that cohesin complexes could dimerise 
circular minichromosomes (Ivanov and Nasmyth, 2007) and predicted that if cohesin 
held chromatids together by way of a ring structure, then minichromosome dimers 
held by a covalently closed ring would survive protein denaturation.  This was found 
to indeed be the case when minichromosome dimers held with their covalently 
closed rings were treated with SDS, demonstrating that cohesin can encircle the 
DNA.  These minichromosome dimers could be easily separated using TEV protease, 
showing that it is the ring structure that is necessary for dimerisation.  To determine 
if these dimers were held by a single cohesin ring, or by dimers of cohesin rings, the 
efficiency of cross-linking was estimated at 30%.  The efficiency of dimerisation was 
also found to be 30%, demonstrating that only a single ring of cohesin is needed to 
dimerise two minichromosomes.  Evidence from Ghosh et al (2010) supports this 
model in vivo in the case of the S. cerevisiae 2 micron plasmid.  This group used a 
fusion protein of Scc1 that contained a TEV cleavable element, and expressed this at 
an equal ratio to wildtype Scc1.  Cleavage of Scc1 would then result in a 1:1 ratio of 
2 micron plasmid dimers compared to separated dimers if the ring model were true, 
whilst any model requiring two cohesin rings would give a 1:3 ratio of dimers to 
separated dimers.  The ratio of cleaved to uncleaved dimers was around 1:1, 
suggesting that pairs of DNA strands are enclosed by a single cohesin ring.  Whilst 
this model is very convincing, we must consider the form that the chromatin takes in 
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this model; the cohesin ring is only 35nm in diameter, which would not be large 
enough to hold two 30nm chromatin fibres, so perhaps chromatin decondenses at 
regions of cohesin binding so that only the 10nm wide beads-on-a-string fibre 
interacts with cohesin. 
In contrast, Zhang et al (2008) have evidence suggesting that cohesin forms a 
handcuff structure, made up of two cohesin rings, each holding a single DNA strand, 
held together by SA1 or SA2 at the two Rad21 linkers (Figure 1.5A).  They show, by 
co-immunoprecipitation, a protein fragment assay and a yeast two-hybrid assay, that 
Rad21, SMC1L1 and SMC3 interact with themselves.  SA1 and SA2 do not interact 
with themselves or each other, however one of them is necessary for the other 
cohesin subunits to interact with themselves.  It is suggested that either SA1 or SA2, 
it does not matter which, holds the two cohesin rings together, holding the two 
Rad21 molecules in an antiparallel fashion.  Inhibition of both SA1 and SA2 results 
in loss of Rad21-Rad21 interaction and loss of cohesion.  This handcuff model would 
allow two 30nm fibres to be held together by one complex of two cohesin rings.  
They suggest that, at S-phase, single cohesin rings encircle the unreplicated DNA.  
On replication, cohesin rings can go to either DNA strand; pairs of cohesin rings on 
opposite strands are then tethered together by SA1 or SA2.  The handcuff model is 
not compatible with the evidence shown by Haering et al (2008), as dimers of 
cohesin would not survive protein denaturation, unless they were looped within each 
other like links in a chain. Also Haering et al (2008) do not covalently link Scc3 
(homologue to SA1/SA2) to their covalently closed cohesin complex, suggesting that 
Scc3 is not necessary for cohesion.  However it is possible that these two 
configurations both exist, but function under different circumstances, for example it 
is possible that the ring shape encircles pairs of sister chromatids at mitosis, whilst 
the handcuff shape holds together DNA loops for gene expression, or vice versa.   
 
1.2.4 The role of cohesin in the cell cycle 
During S-phase and G2, replicated sister chromatids remain tightly associated 
with one another.  At metaphase, the chromatids line up and the microtubule spindles 
connect the kinetochores of the sisters to the spindle poles.  The great tension on the 
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kinetochores as the spindles pull the chromatids from the opposite poles is necessary 
for the chromatids to line up perfectly, but is not sufficient to pull the two sisters 
apart until anaphase, when all the chromatids separate with flawless synchronicity.  
This synchronicity is achieved by cohesin (Nasmyth, 1999; Figure 1.6). 
 
1.2.4.1 Cohesin loads onto the chromatin in G1 
Cohesin is loaded onto DNA during G1, dependent upon Rad21 synthesis (Figure 
1.6).  Rad21 is synthesised in late G1, before it is degraded at the metaphase-
anaphase transition.  Rad21 is able to associate with chromosomes if it is synthesised 
after S-phase, however it fails to establish cohesion (Uhlmann and Nasmyth, 1998).  
Cohesin rings form and load onto the single chromatin strand in late G1.  Both SMC 
proteins have an ATP-binding motif at both their N and C termini, which come into 
contact in the head domain.  Mutagenesis of these binding motifs results in formation 
of the tripartite ring but this ring is not stable enough for cohesin function, which 
gives loss of viability due to lack of sister chromatid cohesion (Mishra et al, 2010).  
ATP binding is necessary for Rad21 association with both SMC1L1 and SMC3 but 
hydrolysis of ATP is not (Arumugam et al, 2003).  Loading of the complex onto 
DNA requires NIPBL and ATP hydrolysis.  Inactivation of the yeast NIPBL 
homologue, Scc2, results in a phenotype whereby the tripartite ring is able to form, 
but does not load onto chromosomes.  It is suggested that Scc2 acts by promoting 
ATP hydrolysis in the head domains of the SMC proteins, and this is necessary for 
the loading of cohesin onto chromosomes (Ciosk et al, 2000).  ATP hydrolysis is 
also the method by which NIPBL is thought to load condensin (D’Ambrosio et al, 
2008; Lindroos  et al, 2006).  When the MAU-2 orthologue, Scc4, is depleted, 
mitotic chromosomes completely lack cohesin, and as a result arrest in prometaphase 
with PSCS (Watrin et al; 2006; Seitan et al, 2006).   Fluorescence recovery after 
photobleaching (FRAP) studies in Drosophila suggest that Nipped-B converts 
cohesin into a stable, DNA encircling form, as depletion of Nipped-B reduces the 
amount of stable cohesin without reducing its residence time on DNA (Gause et al, 
2010).  In Xenopus egg extracts, the activity of NIPBL is shown to be dependent on 





































































































































































































inhibited by geminin, a replication inhibitor that ensures only one round of DNA 
replication takes place (Gillespie and Hirano, 2004; Takahashi et al, 2004). 
Cohesin binding at the centromeres is dependent on heterochromatin, but on the 
chromosome arms it is dependent on RSC (chromatin structure remodelling) in yeast.  
Loss of Swi6 (the S. pombe orthologue of heterochromatin protein 1 (HP1)) results in 
a complete loss of cohesin at the centromeres, however this does not alter 
localisation of cohesin on the chromosome arms (Bernard et al, 2001).  Vertebrate 
NIPBL has a canonical PxVxL domain that is known to interact with HP1 proteins, 
and pull-down experiments show that this interaction does indeed take place in 
humans, and is abrogated upon mutation of the PxVxL motif (Lechner et al, 2005).  
However in human cells, RNAi of all three HP1 proteins (α,β and γ) does not affect 
bulk binding of cohesin to chromatin in interphase, or the pericentromeric 
accumulation of cohesin in metaphase (Serrano et al, 2009). 
At the chromosome arms, the RSC nucleosome remodelling complex is found to 
be necessary for association with cohesin.  In S. cerevisiae RSC cycles on and off the 
chromosome arms in a manner that precedes Scc1 (Rad21) binding.  Rsc mutants 
exhibit cohesion defects, with chromosome arms coming apart prematurely but the 
centromeres remaining intact, as Scc1 is not able to associate with the chromosome 
arms, but is still able to associate with the centromeres (Huang et al, 2004).  In 
human cells, Rad21 interacts directly with SNF2h, a member of the SWI/SNF 
nucleosome remodelling protein family, in a chromatin remodelling complex.  This 
interaction is necessary for cohesin activity, as mutation of the ATPase activity of 
SNF2h results in disruption of Rad21 association with chromatin.  5-Aza-cytidine 
treatment of cells, which depletes DNA methyltransferases (DNMTs) thus 
decreasing the level of DNA methylation, increases Rad21 and SNF2h association 
with Alu repeats, suggesting that cohesin preferentially binds to unmethylated DNA 
(Liu et al, 2010).  A correlation has also been observed between cohesin binding and 
acetylation of histones H3 and H4 (Hakimi et al, 2002). 
After loading, the localisation of cohesin along the genome varies between 
species, as determined by ChIP.  In yeasts, cohesin binds approximately every 10kb 
along the genome with narrow peaks of cohesin binding.  Cohesin relocalises to sites 
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of convergent transcription and in S. pombe cohesin has been shown to promote 
transcription termination at these sites (Legronne et al, 2004; Gullerova and 
Proudfoot, 2008).  However Kogut et al (2009) disagree and suggest that in budding 
yeast, cohesin is localised to sites of Scc2/Scc4 binding and not relocated by 
transcription.  During G1 Scc2/Scc4 has a poor affinity for cohesin binding sites, but 
as the cell approaches S phase, its affinity increases.  Scc2/Scc4 then remains bound 
to the chromosomes and cohesin associates with it, and is loaded onto the chromatin. 
In Drosophila, cohesin remains closely associated with Nipped-B.  In contrast to 
yeasts, RNA polymerase is not able to relocate cohesin, and there is actually a strong 
correlation between the localisation of RNA polymerase and cohesin.  Indeed 
cohesin binding varies depending on the expression status of a particular gene 
(Misulovin et al, 2008).  Cohesin loading sites coincide with the origin recognition 
complex (ORC) in Drosophila, probably to allow establishment of cohesin 
immediately upon DNA replication (MacAlpine et al, 2010). 
In mammals cohesin sites, determined by ChIP, colocalise with CTCF, the 
insulator protein (this will be discussed further in Section 1.5; Wendt et al, 2008; 
Stedman et al, 2008; Parelho et al, 2008).  However other studies have found that 
cohesin colocalises with Mediator and tissue specific transcription factors, 
exclusively of CTCF (Section 1.6; Kernohan et al, 2010; Schmidt et al, 2010; Kagey 
et al, 2010). 
 
1.2.4.2 Sister chromatid cohesion is established at S-phase 
Replication of DNA in the presence of cohesin is not sufficient to establish 
cohesion.  If Haering et al (2008)’s ring model is correct, then it is possible that as 
DNA replicates, DNA polymerase moves through the cohesin ring, which was 
loaded during G1, and the two DNA strands remain inside the ring (Figure 1.5A).  If 
the handcuff model proposed by Zhang et al (2008) is correct, then upon replication, 
cohesin bound to unreplicated DNA is shared between the two strands, then SA1 or 
SA2 is required to tether pairs of rings together (Figure 1.5B).  Since we know that 
establishment of cohesion is an active process, I think it is likely that the second 
model is correct. 
23
In yeasts, establishment of cohesion requires the acetyltransferase Eco/Ctf7, 
which acetylates two lysine residues in the ATPase head domain of Smc3 (Figure 
1.6).  Mutation of these lysine residues leads to cohesion defects and lethality in 
yeasts.  In humans there are two homologues of Eco1, ESCO1 and ESCO2; both are 
necessary for cohesion.  Although paralogous, the two proteins are not functionally 
homolgous, as only ESCO1 has been shown to acetylate SMC3 at the same residues 
as it is in yeast, and only ESCO2 has been implicated in RBS (Peters et al, 2008; 
Zhang et al, 2008).  Mutation within the acetyltransferase domain has been shown to 
be sufficient to cause RBS (Gordillo et al, 2008).  It is thought that Eco1 mediated 
acetylation is necessary to stabilise the interaction between cohesin and sister 
chromatids; indeed FRAP studies show that during G1 cohesin interacts with 
chromatin in a dynamic manner, but during G2 this interaction is stable (Gerlich et al, 
2006).  Acetylation of cohesin has also been shown to affect the speed of the 
replication fork, with replication progressing more quickly when cohesin is 
acetylated (Terret et al, 2009)  
In S. cerevisiae Pds5, Scc3 (SA1/SA2 in humans) and Rad61 (the orthologue of 
Wapl) inhibit the establishment if cohesion until counteracted by Eco1 acetylation 
(Rowland et al, 2009), and in S. pombe pds5 knockouts are able to establish cohesion 
in the absence of Eco1.  In Drosophila, FRAP has shown that reduction of Pds5 
increases the amount of cohesin that is stably bound to chromosomes (Gause et al, 
2010).  However Pds5 is also necessary to maintain cohesion during G2, and there is 
synthetic lethality when it is mutated with either mis4 or Scc2 (Tanaka et al, 2001).  
In vertebrates there are two homologues of Pds5, PDS5A and PDS5B, which appear 
to be functionally redundant in sister chromatid cohesion (Peters et al, 2008).  
PDS5A and Wapl inhibit progression of the replication fork: in their absence DNA 
replicates quickly even if cohesin is unacetylated (Terret et al, 2009). 
In vertebrates, Sororin is also necessary for cohesion; it binds to chromosomes 
upon the onset of DNA replication and is required both during and after S-phase, its 
knockdown leading to loss of sister chromatid cohesion.  It associates with chromatin 
in prophase and a small amount remains on the chromosomes until metaphase, 
similar to the pattern of cohesin binding.  Perhaps Sororin binding is also needed to 
stabilise cohesin’s interaction with sister chromatids (Schmitz et al, 2007). 
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1.2.4.3 Cohesin dissociates from the chromosome arms at prophase 
In vertebrates, much of the cohesin along the chromosome arms dissociates at 
prophase (Losada et al, 1998) and the cohesin left is bound only at centromeres; this 
removal is independent of Separase (Waizenegger et al, 2000; Figure 1.6).  
Fluorescence loss in photobleaching (FLIP) shows that in interphase the residence 
time of cohesin on chromatin is very short, ~60-90s, however that which associates 
with the centromere remains about 50% longer (McNairn and Gerton, 2009).  
Presumably, having cohesin bound only around a concentrated space better ensures 
synchronous cleavage of all the cohesin in the cell (Nasmyth and Schleiffer, 2004).  
Removal of cohesin from the chromosome arms is dependant on Wapl and Polo-like 
kinase 1 (Plk1) in vertebrates, which complex with Rad21 and SA1, and separately 
with PDS5A (Peters et al, 2008; Kueng et al, 2006).  Loss of Wapl results in an 
increase in cohesin stably bound to chromosomes, shown by FRAP (Gause et al, 
2010).  Cohesin is removed by phosphorylation of SA2 by Plk1; although SA1 and 
Rad21 are also phosphorylated, this is not necessary for dissociation.  Wapl is then 
required to dissociate cohesin from chromatin, perhaps controlling the ATPase 
activity of SMC1L1 and SMC3 such that cohesin rings are able to open.  The 
centromere is protected from the activity of Plk1 and Wapl by Shugoshin (Sgo1), 
which is recruited to the centromeres by Bub1.  It is thought to revert Plk1 
phosphorylation of cohesin by recruiting protein phosphatase 2A (PP2A) to the 
centromere (Peters et al, 2008).  In Xenopus egg extracts Wapl and Pds5 directly 
modulate changes in the conformation of cohesin, such that it can dissociate from 
chromatin during prophase, acting antagonistically with Sgo1 (Shintomi and Hirano, 
2009). 
 
1.2.4.4 Cohesin is cleaved by separase at metaphase 
Synchronous separation of the chromosomes occurs as a result of cleavage of the 
Rad21 subunit of cohesin by separase.  Separase is inhibited throughout the cell 
cycle by Securin, however at anaphase Securin is ubiquitinated and targeted for 
degradation by the APC/C complex.  This releases Separase, which cleaves all the 
cohesin complexes associated with the kinetochores.  Cohesin dissociates from the 
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chromatids, the sisters are pulled to the opposite poles and the cell divides (Zou et al, 
1999).  NIPBL dissociates from the chromatin upon entry into mitosis in a process 
that is dependant on Cdc2 in Xenopus (Gillespie and Hirano, 2004).  SMC1 and 
SMC3 interact with the spindle pole bodies at mitosis.  SMC1 also interacts with 
Rae1 (RNA export 1), and RNA binding protein that interacts with the cytoskeleton, 
and phosphorylation of SMC1 is necessary for this interaction.  SMC1 is localised to 
the centre of the microtubule aster at anaphase, thought to be recruited by Rae1.  
Transfection with SMC1 and SMC3 resulted in formation of multipolar spindles, 
however a phenotype for depletion of either protein is not available (Wong and 
Blobel, 2008). 
 
1.2.5 Cohesion in cohesinopathies 
Based on cohesin’s role in mitosis, one would predict that mutation in the 
complex, or proteins associated with it, would lead to aneuploidy giving a 
predisposition towards cancer in humans.  Also cohesin is found to be necessary for 
the function of DNA-damage checkpoints in G2/M and intra-S, by activating the 
checkpoint kinase, Chk2 and recruiting the checkpoint mediator 53BP1, 
independently of its cell cycle function (Watrin and Peters, 2009).  Loss of this 
checkpoint would lead to increased DNA damage which could also contribute to 
carcinogeneis.  However, there are no reports of increased infant or childhood 
cancers in CdLS, nor is cancer reported in adults with CdLS (Kline et al, 2007).  In 
fact, the phenotype of CdLS is more indicative of development defects caused by 
altered gene expression.  It has also been shown that all of the cohesin proteins are 
expressed in non-dividing differentiated cells that have no need for cohesin’s cell 
cycle function (Wendt et al, 2008). 
The NIPBL orthologue in fission yeast, mis4, was identified in screens looking 
for mutants defective in mitosis.  Inactivation of mis4 in G1 resulted in cell death due 
to missegregation of chromosomes as a result of PSCS (Furuya et al, 1998).  In S. 
cerevisiae mutation of scc2 also causes PSCS, as cohesin complexes form normally 
but fail to associate with chromosomes (Ciosk et al, 2000).  Homozygous mutations 
of Nipped-B in Drosophila also result in PSCS in 60% of the second-instar brain 
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cells studied, but there is not an increased level of aneuploidy in Nipped-B mutant 
cells (Rollins et al, 2004).  However all of these studies used homozygous mutations, 
so cannot be extrapolated to CdLS, where mutations are heterozygous. 
PSCS has also been reported in human CdLS cells, however its occurrence is 
extremely variable in both the controls in those experiments and CdLS cells and as 
such it is not considered to be a useful diagnostic tool for CdLS (Kaur et al, 2005; 
Castronovo et al, 2009).  However in CdLS cell lines there is no evidence of 
aneuploidy (Pritchard, E., Master’s Thesis 2007). 
One might speculate that the intact checkpoints of these cells are able to initiate 
apoptosis as soon as PSCS is detected, resulting in the reduced growth rate observed 
both in CdLS patients and when culturing CdLS cells.  This is consistent with work 
in zebrafish and human cells lines that demonstrates that knockdown of SMC results 
in apoptosis (Ghiselli, 2006).  Attempts to generate mammalian cells deficient in 
SMC3 had resulted in apoptosis when SMC3 protein levels fell below a critical level.  
Morpholino-mediated knockdown of SMC3 in zebrafish resulted in necrosis at the 
five-somite stage, due to apoptosis, as seen with Acridine Orange staining.  This was 
shown to be p53 dependant, as components of the p53 apoptosis pathway are 
upregulated in these embryos.  Human cell lines lacking p53 were depleted of SMC3 
by siRNA and were found not to enter apoptosis, whilst in p53 positive cells, the 
same siRNA treatment triggered significant apoptosis (Ghiselli, 2006). 
CdLS mutations in the hinge domains of SMC1L1 and SMC3 affect the DNA 
binding properties of the two encoded proteins.  Hinge dimers of these mutated 
proteins bind DNA with higher affinity than wildtype proteins.  SMC1L1 and SMC3 
mutated CdLS cell lines also display genomic instability (though no PSCS) and 
sensitivity to ionising radiation (Revenkova et al, 2009). 
RBS cells show severe cohesion defects.  There is PSCS, particularly at regions 
of repetitive gene sequences (German, 1979), often resulting in aneuploidy (Jabs et 
al, 1991).  The splitting of sister chromatids in RBS lead them to be described as 
“railroad” chromosomes due to their resemblance to the two lines of railway tracks 
(Van den Berg and Francke, 1993).  However there are no defects in homologous 
recombination or in sister chromatid exchanges in RBS (Van der Lelig et al, 2009). 
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Models of the cohesinopathies have been made in budding yeast, introducing 
mutations known in CdLS and RBS into the endogenous proteins, Scc2, Smc1 and 
Eco1.  Unlike complete Scc2 and Smc1 knockouts, the CdLS mutations do not result 
in cohesion defects, similar to their human counterparts.  The RBS mutations in Eco1 
give railroad chromosomes, just as those seen in humans (Gard et al, 2009). 
These data lead us to believe that cohesin has a role outside of sister chromatid 
cohesion.  This idea is supported by evidence that in post-mitotic cells where there 
are no sister chromatids to cohese, mutation of cohesin still results in aberrant gene 
expression phenotypes (Pauli et al, 2008). 
 
1.3 Cohesin is involved in gene expression 
The clinical phenotypes of CdLS strongly suggest that cohesin has a role in gene 
expression.  Indeed, evidence in many species suggests that this is the case, 
particularly by way of interaction with enhancers (Schaaf et al, 2009; Kawauchi et 
al, 2009; Liu et al, 2009; Skibbens et al, 2010; Kagey et al, 2010).  Enhancers are 
regions of DNA, some distance away from a gene promoter, either in the 3’ or 5’ 
direction, that are able to interact with the promoter to give increased transcription.  
This mechanism by which enhancers work is not currently known, but they are 
speculated to either physically interact with the promoter, or proteins may be 
recruited to the enhancer then translocate along the DNA (reviewed in Sipos and 
Gyurkovics, 2005). 
 
1.3.1 Yeast gene expression 
Cohesin localises to sites of transcription termination in both budding and fission 
yeast.  This localisation is not just a passive result of relocalisation by RNA 
polymerase, as previously hypothesised, but instead cohesin is specifically recruited 
to this location where it plays a functional role in preventing readthrough 
transcription (Legronne et al, 2004).  Readthrough transcription often occurs where 
genes on opposite strands converge, resulting in the formation of dsRNA during G1.  
It is found that these regions transiently take on heterochromatic features during G1, 
28
including trimethylation of H3K9 and association with Swi6, which also interacts 
with Scc3 and Scc2 (SA1/SA2 and NIPBL in humans).  Formation of transient 
heterochromatin is dependant in the RNAi pathway, as deletion of the components of 
the Dicer or RITS (RNA-induced transcriptional silencing) complex resulted in loss 
of formation of this transient heterochromatin.  In G2, following recruitment to these 
regions by Swi6, cohesin then binds to these regions and transcription is terminated 
immediately following the end of the open reading frame (ORF).  Cohesin does not 
localise to these regions unless both the converging genes are transcriptionally active 
(Gullerova and Proudfoot, 2008). 
A role has been reported for Smc1 and Smc3 at boundary elements that separate 
heterochromatin and euchromatin in S. cerevisiae (Biswas et al, 2009; Donze et al, 
1999).  It was demonstrated that certain mutations of smc1 and smc3 abrogate the 
insulator activities of boundary elements flanking the repressed mating type HMR 
locus, resulting in the spreading of heterochromatin outside of HMR (Donze et al, 
1999).  Similarly at the ribosomal DNA locus, RDN1, the same smc1 mutation 
resulted in loss of barrier activity.  Interestingly, there is a known cohesin binding 
site, CARL2 (cohesin associated region L2) in that region but the RDN1 barrier does 
not coincide with it, rather occurring 2.4kb to the left of it (Biswas et al, 2009). 
Genome-wide microarray expression data in S. cerevisiae suggests that even 
transient loss of Scc1 results in changes in transcription of a large number of genes 
(Skibbens et al, 2010).  Many genes were up- or downregulated by culturing 
temperature sensitive Scc1 mutants at the restrictive temperature, of which 29 were 
found to be reproducible, with expression changes greater than 1.5-fold.  The genes 
affected appeared to be of related function, such as those involved in a single 
biosynthetic pathway, for cell wall metabolism or for 18S rRNA maturation.  Also, 
misregulated genes were often in close proximity to one another, with 20% of the 
genes studied adjacent to another gene.  However, the genes misregulated were not 
found to share any common motifs that might suggest where cohesin binds, nor did 




1.3.2 Nipped-B, cohesin and regulation of gene expression in 
Drosophila 
In animals, it appears that cohesin may be involved in the interactions between 
promoters and enhancers.  The first evidence for this was found by Rollins et al 
(1999), who showed that mutation of Nipped-B increases the severity of gypsy 
insertion.  Later evidence has also suggested that cohesin may be involved in axon 
pruning (Schuldiner et al, 2008; Pauli et al, 2008) and may also function as a 
chromatin remodeller (Hallson et al, 2008).  The expression of many genes is altered 
in Nipped-B and Rad21 knockdown cells of Drosophila (Schaaf et al, 2009). 
Cut is an enhancer driven gene in Drosophila, expressed in the wing tip; cut 
mutations result in disruption of the wing tips, with phenotypes varying in severity 
from small gaps in the margin to loss of most of the bristles from the entire wing 
margin.  Mutations within an enhancer region 80kb upstream of the cut promoter 
result in wing tip defects (Jack et al, 1991).  Gypsy is a Drosophila retrotransposon 
that is able to act as an insulator – when it is inserted between an enhancer and 
promoter it is able to interfere with transcription from that promoter (Parkhurst and 
Corces, 1986).  Gypsy insertion in between cut and its enhancer can result in wing 
nicks, such as are seen in either cut or cut enhancer mutation (Jack et al, 1991). 
Nipped-B (the fly NIPBL orthologue) mutation has been shown to increase the 
effect of a gypsy insertion. The wing tips of Nipped-B mutants, which had a gypsy 
insertion in between cut and its enhancer, were more severely affected than those 
with a gypsy insertion but wildtype Nipped-B.  This is certainly a synthetic 
phenotype, as Nipped-B mutants without the gypsy insertion did not have this same 
phenotype (Rollins et al, 1999).  Mutation of PDS5 gives a similar effect to Nipped-
B on the cut wing phenotype (Dorsett et al, 2005). Heterozygous loss-of-function 
mutations in Nipped-B, similar to the NIPBL mutations found in CdLS, were able to 
dominantly increase the severity of various cut and Ubx mutations and reduce the 
expression of wildtype cut (Gause et al, 2008).  In cultured cells, a cohesin binding 
site was found between a remote wing margin enhancer and the cut promoter.  
Reducing the expression of Smc1 or pds5 mutation in these cells, or knockdown Scc3 
or Rad21 in the wing tip gave an increase in cut expression, whilst Nipped-B 
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knockdown inhibits cut expression (Rollins et al, 2004; Dorsett et al, 2005).  These 
data prompted the hypothesis that Nipped-B may regulate binding of cohesin at this 
region, where cohesin blocks interactions between the promoter and enhancer 
(Rollins et al, 2004).     
A role has also been found for cohesins in Drosophila neurons.  Deletion of smc1 
by piggyback insertion in neuroblast clones results in a loss of axon pruning.  At 
puparium formation in larval development, axons normally extend into the dorsal 
and medial lobes, but 18 hours later they are pruned back.  In smc1 mutants these 
axons are not pruned, and these unpruned axons persist into the adult brain.  This 
phenotype can be rescued by post-mitotically expressing smc1 in neurons 
(Schuldiner et al, 2008).  TEV protease cleavage of Rad21 gives a similar phenotype 
with loss of axon pruning after puparium formation, persisting into the adult brain 
(Pauli et al, 2008).  Similarly, MAU-2 is involved in axon migration guidance in 
Caenorhabditis elegans (Seitan et al, 2006; Watrin et al, 2006).  It is clear that 
cohesin proteins are necessary for post-mitotic axon organisation in invertebrates, but 
whether this is due to altered long-range chromatin interaction is unknown. 
However Drosophila cohesins may also be able to regulate gene expression 
through chromatin remodelling complexes (Hallson et al, 2008).  The Drosophila 
Rad21 protein is encoded by the locus verthandi (vtd), mutations of which are 
associated with trithorax group (trxG) phenotypes.  TrxG genes are implicated in 
transcriptional regulation, and can regulate homeotic genes, often acting 
antagonistically to polycomb group (PcG) genes which maintain the repressed state 
of homeotic genes.  One of the genes regulated by vtd is hedgehog (hh), and vtd 
suppresses dominant gain-of-function alleles of hh.  Like vtd mutations, Nipped-B 
mutations dominantly suppress PcG and gain of function hh mutations, however 
mutations in Pds5 and Smc1 had no effect on PcG or hh.  Vtd displayed a role in 
sister chromatid cohesion as mutations were able to disrupt the cell cycle due to 
failure of initiation and maintenance of sister chromatid cohesion. 
In flies, cohesin colocalises with active genes and RNA polymerase II, and away 
from PcG-mediated silencing marks (Misulovin et al, 2008).  Genome wide 
expression microarray data shows that genes with altered expression after RNAi of 
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Nipped-B or Rad21 are localised close to cohesin binding sites, and that there is a 
linear correlation between genes affected by RNAi of Rad21 and those affected by 
RNAi of Nipped-B (Schaaf et al, 2009).  There are some genes, such as the invected-
engrailed complex, and the Enhancer of split complex (E(spl)), that appear to be 
hypersensitive to loss of either Nipped-B or cohesin.  Weak knockdown of either 
Nipped-B or Rad21 gives a small decrease in expression of these genes, whilst strong 
knockdown gives up to a 130-fold increase in expression.  These genes occur in 
regions that have both PcG and TrxG marks in pluripotent cells; it is thought that 
these genes may be maintained in this bivalent state, with control by cohesin, so that 
they can be switched on or off very quickly.  Indeed this may suggest why Rad21 has 
been identified as a TrxG protein (Hallson et al, 2008).  However invected-engrailed 
and E(spl) are by no means typical, the effect of cohesin knockdown on the 
expression of most genes is less than two-fold (Schaaf et al, 2009).  Perhaps cohesin 
controls enhancer and promoter interactions at most locations, but also plays a role in 
maintenance of bivalent state at other regions. 
 
1.3.3 The effect of cohesin and NIPBL on vertebrate gene 
expression 
In the zebrafish Danio rerio, both cohesin and condensin genes, including smc1a, 
rad21, pds5b, smc3, smc2 and smc4, are expressed in proliferating regions during 
development, overlapping with expression of pcna.  However, cohesin genes are 
additionally expressed in non-proliferating regions in the mature zebrafish brain and 
eye, suggesting that as in invertebrates, cohesin has a role in zebrafish other than in 
sister chromatid cohesion (Mönnich et al, 2009). 
Like in Drosophila, decreased cohesin function in zebrafish results in altered 
gene expression, such as that of runx transcription factors, which determine the fate 
of many cell lineages, with roles in both proliferation and differentiation.  An N-
ethyl-N-nitrosourea (ENU) mutagenesis screen in zebrafish, searching for regulators 
of runx1 expression by in situ hybridisation, identified a nonsense mutation in 
Rad21.  Runx1 expression was lost in the early embryo with the Rad21 mutation, and 
embryos suffered from a developmental delay due to a block in mitosis.  Other 
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haematopoietic transcription factors were expressed normally in the mutants, but 
markers of differentiated blood cells were lost at later stages.  Runx1 expression was 
also lost following morpholino knockdown of smc3.  To determine if this effect was 
directly due to loss of cohesin or loss of progression through the cell cycle, embryos 
were treated with two cell cycle inhibitors, hydroxyurea (HU) and aphidicolin, 
neither of which replicated the effect of loss of cohesin (Horsfield et al, 2007). 
Morpholino knockdown of MAU-2 or NIPBL in Xenopus tropicalis results in 
phenotypes that are reminiscent of CdLS.  Both knockdowns result in delayed 
development from gastrula stages, and at later stages the embryos exhibit defects in 
neural, somite, head, eye and tail development, with truncated anterior-posterior axes 
and ventralisation (Seitan et al, 2006; Watrin et al, 2006). 
 
1.3.4 Cohesinopathy mutations affect gene expression in 
mammals 
The first CdLS-like mouse model was generated by mutation of pds5b (Zhang et 
al, 2007; Zhang et al, 2009; Figure 1.7).  It gives a phenotype very similar to that 
found in CdLS, including small size, short limbs, small head and facial 
dysmorphisms resembling those of CdLS patients.  Alcian Blue staining revealed the 
upper limbs had shortened bones, but not the limb truncations or fused digits seen in 
severe cases of CdLS, however such major limb abnormalities were also not 
observed in the human family with PDS5B mutation (Zhang et al, 2009).  The mice 
showed complete secondary palate cleft and non-meeting palatal bones.  Atrial septal 
defects, ventricular septal defects and atrioventricular canal defects were observed in 
the mutant mice, as with CdLS patients.  No obvious cohesion defects, such as 
PSCS, were observed in these mice. 
A NIPBL knockout mouse model of CdLS has more recently been generated 
(Kawauchi et al, 2009; Figure 1.7).  A gene-trap in the intron between exon 1 and 
exon 2 (this intron occurs prior to the transcription start site) gave complete loss of 
protein expression from that allele, however Nipbl protein levels were only reduced 
by 25-30%, similar to in humans with CdLS, suggesting that Nipbl may be 
autoregulatory.  Heterozygotes showed 75% lethality at birth, with a third of the 
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remaining mice failing to thrive and dying in the first two weeks; surviving mice 
display “catch-up” growth but never achieve wildtype size.  The adults show similar 
phenotypes to CdLS patients, including abnormal faces, cardiac defects, eye 
abnormalities, microcephaly, repetitive behaviours, seizures, auditory defects and 
shortened long-bones.  No severe limb abnormalities, similar to those seen in CdLS, 
were observed, nor were cohesion defects observed.  Microarray analyses were 
performed on RNA extracted from mouse embryonic fibroblasts (MEFs) generated 
from NIPBL
+/-
 embryos, and from the brains of these mice.  978 genes in the brain 
extracts, and 81 genes in the MEFs were subtly misregulated in the CdLS models 
compared to wildtype.  97% of genes misexpressed showed less than a 1.5-fold 
change in expression, and less than 0.4% of genes had more than a two-fold change.  
However it is difficult to determine which genes are directly affected by the 
mutation, and which were knock-on effects of other gene expression changes.   These 
data confirm the idea that CdLS is caused by subtle changes in expression of a large 
number of genes, rather than gross effects on a small number of genes.  This is 
consistent with cohesin acting as a general regulator of gene expression, rather than 
as a specific transcription factor (Kawauchi et al, 2009). 
Some of the misregulated genes identified in mice may give us clues to the 
phenotypes we observe in humans in CdLS, and in the mechanism by which cohesin 
can affect gene expression.  Identified in the brain study were some genes that are 
known to be associated with autism and epilepsy, suggesting a possible mechanism 
for the mental retardation, behaviour and seizure phenotypes observed in CdLS 
patients.  Studies in the MEFs identified genes involved in adipogenic differentiation, 
and the MEFs were shown to be unable to differentiate into adipocytes, which may 
suggest a mechanism for the lean-ness of both CdLS patients and NIPBL
+/-
 mice.  
Decreases in expression of all 22 genes of the protocadherin beta (Pcdhb) cluster on 
mouse chromosome 18 suggest that effects of Nipbl on gene expression are position 
specific.  The strongest effects occurred in the genes at the 3’ end of the cluster, 
which are already more highly expressed than those at the 5’ end.  These data 
suggest that there is an enhancer at the 3’ end of the cluster, which depends upon 
Nipbl (Kawauchi et al, 2009). 
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Wildtype     Nipbl gene-trap heterozygote
Wildtype      Pds5b-/-
A
B
Figure 1.7 - Mouse models of CdLS.
A, A newborn mouse heterozygous for a Nipbl gene trap, 
compared to a wildtype littermate (from Kawauchi et al, 2009).  
B, A newborn mouse homozygous for a Pds5b mutation, 
compared to a widtype litter mate (from Zhang et al, 2007) 
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Knockdown of Nipbl and SMC1 by siRNA in mouse embryonic stem (ES) cells 
also gives subtle misregulation of a large number of genes (Kagey et al, 2010).  
Genes downregulated in ES cells include the pluripotency associated transcription 
factors that give ES cells their “stem-ness”, and genes upregulated include 
developmental transcription factors, suggesting that loss of Nipbl and SMC1 can 
cause early differentiation of stem cells. 
Expression microarray studies have been carried out on mRNA from NIPBL 
mutated patient lymphoblastoid cells lines to determine the genes misexpressed in 
CdLS (Liu et al, 2009).  mRNA from 16 CdLS probands compared to 17 healthy 
controls identified between 339 and 1,501 nonredundant genes, depending on the 
stringency of scoring, that were consistently differentially expressed in CdLS.  As 
with the mouse model (Kawauchi et al, 2009), the changes in expression level for all 
genes are low; the mean fold change in either direction is 1.42, and the maximum 
upregulation 4.61-fold and the maximum downregulation 3.38-fold.  A ten-gene 
expression profile for CdLS was created which was then tested on 80 probands, of 
which 62 suffered from CdLS of varying severity, mutations in different genes and 
unknown mutations, and four suffered from other congential multisystem disorders, 
to determine if it could predict incidence of CdLS based on gene expression alone.  
This algorithm correctly identified all CdLS patients, excluded all healthy cohorts 
and three of the four cohorts with other genetic disorders, however it did classify 
RBS as CdLS, demonstrating how similar the expression profile of RBS is to CdLS.  
The degree of misexpression of genes reflected the severity of the patients’ 
conditions, which severely affected individuals showing high levels of gene 
misexpression, and milder cases with less misexpression.  The microarray data was 
compared to Chromatin Immunoprecipitation (ChIP) for Rad21, and it was found 
that cohesin is often found bound close to the 5’ UTR and the transcription start site 
of genes misregulated in CdLS, often overlapping with CTCF sites.  Indeed, most 
misexpressed genes had a cohesin binding site within 1kb of the transcription start 
site.  In CdLS, binding of Rad21 at these sites was reduced, suggesting a causal link 
between cohesin binding and gene expression (Liu et al, 2009).  
A genome wide methylation study in CdLS cell lines found that there is little 
alteration in DNA methylation patterns on autosomal chromosomes in CdLS 
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compared to wildtype, demonstrating that DNA methylation is not the mechanism by 
which cohesin modulates autosomal gene expression in humans.  However there are 
changes in DNA methylation on the X-chromosomes in CdLS cell lines: in females 
the methylation of hypomethylated sites on the X-chromosome is increased however 
in males it is decreased (Liu et al, 2010). 
Gene expression may also be affected by the interaction of NIPBL with histone 
deacetylase 1 (HDAC1) and HDAC3.  NIPBL is able repress promoter activity of a 
reporter gene by recruiting HDACs to the promoter, while CdLS mutations in NIPBL 
reduce this repression, similar to the effect seen in chemical inhibition of HDACs 
(Jahnke et al, 2008). 
 
1.4 Chromatin and higher order structures 
One possible mechanism for the general low-level effect of CdLS on gene 
expression may be through nuclear organisation and chromatin looping mediated by 
cohesin. 
 
1.4.1 Gene activation and chromatin organisation 
Chromosomes occupy specific regions of the nucleus, called chromosome 
territories (CTs).  The position of a chromosome in the nucleus is dependant on its 
size, with smaller chromosomes found towards the interior and larger ones towards 
the periphery, and on its gene density, with gene-rich chromosomes towards the 
interior and gene poor ones at the periphery.  Gene-rich regions and active genes tend 
to be located on the surface of the CT, whilst heterochromatic, gene-poor and 
inactive regions will be located within the CT (Boyle et al, 2001; Cremer and 
Cremer, 2001; Lieberman-Aiden et al, 2009; Mahy et al, 2002a). 
Whilst the transcriptional machinery is able to access all chromatin in the 
nucleus, including that buried in the middle of CTs, this machinery is often 
concentrated within distinct foci, called transcription factories.  Transcription 
factories contain aggregates of Rpol II and remain intact, even in the absence of 
transcription (Mitchell and Fraser, 2008; Sutherland and Bickmore, 2009).  Some 
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genes actively loop out of their CTs upon activation.  This looping has been 
demonstrated by FISH to occur at active gene-rich regions on chromosome 11 (Mahy 
et al, 2002b), across the HoxB locus during development (Chambeyron and 
Bickmore, 2004), at HoxD upon cell differentiation (Morey et al, 2007) and at the 
major histocompatibility complex upon activation (Volpi et al, 2000).  It is through 
this looping that active chromatin hubs (ACHs) may form that become associated 
with transcription factories (Mitchell and Fraser, 2008), however looping out itself is 
not sufficient for gene activation, and transcription factories are able to associate 
with genes within the CT (Morey et al, 2009; Heard and Bickmore, 2007). 
 
1.4.2 Chromatin folding follows a random-walk giant-loop model 
At a higher order, chromatin is thought to follow a random-walk giant-loop 
model (Figure 1.8).  Chromatin may be tethered together at intervals, forming “giant 
loops” but within those loops it follows a random walk.  A random walk model 
assumes that chromatin behaves as a freely jointed polymer chain.  This model was 
developed using data from FISH experiments.  Pairs of fluorescently labelled probes 
with separations from 100kb to 4Mb were hybridised to the nuclei of fixed G0/G1 
cells then imaged.  The physical distance between the two probes was measured and 
compared to the known genomic distance between them.  It was found that with 
separations between 100kb and 1.5Mb, the relationship between mean-squared 
physical distance and genomic distance was linear and conformed to a random walk 
model (Figure 1.8B; van den Engh et al, 1992; Mateos-Langerak et al, 2009). 
Under a random walk model of polymer folding, the distance along the polymer 
will be directly proportional to the mean of the physical distance squared, taking into 
account greater variances as the distances get larger.  A set of physical distance 
measurements of one known polymer distance will conform to a Rayleigh 
distribution.  A Rayleigh distribution is similar to a Normal distribution, however the 
variable can extend to infinity (or a sufficiently high number that it appears to extend 
to infinity) to the right of the distribution, and has a discrete cut-off, often zero, to the 
left of the distribution (Figure 1.8C).  The result of this is that the distribution of data 








































Figure 1.8 – The random-walk giant-loop model of chromatin compaction.
A, an illustration of the random-walk giant-loop model; in this model of polymer folding, the 
polymer follows a random walk up to a certain distance, then is tethered together.  In the case of 
chromatin this is thought to be via proteins (blue circles) every ~1.5Mb (from Mateos-Langerak et 
al, 2009).  B, an illustration of a FISH probed nucleus testing the random-walk giant-loop model.  
Probes of known distance apart are hybridised to interphase nuclei and the physical distance 
between them is measured.  C, an illustration of a Rayleigh distribution obtained from a FISH 
experiment. D, an illustration of the relationship between genomic distance and mean interphase 
distance squared.  These values are directly proportional up to the genomic distance of ~1.5Mb 
(van den Engh et al, 1992).
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the data will always be slightly higher than the median (median: mean ~ 0.9) and the 
standard deviation will always be around half the value of the mean (van den Engh et 
al, 1992). 
Above 1.5Mb, there must be some other chromatin organisation happening.  A 
giant-loop model is the simplest way to model this, and it is predicted that the giant 
loops in chromatin are around 2-3Mb and secured by proteins (Sachs et al, 1995).  It 
is found that physical distances increase then locally decrease with increasing 
separation, with this transition occurring at ~2Mb, supporting the model of giant 
loops (Yokota et al, 2005). 
The level of chromatin compaction varies across the genome, and can be 
observed by FISH.  G-band, gene poor regions are more compact than R-band.  
Whilst both follow a random walk, the slope comparing mean square physical 
distance to genomic distance is less steep in G-bands than in R-bands.  This is 
consistent with the higher compaction of chromatin from G-bands that can be 
observed with sucrose sedimentation, as the more compact G-bands move more 
quickly through a sucrose gradient than the less dense R-bands (Yokota et al, 1997; 
Gilbert et al, 2004).  Indeed G-bands and R-bands form distinct compartments within 
the nucleus that are not able to interact with one another.  Within those 
compartments, there are many more interactions between G-band chromatin, than 
between R-band chromatin (Lieberman-Aiden et al, 2009). 
FISH assays can also detect changes in chromatin compaction at particular loci.  
It is found that chromatin compaction can vary as genes are differentially expressed 
during development (Chambeyron et al, 2004), and as a result of a mutation in a 
component of chromatin (Eskeland et al, 2010). 
Another method of studying chromatin compaction is Chromosome conformation 
capture (3C), which detects the occurance of interactions between genomic regions 
(Figure 1.9).  Cross-links between interactions are created using formaldehyde, then 
the genome is digested with a restriction enzyme.  The formaldehyde links remain 
leaving pairs of short DNA fragments joined by cross-links.  An intramolecular 
ligation step is carried out and the cross-links reversed.  The ligation product can be 
detected by qPCR (quantitative polymerase chain reaction) using one primer from 
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each region of interest.  This method is able to measure the interaction between two 
known regions (Dekker et al, 2002).  To find the interaction between one known 
region and any number of unknown genomic regions 4C (circular 3C or 3C on chip) 
is used.  Both ends of the fragment are ligated together giving a circular molecule.  
Using a pair of primers, one from each end of the region of interest, any regions that 
interact with the region of interest can be identified by sequencing, or by hybridising 
to microarrays (Zhao et al, 2006; Simonis et al, 2006).  5C (3C carbon copy) can also 
be used to study interactions on a large scale.  A 3C library of cross-linked fragments 
is created and these are annealed to multiplex oligonucleotides.  Oligonucleotides are 
designed to anneal to all predicted junctions, and can be either forward or reverse 
oligonucleotides.  Forward oligonucleotides anneal to the 3’ end of restriction 
fragments on the sense strand and have a T7 tag at the 5’ end, and reverse 
oligonucleotides anneal to the 3’ end of restriction fragments on the antisense strand 
and have a T3 tag at the 3’ end.  These then give a continuous oligonucleotide across 
the ligated ends which can then be ligated together using Taq ligase, forming a 
carbon copy library.   The carbon copy library is then amplified using primers 
corresponding to the T7 and T3 tags, and can then be sequenced or studied by DNA 
microarrays (Dostie et al, 2006).  3C can be combined with ChIP analysis in 6C 
(combined 3C-ChIP-cloning), whereby 3C is carried out to the point of ligation, the 
ChIP is used to enrich for fragments containing the protein of interest.  The 
fragments are then purified, reverse cross-linked and cloned into a vector.  These can 
be screened by digestion, and fragments of interest are identified then verified by 
both 3C and ChIP (Tiwari et al, 2008). 
More recently a technique called Hi-C has revealed the long-range interactions 
that occur across the genome.  As with 3C, interacting DNA is crosslinked by 
formaldehyde, and cut up with restriction enzymes, however before ligation, ends are 
marked with biotin, which allows pull-down of the ligated fragments using 
Streptavidin beads.  High throughput sequencing can then be used to identify 
interacting regions.  Hi-C of the entire human genome confirmed the existence of 
CTs, the two distinct chromatin states of G and R bands and a hierarchical folding 
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Figure 1.9 - 3C to Hi-C.
The C methods involve formaldehyde crosslinking of regions of the genome that interact with one 
another, cutting of the genome using restriction enzymes, ligation of those regions, then identification 
of those regions by various methods (Dekker et al, 2002; Zhao et al, 2006; Simonis et al, 2006; 
Dostie et al, 2006; Tiwari et al, 2008; Lieberman-Aiden et al, 2009).
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1.5 Cohesin colocalises with CTCF on mammalian 
genome arrays 
ChIP has been used to study cohesin localisation on mammalian genomes.  Three 
independent studies found that cohesin colocalises with CCCTC-binding factor 
(CTCF) on chromosome arms (Figure 1.10; Wendt et al, 2008; Parelho et al, 2008; 
Stedman et al, 2008).  It was found that 88% of CTCF sites are associated with 
cohesin and 79% of all cohesin binding sites can also associate with CTCF (Parelho 
et al, 2008).  Moreover CTCF is shown to interact with SA1 (Rubio et al, 2008).  
The consensus binding sites of CTCF and cohesin are identical: 
CCACCAG(G/A)(G/T)GGC, the only difference being the probabilities of certain 
nucleotides (Parelho et al, 2008; Wendt et al, 2008) and this motif is essential for 
both CTCF and cohesin binding (Stedman et al, 2008).  CTCF is essential for 
cohesin positioning, which is lost upon CTCF knockdown.   There is conflicting 
evidence as to whether cohesin is required for positioning CTCF, as Wendt et al 
(2008) showed that knockdown of Rad21 gave loss of CTCF positioning but Parelho 
et al (2008) demonstrated that it did not. 
The interaction of cohesin and CTCF at the Kaposi’s Sarcoma-associated 
Herpes-Virus (KSHV) has been more intensely studied through the cell cycle 
(Stedman et al, 2008; Kang and Lieberman, 2009).  In lymphocytes CTCF and 
cohesin associate with cohesin/CTCF binding sites within the virus episome in its 
latent phase.  From G0/G1 to M phase, both CTCF and the cohesin proteins 
accumulate, preferentially interacting with one another and with the KSHV binding 
sites in G1-S, dissociating in G2-M.  An increase in KSHV latency associated  
transcripts from G1 to G2 is correlated with the accumulation of CTCF and cohesin 
proteins, and this cell cycle control is lost on mutation of CTCF binding sites in 
KSHV, suggesting that cohesin/CTCF binding is necessary for cell cycle regulation 
of gene expression.  Association of cohesin with CTCF is able to repress the KSHV 
lytic genes, maintaining the latent state (Kang and Lieberman, 2009).  It is unclear 
whether this cell-cycle dependant role of cohesin/CTCF in gene expression is linked 














































































































































1.5.1 CTCF is an insulator protein 
The previously discussed gypsy transposon is a well-known insulator in 
Drosophila (Parkhurst and Corces, 1986; Section 1.3.2).  Like Suppressor of Hairy 
wing (Su(Hw)), the protein that interacts with the gypsy transposon in flies, CTCF is 
a Zinc-finger protein.  CTCF is one of the best characterised insulator proteins in 
vertebrates.   
The function of CTCF has been determined at the H19/Igf2 imprinted region 
(Figure 1.11).  H19 and Igf2 are expressed in a parent-of-origin specific manner due 
to imprinting.  The locus consists of the Igf2 gene, followed by the imprinting control 
region (ICR), which contains a CTCF binding site and two differentially methylated 
regions (DMRs), the H19 gene and an enhancer.  Igf2 has a stronger promoter than 
H19, however both can only be transcribed with help from the long-range enhancer 
located downstream of H19.  On the maternal allele CTCF binds to the ICR, 
blocking the enhancer from activating Igf2, allowing transcription of H19.  On the 
paternal allele the ICR is methylated, preventing CTCF binding and allowing Igf2 to 
interact with the enhancer.  The strength of Igf2’s promoter is such that only Igf2 is 
activated, and not H19 (Kurukuti et al, 2006).   
CTCF activity has been suggested to be dependant on a post-translational 
poly(ADP-ribosyl)ation.  Insulator function is sensitive to inhibition of poly(ADP-
ribose) polymerase by 3-aminobenzamide, in both CTCF reporter assays and at the 
H19/Igf2 locus (Yu et al, 2004). 
Much of the current data suggests that enhancers and insulators, such as CTCF, 
function through chromatin looping (Kurukuti et al, 2006; Splinter et al, 2006), 
however other possibilities have been proposed.  For example it is suggested that 
CTCF may bind to particular nuclear sub-compartments via the nuclear matrix (Dunn 
et al, 2003).  Co-purification of CTCF identified many proteins, including a strong 
interaction with nucleophosmin, a molecular chaperone involved in the transport of 
ribosome subunits and histones from the cytoplasm to the nucleus and nucleolus.  
ChIP showed that nucleophosmin binds to known CTCF insulated sites.  A reporter 
transgene containing CTCF binding sites was studied using FISH and found to 
localise preferentially to the nucleolus.  These findings suggest that CTCF may act 
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IGF2 ICR H19 Enhancer




Figure 1.11– The imprinted H19/Igf2 region.
On the paternal allele the ICR is methylated, blocking CTCF binding so that the enhancer 
can interact with the stronger promoter on Igf2, causing Igf2 transcription.  On the maternal 
allele, CTCF binds to the unmethylated ICR, and the enhancer is only able to interact with 
the closer H19 promoter and only H19 is transcribed.  The lollipops indicate the DMRs 
within the ICR: filled circles indicate methyled CpGs and open circles indicate unmethylated 
CpGs.
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by tethering DNA to the nucleolus (Yustufzai et al, 2004), however given how 
regularly CTCF binds along the genome, and that most of the genome is excluded 
from the nucleolus, this in unlikely to be the case in vivo.  The epigenetic state of 
associated chromatin can also be altered by CTCF binding.  CTCF associates with 
chromodomain helicase DNA-binding protein 8 (CHD8) at CTCF binding sites; 
RNAi knockdown of CHD8 results in loss of Igf2/H19 imprinting and alteration of 
CpG methylation and histone acetylation adjacent to CTCF binding sites (Ishihara et 
al, 2006).  The absence of CTCF binding can alter histone modifications at the β-
globin locus, giving increased di-meH3K9 and di-meH3K27 (Splinter et al, 2006) 
and can lead to methylation of the ICR on the maternal allele of the H19/Igf2 locus 
(Kurukuti et al, 2006). 
A subpopulation of CTCF is suggested to associate with the largest subunit of 
RNA polymerase II (Rpol II), via the C-terminus of CTCF.  They colocalise in the 
nucleus, through the genome, possibly associating at ACHs.  The association of Rpol 
II with the ACH of the H19/Igf2 locus was found to be dependant on CTCF binding 
site function in the ICR (Chernukhin et al, 2007).  If this interaction does indeed take 
place, it can only be very transient, as ChIP data does not suggest colocalisation of 
CTCF and Rpol II on the genome (Barski et al, 2007). 
By comparing CTCF/cohesin sites in B-cells and T-cells, it was seen that cohesin 
and CTCF associate with DNA in a cell type specific manner, which is dependant on 
DNA methylation, suggesting a mechanism by which CTCF/cohesin localisation 
might be maintained through cell division (Hadjur et al, 2009). 
Genome wide CTCF binding sites have been mapped by ChIP (Barski et al, 
2007; Kim et al, 2007; Bao et al, 2007).  Taking every “hit” from ChIP experiments, 
CTCF binds to the genome at an average density of 906 sites/Mb.  However when a 
binding threshold is applied to this data, the average density is 4.6 sites/Mb (Wendt 
et al, 2008). 
It is likely that cohesin and CTCF act together to alter aspects of higher order 
chromatin structure to mediate insulation and enhancement in non-replicating cells.  
CTCF may create interactions between binding sites and cohesin may hold them in 
place.  For example the ACH seen at the H19/Igf2 and β-globin loci may begin as 
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interactions between CTCF and its binding sites, but they are secured by cohesin 
rings (Nativio et al, 2009). 
 
1.5.2 Cohesin and CTCF contribute to DNA looping 
The effect of cohesin and CTCT on chromatin looping has been studied at a 
number of locations in the human genome using 3C.  In the older data, CTCF is 
shown to be necessary for DNA looping and correct gene expression (Zhao et al, 
2006; Kurukuti et al, 2006; Splinter et al, 2006), whereas more recent studies include 
data identifying cohesin as equally necessary for looping and gene expression 
(Nativio et al, 2006; Degner et al, 2009; Hadjur et al, 2009; Mishiro et al, 2009; Hou 
et al, 2010).  
CTCF has been implicated in looping at the β-globin locus, which contains a 
number of developmentally regulated erythroid specific genes under control of an 
upstream locus control region (LCR).  Three CTCF binding sites have been 
identified upstream of the locus (HS-85, HS-62 and HS-5) and one downstream 
(3’HS-1) in mice.  3C data shows that in erythroid cells, the four CTCF binding sites 
spatially interact with the LCR and the active β-globin genes (Splinter et al, 2006).  
Further data suggests that long-range interactions at this region are cell type specific, 
with a more densely clustered organisation in the absence of β-globin activity.  These 
interactions are dependant on both cohesin and CTCF.  Knockdown of CTCF in 
erythroid cells, which express globin genes, leads to acquisition of repressive histone 
marks at the β-globin locus and loss of β-globin expression (Hou et al, 2010).  It 
seems counterintuitive that loss of CTCF should lead to loss of gene expression, 
when non-expressing cells have denser CTCF interactions, but it is possible that 
repressive histone marks act as a fail-safe, to knockdown gene expression in the 
absence of the repressive CTCF loops. 
More recent data is available for the imprinted H19/Igf2 region (Figure 1.11).  
RNAi experiments show that both CTCF and cohesin are essential for imprinting at 
the H19/Igf2 locus (Figure 1.11; Wendt et al, 2008; Parelho et al, 2008; Stedman et 
al, 2008; Nativio et al, 2009).  There are 114 intra- and interchromosomal 
interactions with the maternal H19/Igf2 ICR (Zhao et al, 2006).  A 3C study found 
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that at the imprinted H19/Igf2 region, there was no enhancer access to the maternal 
Igf2 allele, whilst the paternal allele was accessible, however there was no difference 
in enhancer access to the H19 promoter between the methylated paternal allele and 
the unmethylated maternal allele.  The ICR remains in close physical proximity to all 
regions in the Igf2/H19 domain on both the maternal and paternal allele, except the 
paternal DMR1, maternal P1/DMR2 and paternal MAR3, which are excluded from 
the ICR.  This gives evidence of higher order looping that may regulate gene 
expression at this locus, bringing the active genes into an ACH containing regulatory 
elements and genes (Kurukuti et al, 2006).  Another 3C study confirmed the 
existence of these interactions and found that looping at the H19/Igf2 region was 
abrogated upon Rad21 knockdown by RNAi.  This effect was tested in cells 
synchronised in G1 and in G2 by double thymidine block, demonstrating that cohesin 
mediates looping independently of the cell cycle (Nativio et al, 2009).  It is 
interesting to note that, even though these studies indicate that cohesin appears to be 
essential for imprinting, no imprinting phenotypes, such as those seen in Beckwith-
Wiedemann syndrome, are observed in CdLS.  This questions the biological role of 
cohesin, or at least NIPBL, in imprinting in vivo. 
At the Interferon γ (IFNγ) locus, CTCF and cohesin are also shown to mediate 
loops that affect gene expression.  In Th2 cells, which do not express IFNγ, far less 
cohesin and CTCF binds at the three cohesin/CTCF binding sites, upstream, 
intragenic and downstream of the IFNγ locus, compared to Th1 cells, which do 
express IFNγ.  A 3C assay shows that in Th1 cells, but not in Th2, these three 
binding sites interact with one another, and these interactions are abrogated on RNAi 
knockdown of CTCF or Rad21.  Knockdown of CTCF results in loss of cohesin 
localisation at these sites, whilst CTCF localisation was retained after Rad21 
knockdown, however there was decreased IFNγ expression.  These data suggest that 
in Th1 cells, CTCF localised cohesin to these sites, forming loops which are required 
for optimal expression of IFNγ (Hadjur et al, 2009). 
Similarly, CTCF and cohesin binding sites were identified at the apolipoprotein 
(APO) gene cluster, which contains genes essential for the metabolism and 
redistribution of lipids and lipoproteins.  Like the IFNγ locus, the APO cluster has 
three CTCF binding sites, which also bind cohesin.  3C found that these sites are able 
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to interact with one another, and that these interactions are dependant on CTCF and 
cohesin.  Knockdown of CTCF or cohesin also reduced the transcription of APOC3 
and increased the transcription of APOA1 and the surrounding genes.  It is thought 
that CTCF and cohesin hold the APO cluster in a loop conformation that facilitates 
transcription of APOC3, but suppresses transcription of APOA1 (Mishiro et al, 
2009).  
Cohesin and CTCF have been shown to have a role in genome rearrangement at 
the Igh locus, which encodes the heavy chain of antibodies, and the Igκ and Igλ loci, 
which encode the two forms of the light chain of antibodies.  All of these loci 
undergo genomic recombination, giving the many variants of antibodies that are 
necessary for the acquired immune response.  At Igκ and Igλ, a significant 
contraction occurs at the appropriate time for genome rearrangement in pro-B cells, 
and this correlates to stage specific recruitment of cohesin and CTCF to the loci.  
While this is a different effect to the gene expression role at other loci, there is no 
reason to consider that the same mechanism, of looping mediated by CTCF and 
cohesin, is not responsible for this contraction (Degner et al, 2009).  However, no 
immune deficiencies have been observed in CdLS patients. 
It is reasonable to consider that the specific interactions that have been studied at 
the β-globin locus, the imprinted H19/Igf2 region, the IFNγ locus and the APO gene 
cluster and the Igh, Igκ and Igλ loci are representative of other regions of the 
genome.  Throughout the genome interactions such as this may be speculated to take 
place, and in CdLS even a minor disruption of these interactions may give the 
general low-level dysregulation of gene expression that is observed in this disease 
(Liu et al, 2009). 
 
1.5.3 CTCF and cohesin can regulate gene expression by 
insulation 
CTCF and cohesin have also been found to colocalise at intragenic chromatin 
boundaries (Gomes and Espinosa, 2010).  The PUMA (p53 upregulated modulator of 
apoptosis) locus, which orchestrates programmed cell death upon upregulation by 
p53, is found to constituently produce a 6kb unprocessed non-coding transcript in the 
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absence of p53, which presumably represses PUMA expression.  The 6kb locus that 
this RNA is transcribed from is marked by active histone marks including H3K4me3 
and H3K9Ac, and is flanked by repressive H3K9me3 marks.  CTCF and cohesin 
binding is also found across the 6kb locus and in the absence of CTCF, PUMA 
expression is increased and the chromatin marks on this region are lost.  It is 
considered that CTCF and cohesin somehow maintain the chromatin state of this 
region, giving the continual expression of the 6kb transcript, required to repress 
PUMA. 
 
1.6 Cohesin and NIPBL associate with transcription 
factors without CTCF 
Evidence also suggests that cohesin and NIPBL can affect gene expression 
independently of CTCF.  Cohesin and NIPBL have been shown to associate with 
transcription factors and components of the transcription machinery in a variety of 
tissues to regulate gene expression via chromatin looping (Kernohan et al, 2010; 
Schmidt et al, 2010; Kagey et al, 2010). 
At the H19/Igf2 and Gtl2/Dlk1 loci, ATRX (α-Thallassaemia mental retardation 
X-linked) and MeCP2 (methyl CpG binding protein 2) are shown to be necessary for 
silencing of imprinted genes (Kernohan et al, 2010; Cunningham et al, 2010).  In 
post-mitotic cells in the mouse brain, ATRX and MeCP2 are found to co-
immunoprecipitate with SMC1 and SMC3, and both are found to colocalise with 
cohesin at the H19/Igf2 locus.  At this locus, ATRX and MeCP2 associate not with 
the methylated paternal ICR, but with the unmethylated CTCF/cohesin-bound 
maternal ICR.  At the Gtl2/Dlk1 locus, ATRX and MeCP2 localised adjacent to 
CTCF/cohesin sites.  Like H19, Gtl2 is maternally expressed as CTCF binds to the 
DMR, and Dlk1, like Igf2, is expressed from the paternal allele where the DMR is 
methylated.  The interaction of these proteins in silencing imprinted genes may 
explain the small overlap in mental retardation phenotypes between α-Thallassaemia 
mental retardation X-linked (caused by mutation of ATRX), Rett syndrome (caused 
by mutation of MeCP2) and CdLS. 
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A ChIP-seq study in breast and liver cancer cells found that where cohesin binds 
in the absence of CTCF, it binds instead with a tissue specific global regulator 
(Schmidt et al, 2010).  Many oestrogen regulated genes in MCF-7 breast cancer cells 
bound to both cohesin and oestrogen receptor alpha (ER), but not CTCF, and these 
regions are enriched for interchromosomal loop anchors.  Knockdown of cohesin 
prevented re-entry into the cell cycle when cells were stimulated with oestrogen, 
however it is not clear if this is due to loss of sister chromatid cohesion or a problem 
with oestrogen stimulated gene expression.  Although this gene regulation by cohesin 
is independent of CTCF, it appears to occur by a similar mechanism, by tethering 
loops of DNA together that may have been created by another protein, in this case 
ER.  Similarly, in liver cancer cells, cohesin was found to associate with the liver-
specific transcription factors, HNF4A and CEBPA, at different genomic locations.   
Most recently, genome wide studies in mouse ES cells have found that cohesin 
and Nipbl associate with the Mediator complex (Figure 1.12; Kagey et al, 2010).  
Mediator is a global regulator of transcription that interacts with RpolII.  The 
complex is 1.2MDa and has 26 subunits, which change in structure and composition 
depending upon the context of the promoter.  It is this versatility that is thought to 
allow Mediator to regulate gene expression in such a global and yet tissue-specific 
manner (Taatjes, 2010).  Mediator, Nipbl and cohesin were shown to co-precipitate 
and co-localise at enhancers and promoters, promoting the formation of loops 
between enhancers and promoters, as shown by 3C.  These interactions were specific 
to ES cells, and associated with ES-cell specific genes.  Mediator did not associate 
with all cohesin binding sites, and its association was mutually exclusive with CTCF 
binding.  Interestingly Nipbl only associated with Mediator-cohesin binding sites, 
and not with CTCF-cohesin binding sites suggesting that Mediator-cohesin mediated 
looping is a far more significant contributor to CdLS than CTCF-cohesin mediated 
looping.  Mediator and cohesin co-occupied different sets of promoters in ES cells 
and MEFs, unlike cohesin and CTCF, which co-occupied the same sites in both cell 
lines, suggesting that Mediator and cohesin regulate expression of tissue specific 
genes, whereas CTCF and cohesin regulate more housekeeping genes. 
These data, taken together, suggest that CTCF may colocalise with cohesin on 
chromatin to regulate expression of some genes.  However Mediator and cohesin, 
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Figure 1.12 - Mediator, cohesin and Nipbl colocalise on mouse chromatin to 
regulate chromosome topology. 
Data showing the interaction of Mediator, coheisn and Nipbl at the Nanog locus in 
mouse ES cells (from Kagey et al, 2010).  A schematic showing the Nanog locus is 
shown at the top with ChIP-seq data showing the binding of Med12, Smc1a and Nipbl in 
ES cells and MEFs (shown in reads per million with the y axis floor set to 0.5 reads per 
million).  The site of restrictions enzymes is shown below, with a 3C graph at the bottom 
(error bars represent the standard error of the average of 3 independent PCR 
reactions).  The genomic coordinates are build NCBI36/mm8.
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interacting with tissue specific transcription factors, may regulate certain tissue 
specific genes. 
 
1.7 The effect of cohesinopathies on chromatin 
conformation 
1.7.1 Yeast cohesinopathy models have defects in chromatin 
conformation 
Models of the cohesinopathies have been made in budding yeast, introducing 
CdLS and RBS associated mutations into the endogenous cohesin proteins, Scc2, 
Smc1 and Eco1.  Nuclear organisation was studied in these mutants (Gard et al, 
2009).  The morphology of the nucleolus of the CdLS and RBS mutants was altered.  
In yeast, the telomeres and centromeres are tethered to the nuclear periphery, and 
some genes are able to relocate within the nucleus upon activation.  In the CdLS 
mutants neither the centromere nor telomere localisation was affected, however in 
the RBS mutants telomeres clustering was lost. 
The GAL2 gene is normally localised close to the nucleolus, as it is genomically 
close to the rDNA, but moves to the nuclear periphery upon activation, still 
remaining close to the nucleolus.  GAL2 also contains a cohesin binding site that 
alters upon activation.  In the cohesinopathy mutants, GAL2 loses its colocalisation 
with the nucleolus, and when induced it is massively overexpressed.  General 
chromatin compaction was also measured in these yeast models by introducing pairs 
of LacO operators into the genome, a known distance apart.  These could then be 
visualised in live cells by introducing LacI repressor fused with GFP, and the 
distance between pairs determined as a measure of chromatin compaction.  It was 
found that in CdLS and RBS models chromatin tended to be less condensed than 
wildtype. 
The tRNA genes (transcribed by Rpol III) cluster near the nucleolus in yeast, and 
can silence neighbouring Rpol II transcribed genes, known as tRNA gene-mediated 
(tgm) silencing.  The CdLS and RBS mutations alleviated tgm-silencing of an 
adjacent gene, and FISH demonstrated that in the cohesinopathy mutants, the tRNA 
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genes did not cluster by the nucleolus.  It is known that condensin mutants also 
disrupt tRNA gene localisation and alleviate tgm-silencing, and both CdLS and RBS 
mutations disrupted condensin loading, so it is unclear whether this is a direct or 
indirect effect.  However while it is unsurprising that mutation of Scc2, which also 
loads condensin, affected condensin binding, it is interesting that Eco1 mutation also 
affected condensin. 
 
1.7.2 Possible mechanisms for altered chromatin conformation 
in cohesinopathies 
A yeast two-hybrid experiment showed that NIPBL interacts with HDAC1 and 
HDAC3, and that NIPBL is able to recruit the HDACs to a reporter construct.  This 
effect was abrogated with CdLS mutations of NIPBL, and with treatment by the 
histone deacetylase inhibitor TSA.  Histone acetylation was also shown to be 
increased in NIPBL mutants (Jahnke et al, 2008).  It is known that histone 
modifications are able to affect the condensation of chromatin, and acetylation of 
H4-K16 results in the decompaction of chromatin (Tse et al, 1998; Carruthers and 
Hansen, 2000; Tóth et al, 2004; Shogren-Knaak et al, 2006; Robinson et al, 2008).  
However, as the link has, so far, only been shown between NIPBL and HDACs, this 
does not explain any changes in chromatin condensation in SMC1L1 or ESCO2 
mutants, as observed in yeast RBS and CdLS models (Gard et al, 2009). 
NIPBL does not only load cohesin, but, in S. cerevisiae, Scc2 also loads 
condensin, which is involved in compacting the chromatin prior to metaphase 
(D’Ambrosio et al, 2008).  One could hypothesise that condensin may also compact 
chromatin throughout the cell cycle, however there is not yet any evidence to suggest 
this.  
There is plenty of evidence to suggest that cohesin and CTCF may work together 
to mediate intra-chromosomal interactions (Wendt et al, 2008; Hadjur et al, 2009; 
Parelho et al, 2008; Stedman et al, 2008; Degner et al, 2009; Nativio et al, 2009; 
Mishiro et al, 2009), and that cohesin may work with other transcription factors 
including Mediator in the same way (Kagey et al, 2010; Schmidt et al, 2010).  Loss 
of these tightly mediated loops may result in a general disorganisation of chromatin, 
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In this thesis I have set out to explore the behaviour of chromatin in CdLS by 
analysing its compaction using the FISH assay.  I have begun to analyse the role of 
the different proteins involved in this compaction, including CTCF, NIPBL and 
cohesin itself using RNAi.  I have also considered the differing effects between 
different species and cell lines. 
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2  Materials and Methods 
 
2.1 Reagents, stock solutions and buffers  
Acetate buffer: 5M potassium acetate and 11.5% glacial acetic acid in dH2O. 
Antibiotics: Stock solutions of antibiotics were made up at 1000 X.  
Chloramphenicol was made up to 25mg/ml in ethanol (EtOH). 
Citrate buffer: A 1l stock was made up by dissolving 85.5g sucrose and 
11.76g of trisodium citrate in 800ml dH2O with 50ml DMSO, adjusted to pH 7.6 
with 2-3 drops of concentrated HCl.  This was made up to 1l with dH2O and could be 
stored at 4°C for up to 2 years. 
Cold lysis buffer: 0.2N NaOH with 1% SDS in dH2O, made fresh for each use. 
Diethylpyrocarbonate (DEPC) treated water: dH2O is treated with 0.1% (w/v) 
DEPC for 1 hour at 37°C then autoclaved.  
DNase I Buffer: Supplied as a 10 X buffer, made up of 100mM Tris-HCl pH 
7.5, 25mM MgCl2 and 5mM CaCl2, from Ambion. 
Elutriation buffer: PBS with 1% FCS, 0.3mM EDTA and 0.1% glucose. 
FACS Solution A: 20μg/ml Trypsin Type IX-S (T0303, Sigma) in Stock Solution 
pH 7.6, stored at -20°C. 
FACS Solution B: 0.5mg/ml Trypsin Inhibitor (T9253, Sigma) and 0.1mg/ml 
RNAse A (R4875, Sigma) in Stock Solution pH 7.6, stored at -20°C. 
FACS Solution C: 416μg/ml Propidium Iodide (81845, Sigma) and 1mg/ml 
spermine tetrahydrochloride (S2876, Sigma) in Stock Solution pH 7.6, stored at -
20°C. 
FACS Stock Solution: Dissolve 1g/l Trisodium Citrate, 60.5mg/l Tris Base, 
522mg/l Spermine Tetrahydrochloride and 0.1% Igepal (v/v) in dH2O adjusted to pH 
7.6. 
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GTE buffer: 50mM glucose, 25mM Tris-HCl pH 8.0 and 10mM EDTA pH 8.0 in 
dH2O.  Just prior to use, 2ml of buffer was aliquoted and a pinch of lyzozyme 
(Sigma) added. 
Hybridisation mix: 50% deionised formamide, 10% dextran sulphate and 1% 
Tween 20 in 2 X SSC, made fresh each time. 
Luria-Bertani (LB) Agar: 10g of tryptone, 5g of yeast extract, 10g of NaCl and 
15g agar was added to 1 litre of dH2O.  NaOH was added to bring the solution to pH 
7.0.  The solution was then autoclaved.  Prepared by technical services at the MRC 
Human Genetics Unit. 
Luria-Bertani (LB) Broth: 10g of tryptone, 5g of yeast extract and 10g of NaCl 
was added to 1 litre of dH2O.  NaOH was added to bring the solution to pH 7.0.  The 
solution was then autoclaved.  Prepared by technical services at the MRC Human 
Genetics Unit. 
MAA: Methanol and acetic acid in a ratio of 3:1, prepared fresh each time. 
Nick Translation Salts: 0.5M Tris pH 7.5, 0.1M MgSO4, 1mM DTT and 
0.5mg/ml BSA fraction V (Sigma), prepared by Shelagh Boyle. 
Orange G loading buffer: 5 X loading buffer was made up of 10% (w/v) sucrose 
and 0.1% (w/v) Orange G in dH2O. 
PCR buffer: 200mM Tris-HCl (pH 8.4) and 500mM KCl in dH2O, prepared by 
Invitrogen. 
Phenol-chloroform: Phenol:chloroform:isoamyl alcohol 25:24:1 was obtained from 
Sigma. 
Phosphate Buffered Saline (PBS): Made up of 10mM phosphate, 137mM NaCl 
and 27mM KCl.  Prepared from tablets purchased from Unipath by technical services 
at the MRC Human Genetics Unit. 
SDS loading buffer: Was prepared as a 4 X stock solution of 250mM tris HCL (pH 
6.5), 8% sodium dodecyl sulphate (w/v), 20% β-mercaptoethanol (v/v), 40% glycerol 
(v/v) and 0.1% bromophenol blue (w/v). 
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SDS-PAGE running buffer: 25mM Tris base, 250mM glycine (pH 8.3) and 0.1% 
sodium dodecyl sulphate (w/v) was prepared as a 5 X stock. 
SiRNA buffer: 60mM KCl, 6mM HEPES pH 7.5 and 0.2mM MgCl2 treated 
with 0.1% (w/v) DEPC for 1 hour at 37°C then autoclaved.  
SSC: 3M NaCl and 0.3M tri-sodium citrate at pH 7.4.  Prepared as a 20 X stock by 
technical services at the MRC Human Genetics Unit.  
SuperScript™ II First Strand Buffer: 5 X buffer 250mM Tris-HCl, 375mM 
KCl and 15mM MgCl2.  Supplied by Invitrogen. 
TE: 10mM Tris HCL (pH 7.6) and 0.1mM EDTA in dH2O and autoclaved.  
Prepared by technical services at the MRC Human Genetics Unit. 
Tris Acetate Buffer, TAE: A 50 X stock solution was made up of 2M Tris acetate 
and 50mM EDTA (pH 8.0), prepared by dissolving 242g Tris Base in 750ml dH2O, 
adding 57.1ml glacial acid acid and 100ml of 0.5M EDTA (pH 8.0) and making up 
to 1l with dH2O.  Prepared by technical services at the MRC Human Genetics Unit.   
Tris Borate Buffer, TBE: A 20 X stock solution was made up of 90mM Tris 
Borate, 2mM EDTA (pH 8.0), prepared by dissolving 108g of Tris Base and 27.5g of 
Boric Acid in 400ml of 0.5M EDTA and 960ml dH2O.  Prepared by technical 
services at the MRC Human Genetics Unit. 
Tris Buffered Saline (TBS): 150mM NaCl and 10mM Tris-HCl (pH7.4) in dH2O. 
TRIZOL® Reagent: TRIZOL® reagent contains phenol and guanidine 
isothiocyanate and is supplied by Invitrogen. 
Western Transfer Buffer: 25mM Tris-Glycine (pH 8.3) with 20% methanol (v/v) 
was made fresh before each use by dissolving 3.03g of Tris base and 14.4g of glycine 







2.2  Plasmids and bacterial culture  
2.2.1 Genomic clones  
Genomic clones were supplied by either the Sanger Institute Clone service 
(service no longer available; http://www.sanger.ac.uk/), or by the BacPac Resources 
Centre at the Children’s Hospital Oakland Research Institute 
(http://bacpac.chori.org/).  Fosmid clones were used for all experiments, which came 
from the WIBR2 library derived from a human female at the Broad Institute cloned 
into a pEpiFOS-5 vector, in DH10B T1 resistant competent cells.  Clones were 
supplied as bacterial stab cultures in agar.  The fosmid clones used are listed in Table 
2.1. 
 
2.2.2  Bacterial culture  
Bacteria were streaked out onto LB-agar plates containing a selective antibiotic.  
The LB-agar was melted in a microwave and the antibiotic added after it had cooled 
slightly, then poured into Petri dishes, ~20ml per 10cm dish.  Bacteria from stab 
cultures or frozen glycerol stocks were streaked out to give single colonies and these 
were left to grow overnight at 37°C.  For growth of fosmid clones, plates were 
supplemented with 25μg/ml chloramphenicol. 
To prepare small quantities of DNA from bacteria, a single colony was used to 
inoculate 5ml of LB-broth, using the same selective antibiotic(s) as used in the LB-
agar.  They were then allowed to grow overnight with shaking at 37°C with at least a 
5:1 air to liquid ratio. 
 
2.2.3  Bacterial glycerol stocks  
Glycerol stocks were prepared by adding 30% (v/v) glycerol to a 1ml aliquot of 
an overnight culture.  Glycerol stocks are frozen at -70°C. 
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Whitehead name Other name Region Source
Start 
position
End position Size (bp) Role
WI2-671I21 G248P80020E11 11q13 Sanger 64768160 64811897 43737
Reference 
probe
WI2-1737E8 G248P86034C4 11q13 Sanger 65019283 65058937 39654
250kb 
probe
WI2-412A22 G248P81370A11 11q13 Sanger 65285668 65329285 43617
500kb 
probe
WI2-2372A13 G248P82828A7 11q13 Sanger 65519199 65559973 40774
750kb 
probe
WI2-3325E18 G248P800138C9 11q13 Sanger 65764738 65807012 42274 1Mb probe
WI2-2080I19 G248P87792E10 EDC Sanger 151830653 151872769 42116
Reference 
probe
WI2-2423D6 G248P80671B3 EDC Sanger 151569368 151609225 39857
250kb 
probe
WI2-553L9 G248P80305F5 EDC Sanger 151280817 151318413 37596
500kb 
probe
WI2-3057F14 G248P800827C7 EDC Sanger 151091201 151129333 38132
750kb 
probe
WI2-784N16 G248P81347G8 EDC Sanger 150776620 150816117 39497 1Mb probe
WI2-3163O19 G248P8056H10 HoxD 2q31 Sanger 176638573 176678511 39938
Reference 
probe
WI2-1038D9 G248P82453B5 HoxD 2q31 Sanger 176890476 176932394 41918
250kb 
probe
WI2-2744M3 G248P8196G2 HoxD 2q31 BacPac 177034650 177074781 40131
375kb 
probe
WI2-1919C15 G248P87408B8 HoxD 2q31 Sanger 177130268 177168594 38326
500kb 
probe
WI2-1957H23 G248P85797D12 HoxD 2q31 Sanger 177381571 177420055 38484
750kb 
probe
WI2-1241H8 G248P82115D4 HoxD 2q31 Sanger 177647644 177682721 35077 1Mb probe
WI2-1702P7 G248P87869H4 18q22 BacPac 64134988 64175629 40641
Reference 
probe
WI2-502C21 G248P8988B11 18q22 BacPac 63893119 63939831 46712
250kb 
probe
WI2-1735D16 G248P85999B8 18q22 BacPac 63759712 63799511 39799
375kb 
probe





















Probe positions are taken from the GRCh37/h19 assembly on the UCSC genome browser (Kent et 
al, 2002; http://genome.ucsc.edu/)
Table 2.1 - Fosmid probes used for FISH
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2.2.4  Preparation of DNA from bacterial overnight cultures  
Fosmid DNA was prepared by alkaline lysis mini-prep.  ~1.5ml cultures were 
pelleted by centrifugation at 16,000g for 30s, and were resuspended in 200μl GTE 
buffer for 5min.  400μl cold lysis buffer was added and left on ice for 5min before 
300μl acetate buffer was added to precipitate the cell debris.  After 5min on ice the 
flocculent precipitate was spun down at 4
o
C for 5min at 16,000g, and the supernatant 
combined with an equal volume (~800μl) of phenol-chloroform to clean.  This was 
spun down at 4°C for 2min at 16,000g and the aqueous top layer removed and mixed 
with an equal volume of isopropanol (~800μl), and kept for one hour at ~20
o
C.  The 
DNA was pelleted by 15min centrifugation at 16,000g at 4
o
C, then washed in 70% 
EtOH, spun down again for 5min at 4°C at 16,000g then resuspended in 30μl TE. 
 
2.3 Preparation and handling of DNA  
2.3.1 Quantification of DNA by spectrophotometry  
DNA concentration was checked at every stage of experiments by 
spectrophotometry, on a nanodrop ND-1000 (Nanodrop technologies) according to 
the manufacturer’s instructions.  The absorbance of the sample was measured at a 
wavelength of 260nm (A260); 50μg/ml of double stranded DNA will give an A260 
measurement of 1. 
 
2.3.2 Resolution of DNA on agarose gels  
For routine DNA analysis, gels were made with an appropriate agarose 
percentage (“Hi-Pure” Low Eeo agarose, BioGene UK, w/v) in Tris-Borate Buffer 
(TBE), with 0.5μg/ml Ethidium Bromide (EtBr).  DNA was made up with Orange G 
loading buffer, with 1 part buffer added to 4 parts sample.  Appropriate commercial 
DNA size markers were used to allow size determination and quantification of size 
fragments.  After resolution, DNA was visualised under UV illumination.  For 
analysis gels were scanned using a 532nm laser and a 575nm Long Pass filter (LPG 
filter on a Fuji FLA-5100 phosphoimager). 
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2.4 Preparation and handling of RNA 
2.4.1 Quantification of RNA by spectrophotometry  
RNA concentration was determined using spectrophotometry, on a nanodrop 
ND-1000 (Nanodrop technologies) according to the manufacturers instructions.  The 
absorbance of the sample was measured at a wavelength of 260nm (A260); 40μg/ml 
of RNA will give an A260 measurement of 1. 
 
2.4.2 RNA isolation and purification  
RNA was isolated from cells using TRIZOL® reagent (Invitrogen), according to 
the manufacturer’s instructions.  Cells in suspension were pelleted by centrifugation 
at 1200g for 4min.  1ml per 5-10 X 10
6
 cells of TRIZOL® Reagent was added and 
mixed by pipetting to lyse the cells.  The cells were homogenised for 5min at room 
temperature, then 200μl chloroform was added to separate the mixture into phases.  
The tubes were mixed well and incubated at room temperature for 2-3min, before 
centrifugation at 12,000g for 15min at 4°C.  This separated the mixture into three 
phases, a red phenol-chloroform phase, a small white phase and a clear aqueous 
phase that contained the RNA.  The RNA containing phase was transferred to a clean 
tube, and isopropanol added, around half the original volume of TRIZOL® Reagent.  
RNA was precipitated at room temperature for 10min and pelleted by 10min 
centrifugation at 4°C at 12,000g.  The pellet was washed in 75% EtOH made with 
Diethylpyrocarbonate (DEPC) treated dH2O, the same volume as the volume of 
TRIZOL® Reagent used, and centrifuged at 7,500g for 5min at 4°C.  The pellet was 
then dissolved in 25μl DEPC treated dH2O and the RNA concentration estimated 
using a Nanodrop. 
 
2.4.3 DNase treatment of RNA  
RNA was DNase treated using the Ambion DNA-free™ kit, according to the 
manufacturer’s instructions.  3μl 10 X DNase I buffer was added to the RNA 
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solution along with 1μl rDNase I, and mixed gently.  The reaction was incubated at 
37°C for 30min, then stopped by adding 3μl DNase Inactivation Reagent and 
incubating for 2min at room temperature.  This was then centrifuged at 10,000g for 
1min 30s and the supernatant transferred to a fresh tube.  The RNA concentration 
was then estimated using a Nanodrop. 
 
2.4.4 Resolution of RNA on agarose gels  
For routine RNA analysis, gels were made with an appropriate agarose 
percentage (“Hi-Pure” Low Eeo agarose, BioGene UK, w/v) in Tris-Acetate Buffer 
(TAE), with 0.5μg/ml ErBr.  RNA was made up with Orange G loading buffer and 
50% formamide, then denatured at 65°C for 10min and cooled on ice for 5min.  
Appropriate commercial RNA size markers were used to allow size determination 
and quantification of size fragments.  After resolution, RNA was visualised under 
UV illumination.  For analysis, gels were scanned using a 532nm laser and a 575nm 
Long Pass filter (LPG filter on a Fuji FLA-5100 phosphoimager). 
 
2.4.5 Reverse transcription polymerase chain reaction (RT-PCR)  
cDNA was prepared using a modified Invitrogen SuperScript™ II protocol.  For 
each reaction, 4μl of Random Primers (Promega) were mixed with 1μg RNA and 
made up to 11.5μl with dH2O.  This was denatured for 5min at 65°C, then cooled for 
5min on ice.  1μl 10mM dNTP mix, 4μl First-Strand buffer (Invitrogen), 2μl 0.1M 
DTT (Invitrogen) and 0.5μl RNase inhibitor (Invitrogen) were added to each tube, 
and incubated for 2min at room temperature.  For each sample, a reverse 
transcriptase positive (RT+) test and a reverse transcriptase negative (RT-) control 
was set up; 1μl SuperScript™ II reverse transcriptase was added to the RT+ tubes, 
and 1μl dH2O added to the RT- tubes.  These were incubated at room temperature for 
10min, at 42°C for one hour and inactivated at 70°C for 15min. 
PCR was carried out using 1 X PCR buffer (Invitrogen), 2.5μM MgCl2, 0.5μM of 
each primer, 0.2mM of each dNTP and 0.2 units Platinum Taq (Invitrogen), with 1μl 
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cDNA to give a total volume of 25μl.  PCR reactions were carried out on a Peltier 
Thermal Cycler 225 from MJ Research.  The PCR protocol used was: 
1. 95°C for 10min 
2. 95°C for 30s 
3. 58°C for 30s 
4. 72°C for 30s 
5. Return to step two, number (Table 2.2) times 
6. 72°C for 3min 
Quantitative PCR (qPCR) was carried out on a Roche Lightcycler 480, using 
Quantitect® SYBR® Green from Qiagen.  1μl cDNA was made up with 1 X 
Quantitect® SYBR® Green PCR master mix and 0.3μM of each primer to give a 
total volume of 50μl.  The qPCR protocol was: 
1. 95°C for 15min 
2. 95°C for 15s 
3. 56°C for 30s 
4. 72°C for 30s with a single acquisition of data 
5. Return to step two, 49 times 
6. 95°C for 5s 
7. 65°C for 1min 
8. Heat to 97°C at a rate of 0.29°C/s, acquiring data every 0.5°C 
9. 40°C for 30s 
The relative gene expression was calculated by comparison to expression of 
GAPDH.  



















Nip1F 5'-CTGCGGAGTGACATGGCTAA-3' 60.0 NIPBL 162 35
Nip1R 5'-AATTGCTTTGTTCCGAGCAT-3' 59.7 NIPBL 162 35
GAPDH1F 5'-GAGTCAACGGATTTGGTCGT-3' 60.0 GAPDH 265 25
GAPDH1R 5'-TTGATTTTGGAGGGATCTCG-3' 60.0 GAPDH 265 25
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2.5 Preparation and handling of protein 
2.5.1 Preparation of whole cell extracts  
Whole cell protein extracts were prepared by trypsinising cells and centrifuging 
at 1200g for 4min.  The cells were then washed in ice-cold PBS, and an appropriate 
volume of 2 X SDS loading buffer was added to lyse the cells.  The solution was 
then transferred to a microcentrifuge tube and boiled at 95°C for 20min to denature 
the proteins.  Samples were then sonicated briefly to shear the DNA.  The samples 
were centrifuged at 16,000g for 10min at 4°C and the supernatant transferred to a 
clean tube. 
 
2.5.2 SDS PAGE resolution of proteins  
Protein extracts were resolved by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE).  Denaturing polyacrylamide mini-gels with 7-12% 
acrylamide (v/v), 0.39M Tris-HCl (pH 8.8), 0.1% SDS (w/v) 0.1% ammonium 
persulphate (w/v) and 0.04% N,N,N',N'-tetramethyl-ethane-1,2-diamine (TEMED; 
v/v) were prepared in dH2O and left to set with an isopropanol overlay.  The alcohol 
was then removed and replaced with a stacking gel made of 5% acrylamide (v/v), 
0.13M Tris-HCl (pH 8.8), 0.1% SDS (w/v) 0.1% ammonium persulphate (w/v) and 
1% TEMED (v/v), topped with a comb.  Once the gel was set, it was placed in an 
Invitrogen Novex Mini-Cell gel tank with SDS loading buffer, the samples loaded 
and run for ~2hrs at 110V.  BenchMark™ and HiMark™ pre-stained protein 
standards from Invitrogen were run alongside samples to aid analysis. 
Proteins were visualised by treating a gel overnight with GelCode Blue (Thermo 
Scientific) at 4°C with shaking.  The stain was then removed by rinsing in tap water.  
The staining was used to estimate the approximate protein concentration, so that 





2.5.3 Western blotting  
After resolution on an SDS-PAGE gel, proteins were transferred to nitrocellulose 
membrane (Whatmann) using a Genie Blotter (Idea Scientific).  The membrane and 
the gel were separately soaked in Western Transfer Buffer for 5min.  The apparatus 
was assembled following the manufacturer’s instructions sandwiching the gel and the 
membrane between 3mm paper (Whatmann), with the gel towards the cathode and 
the membrane towards the anode.  The proteins were transferred for 1hr 30min at 
24V, 2.5A. 
Membranes were first blocked for 1hr at room temperature in TBST (TBS with 
0.05% Tween 20) with 3% BSA to reduce background.  Primary antibodies were 
then diluted to an appropriate concentration (Table 2.3) in 1% BSA in TBST, and 
were incubated with the membrane for 1hr at room temperature.  The membrane was 
then washed in TBST three times for 10min each time, and was then incubated for 
1hr with horseradish peroxidase conjugated secondary antibodies, diluted to an 
appropriate concentration (Table 2.3) in 1% BSA in TBST.  The membrane was 
washed again, as above. 
Membranes were developed using enhanced chemiluminescent (ECL) detection 
with SuperSignal Western Pico Reagent from Pierce.  Signals were exposed on 
Hyperfilm Ecl (Amersham-Pharmacia). 
 
2.6 Cell culture 
2.6.1 Cell lines  
Ten human Epstein-Barr virus- (EBV-) transformed  lymphoblastoid cell lines 
(LCLs) were used, four control lines from healthy probands and six with NIPBL 
mutations (Table 2.4), obtained from Professor Tom Strachan at the University of 
Newcastle, and from Dr. Matt Deardorff at the Children’s Hospital of Philadelphia.  
The HT1080, a human fibrosarcoma cell line (Rasheed et al, 1974), was used for 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.6.2 Storing cells in liquid nitrogen  
Approximately 2-5 X 10
6
 LCL cells were frozen in 1ml foetal calf serum (FCS) 
supplemented with 7% dimethyl sulphoxide (DMSO), at -80°C in a polystyrene box, 
then transferred to liquid nitrogen after one week.  To freeze HT1080s, one t25cm² 
tissue culture flask was split between two aliquots of 1ml FCS with 7% DMSO, and 
frozen as above. 
Cells were thawed at 37°C, then diluted in tissue culture media, and centrifuged 
at 1200g for 4min.  The media was aspirated from the cells to remove the DMSO.  
LCLs were then suspended in 5ml media and seeded into a t25cm² flask and 
HT1080s were suspended in 15ml media and seeded into a t75cm² flask. 
 
2.6.3 Culture of cell lines  
LCLs were grown in Invitrogen Roswell Park Memorial Institute (RPMI) 1640 
media, supplemented with 10% FCS, 1% Penicillin/Streptomycin and 1% L-
Glutamine.  Cells were grown at 37°C with 5% CO2 in upright flasks.  The volume 
of culture media was doubled by adding an equal volume of media when the cells 
had approximately 2-5 X 10
5
 cells/ml as judged by eye (as LCLs form clumps it is 
possible to judge their approximate concentration without a microscope).  Once the 
flask was one third full, the cells were split by centrifugation at 1200g for 4min, and 
the media taken off.  They were flicked to dislodge the cells then resuspended in an 
equal volume of media as before splitting and split between two new flasks.  LCLs 
are cultured at containment level 2, following local rules. 
HT1080s were grown in Invitrogen Dulbecco’s Modified Eagle Medium 
(DMEM), supplemented with 10% FCS, 1% Penicillin/Streptomycin and 1% L-
Glutamine.  Cells are grown at 37°C with 5% CO2.  Cells were grown to near 
confluency then split.  The media was aspirated off, then the cells were washed with 
PBS, before addition of a small amount of 1:1 Trypsin-Versene for 1min at 37°C.  
The activity of the enzyme was stopped by addition of supplemented DMEM, and 
the cells pelleted at 1200g for 4min.  The cell pellet was resuspended in fresh media 
and seeded into appropriate tissue culture flasks.  Cells were split at between 1:2 to 
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1:4, depending on when the cells were required.  HT1080 cells were cultured at 
containment level 1, following local rules. 
 
2.6.4 Sorting cells by centrifugal elutriation  
LCLs were separated into the three stages of interphase (G1, S and G2) by 
centrifugal elutriation (CE).  The few cells in mitosis would separate out with G2 
cells.  CE separates cells on the basis of size by centrifugation combined with a 
pump.  A Beckman J6-MC elutriator was used combined with a Masterflex pump.  
10
8
 cells were suspended in 10ml Elutriation Buffer.  These were pumped into the 
elutriation chamber with the centrifuge spinning at 2500rpm at 16°C, with the pump 
set to 50 (this is an arbitrary setting on the pump), an approximate rate of 1ml/s.  
Elutriation buffer was pumped through the system and the pump speed was increased 
to 60, and 100ml of the first fraction was taken off.  100ml of each fraction was 
taken, increasing the pump speed by 10 each time, until fraction 9 (pump speed 140), 
then fraction 10 was taken at pump speed 140, reducing the centrifuge to 2000rpm. 
Each fraction was split in two, one half was fixed in MAA for FISH analysis 
(Section 2.8), and the other half prepared for fluorescence activated cell sorting 
(FACS) analysis (Section 2.9).  Fractions were then analysed by FACS to determine 
the DNA content and hence the cell cycle stage.  As cells become larger as they 
progress through the cell cycle, the fractions roughly corresponded to different cell 
cycle stages. 
 
2.6.5 Pulsing cells with Bromodeoxyuridine to mark DNA 
replication 
10ml of cell suspension was transferred to a Petri dish.  10μl of 10mM BrdU in 
PBS was added to the cells, giving a final concentration of 10μM BrdU.  The cells 




2.7 RNA interference 
2.7.1 Preparation of stock solutions of siRNA  
ON-TARGETplus siRNA pools were purchased from Dharmacon (Table 2.5).   
siRNA was supplied as a 5nmol pellet in a microcentrifuge tube, which was 
briefly centrifuged, and resuspended in 250μl siRNA buffer by shaking for 30min, 
giving a 20μM stock.  The siRNA stock was aliquoted and frozen at -20°C. 
 
2.7.2 Transfection of cells with siRNA pools  
HT1080 cells were diluted to a plating density of 5 X 10
4
 cells/ml in antibiotic-
free media, and 2ml were placed in wells of 6-well plates.  The cells were grown 
overnight at 37°C in 5% CO2. 
The stock siRNA solution was diluted to give a 2μM solution.  100μl siRNA and 
100μl serum-free medium were mixed in one tube and incubated for 5min at room 
temperature.  In a separate tube 4μl Dharmafect 4 reagent and 196μl serum-free 
medium were mixed and incubated for 5min at room temperature.  The contents of 
the two tubes were mixed together and incubated for 20min at room temperature.  
1.6ml of medium with 5% FCS and no antibiotic was added to the tube, giving 2ml 
of transfection mixture containing 100nM siRNA.  The medium was removed from 
the cells plated out the previous day, and replaced with the transfection mixture.  The 
cells were then cultured at 37°C until needed. 
Two controls were used in every RNAi experiment, a mock transfection and a 
non-coding negative control.  In the mock transfection, siRNA buffer was used 
instead of siRNA.  In the non-coding control, an siRNA pool was used that does not 
correspond to any known genes.  
RNAi treated cells were harvested after two days.  Knockdown of gene 
expression was demonstrated by Western Blotting or by RT-PCR.  Cells could then 
be harvested for either FACS or FISH. 
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2.8 Fluorescence in situ hybridisation (FISH) 
2.8.1 Preparation of FISH probes  
Probes were labelled with biotin-16-dUTP (bio-16-dUTP) and Digoxigenin-11-
dUTP (DIG-11-dUTP; Roche) by nick translation.  4μl nick translation salts, 5μl of 
0.5mM each of dATP, dCTP and dGTP, 5μl of 1mM bio-16-dUTP or 2μl of 1mM 
DIG-11-dUTP and 3μl of dTTP, 12μl DNA (~1µg), 2μl 1:500 DNase 1 (Invitrogen) 
and 2μl DNA polymerase 1 (Invitrogen) were combined and incubated at 16°C for 
90min.  The reaction was stopped by adding 55μl TE, 3μl 20% SDS and 2μ1 EDTA 
pH 8.0.  Unincorporated nucleotides were removed by running through a Quick Spin 
Column (Pharmacia) following the manufacturer’s instructions. 
Chromosome paints were prepared by PCR.  A 50μl mix was made up containing 
200ng DOP primer (5’-CCGACTCGAGNNNNNNATGTGG-3’), 1 X PCR buffer, 
25mM MgCl2, 2mM of each dATP, dCTP and dGTP, 0.5mM dTTP, 1mM DIG-11-
dUTP and 1μl template DNA (~500ng).  A PCR was set up as below: 
1. 94°C for 3min 
2. 94°C for 45s 
3. 60°C for 1min 
4. 72°C for 1min, increasing by 5s for each cycle 
5. Return to step two, 29 times 
6. 72°C for 10min 
Labelling was tested by running the labelled paints in a 2% agarose gel, a 
successful paint giving a smear at around 300bp.  Unincorporated nucleotides were 
cleaned up by running through a Quick Spin Column (Pharmacia) following the 
manufacturer’s instructions.  Paints for chromosomes 11 and 13 were prepared by 
this method; paints for chromosomes 17 and 18 were purchased from StarFISH. 
 
2.8.2 Quantification of label incorporation  
Labelling was detected using either Streptavidin alkaline phosphatase or anti-
DIG alkaline phosphatase.  Gridded nitrocellulose filters were washed with dH2O 
followed by 20 X SSC, then dried.  1/500, 1/1000, 1/5000 and 1/10,000 dilutions of 
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probes were spotted onto the filter, along with 20pg, 10pg, 2pg and 1pg labelled 
lambda DNA standards.  The DNA was crosslinked onto the filter by 1500mJ UV 
irradiation in a Stratalinker.  The filter was washed for 5min in 0.1M Tris pH 7.5, 
0.15M NaCl and then incubated for 30min at 60
o
C with this buffer containing 3% 
BSA.  It was then incubated in the same buffer with 1% streptavidin alkaline 
phosphatase and/or anti-DIG alkaline phosphatase for 15min at room temperature.  It 
was washed twice in this buffer alone for 15min then washed once in 0.1M Tris pH 
9.5.  The filter was then sealed in a polythene bag containing 5ml 0.1M Tris pH 9.5 
with two drops of each of buffers 1, 2 and 3 from a Vector BCIP/NBT kit.  The 
presence of alkaline phosphatase gives a blue colour due to the reaction of 5-bromo-
4-chloro-3-idolyl-phosphate and nitroblue tetrazolium.  The membrane was 
incubated in the dark until blue spots appear which could be compared to standards 
of known concentration to estimate the incorporation of labelling of each probe. 
 
2.8.3 Fixing cells for FISH  
2.8.3.1 Harvesting and fixing cells in 3:1 methanol:acetic acid for 2D 
FISH  
20ml of LCLs at ~2-5 X 10
5
 cells/ml, or one well of a 6-well plate of HT1080s 
was harvested then washed once in PBS before treatment with ~10ml hypotonic 
solution of 33mM KCl and 17mM tri-sodium citrate for 10-15min to swell the cells.  
They were centrifuged at 1200g for 4min and the hypotonic solution taken off.  The 
cells were then fixed with 3:1 MAA for one hour; the cells were resuspended by 
adding MAA to them drop by drop whilst vortexing them, to prevent them clumping 
together.  The cells were then centrifuged and put through three more washes in 
MAA of 5min each.  MAA fixed nuclei were stored at –20
o
C until needed. 
Glass slides were stored in dilute solutions of HCl in EtOH, and were dried and 
polished with muslin prior to use.  The fixed cells were spun down again at 1200g for 
4min, and resuspended in a few drops of MAA to give a milky consistency.  A slide 
was moistened by breathing onto it then single drop of this suspension was dropped 
from a height of around 20cm onto the slide, and blown upon.  The quality of the 
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spread could then be monitored by phase contrast microscopy.  Slides were then aged 
for 24 hours or more at room temperature. 
 
2.8.3.2 Cytospinning and fixing cells for 3D FISH   
Lymphoblastoid cells were prepared for 3D FISH by cytospin.  500μl confluent 
LCLs were harvested and resuspended in 10ml PBS.  500μl of the cell suspension 
was then applied to a Shandon Single Cytofunnel (Thermo Scientific), clipped onto a 
glass slide.  This was centrifuged at 600rpm for 5min in a Shandon Cytospin 3, then 
the slide was removed and allowed to dry. 
Cells were fixed to the slides using 4% paraformaldhyde (pFA) in PBS for 10min 
at room temperature, then washed three times in PBS.  The slides were then placed in 
0.5% Triton X-10 in PBS for 10min to permeablise the cells.  They were washed 
again in PBS three times and stored at 4°C in PBS until needed. 
 
2.8.4 Slide preparation for FISH  
2.8.4.1 Slide preparation for 2D FISH  
Slides were treated with 100μg/ml RNase in 2 X SSC at 37
o
C for 1hr to digest 
any RNA in the cell preparation.  Cells were dehydrated through a series of EtOH 
washes consisting of 2min in each of 70%, 90% then 100% EtOH at room 
temperature then air-dried.  The slides were heated to 70
 o
C for 5min, then denatured 
in 70% formamide in 2 X SSC at pH 7.5 at 70
o
C for 60-75s depending on the age of 
the slides, then washed in ice cold 70% EtOH and through 90% and 100% EtOH 
washes as before, then air-dried. 
 
2.8.4.2 Slide preparation for 3D FISH  
Slides were treated with 100μg/ml RNase in 2 X SSC at 37
o
C for 1hr to digest 
any RNA in the cell preparation.  Cells were dehydrated through a series of EtOH 
washes consisting of 2min in each of 70%, 90% then 100% EtOH at room 
temperature then air-dried.  Slides were treated with 0.1M HCl at 37°C for 5min then 
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dehydrated through alcohols as before.  The slides were then heated to 70
 o
C for 
5min, then denatured in 70% formamide in 2 X SSC at pH 7.5 at 80
o
C for 10min, 
then washed in ice cold 70% EtOH and through 90% and 100% EtOH washes as 
before, then air-dried. 
 
2.8.5 Hybridisation of FISH probes  
For interphase separation measurements 100ng of each of two fosmid probes 
were prepared with 5μg human Cot I (Invitrogen) and 0.5μg salmon sperm DNA.  
For CTs, 150ng of chromosome paint for each arm was prepared with 14μg human 
Cot I and 0.5μg salmon sperm DNA.  For “looping out” studies, 150ng of 
chromosome paint for each arm and 100ng of probe was prepared with 16.5μg 
human Cot I and 0.5μg salmon sperm DNA.  The DNA precipitated with two 
volumes of 100% EtOH then pelleted and dried out in a spin vac.  The dried DNA 
was dissolved in hybridisation mix for one hour.  The probe was denatured at 70
o
C 
for 5min, reannealed at 37
o
C for 15min then applied to the slides and sealed under a 
coverslip with TipTop rubber solution from Rema.  The slides were incubated 
overnight in a covered tray floating in a 37°C waterbath to hybridise. 
 
2.8.6 Washing and detection of FISH signals  
The glue was peeled off then hybridisation mix was washed off the slides using 
four 3min washes in 2 X SSC at 45°C followed by the same in 0.1 X SSC at 60°C.  
To reduce background, the slides were blocked in 5% Marvel in 4 X SSC, prior to 
probe detection using a series of antibody conjugations.  For interphase separation, 
DIG was detected using sequential layers of Fluorescein isothiocyanate (FITC)-
conjugated anti-digoxygenin and FITC-conjugated anti-sheep IgG and biotin was 
detected with sequential layers of Texas Red (TR)-conjugated avidin, biotinylated 
anti-avidin (BAA) and TR-conjugated avidin again.  For chromosome paints, DIG 
was detected in FITC-conjugated avidin, followed by BAA then FITC-conjugated 
avidin again and biotin detected in Rhodamine-conjugated anti-DIG followed by TR-
conjugated anti-sheep.  All antibodies were diluted to an appropriate concentration 
(Table 2.3) in 5% Marvel in 4 X SSC.  The slides were incubated with the antibodies 
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for 30min at 37°C in a humidity chamber with washing three times in 4 X SSC with 
1% Tween 20 for 2min after each conjugation. 
2D FISH slides were mounted in Vectashield (Vector) containing 0.5μg/ml DAPI 
and sealed with PANG rubber solution.  3D FISH slides were incubated in 50ng/ml 
DAPI in 4 X SSC with 1% Tween for 5min before mounting in Vectashield (Vector) 
and sealed with PANG rubber solution. 
 
2.8.7 Dectection of BrdU incorporation 
To detect BrdU incorporation, cells were dropped onto slides and prepared as for 
2D FISH (Section 2.8.3.1; Section 2.8.4.1).  They were then blocked for 5min in 4 X 
SSC with 5% Marvel at room temperature.  Two antibody conjugations were applied, 
first anti-BrdU, followed by Texas-red anti-mouse, both diluted in block solution, 
incubating for 30min in a humidity chamber at room temperature then washing three 
times for 2min in 4 X SSC with 1% Tween after each incubation.  The slides were 
then mounted in Vectashield (Vector) containing 0.5μg/ml DAPI and sealed with 
PANG rubber solution (PANG). 
 
2.8.8 Image capture  
2.8.8.1 Imaging nuclei in 2D 
2D nuclei were photographed using an imaging system which comprises a 
Coolsnap HQ CCD camera (Photometrics Ltd, Tucson, AZ) Zeiss Axioplan II 
fluorescence microscope with Plan-neofluar objectives, a 100W Hg source (Carl 
Zeiss, Welwyn Garden City, UK) and Chroma #83000 triple band pass filter set and 
Chroma #83700 emission filters (Chroma Technology Corp., Rockingham, VT). The 
single excitation and emission filters are installed in motorised filter wheels (Prior 
Scientific Instruments, Cambridge, UK). Image capture and analysis were performed 




2.8.8.2 Imaging nuclei in 3D  
3D nuclei were photographed using an imaging system comprising a Hamamatsu 
Orca AG CCD camera (Hamamatsu Photonics (UK) Ltd, Welwyn Garden City, UK), 
Zeiss Axioskop fluorescence microscope with Plan-neofluar or Plan apochromat 
objectives, a Lumen 200W metal halide light source (Prior Scientific Instruments, 
Cambridge, UK) and Chroma #83000 triple band pass filter set (Chroma Technology 
Corp., Rockingham, VT) with the excitation filters installed in a Prior motorised 
filter wheel. A piezoelectrically driven objective mount (PIFOC model P-721, Physik 
Instrumente GmbH & Co, Karlsruhe) was used to control movement in the z 
dimension. Hardware control, image capture and analysis were performed using in-
house scripts written for IPLab Spectrum (Scanalytics Corp, Fairfax, VA).  Stacks of 
20 images at 0.25μm intervals were taken. 
 
2.9 FACS 
2.9.1 Detection of the DNA content of cells 
2.9.1.1 Fixing and staining LCLs 
Cell suspensions were transferred to 5ml BD Falcon tubes and centrifuged at 
1200g for 4mins.  The medium was removed and the cells resuspended in 100μl 
citrate buffer.  These could then be stored at -20°C until needed. 
On the day of FACS analysis, 450μl FACS Solution A was added to cells, mixed 
and the cells incubated for 2min at room temperature.  375μl FACS Solution B was 
then added, and the cells incubated at room temperature for a further 10 min.  The 
cells were then incubated in the dark on ice for 10min with 250μl FACS Solution C, 
and kept on ice in the dark until needed.  
 
2.9.1.2 Fixing and staining HT080 cells  
RNAi treated HT1080 cells were trypsinised and centrifuged at 1200g for 4min.  
The media was removed and the cells washed in ~10ml of cold PBS.  The cells were 
spun down again and the PBS poured off.  The tubes were flicked to resuspend the 
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cells in the residual PBS, around 100μl and 1ml of ice-cold 70% EtOH was added 
drop-wise while vortexing.  The cells were incubated on ice for 30min, and were 
stored at -20°C until needed.  
DNA was stained with Propidium Iodide (PI) by adding 50μl of 1mg/ml RNase 
and 50μl of 400μg/ml PI.  The cells were incubated at 37°C for 30min in the dark 
and held in the dark on ice until FACS analysis. 
 
2.9.2 Immunostaining for FACS analysis 
To combine immunostaining with FACS analysis, RNAi-treated HT1080s were 
fixed as above, then immunostained. 
For immunostaining cells were pelleted by centrifugation at 1200g for 4min and 
the cells washed in 2ml 5% donkey serum/PBS, then spun down again, resuspended 
in 100μl 5% donkey serum/PBS and incubated at room temperature for 10min.  The 
primary antibody was added to the appropriate concentration (Table 2.2) and the 
cells incubated at room temperature for one hour.  The cells were washed twice in 
5% donkey serum/PBS, centrifuging at 2400g for 4min in between washes, then 
resuspended in 100μl 5% donkey serum/PBS with the secondary antibody diluted to 
an appropriate concentration (Table 2.2).  The cells were incubated for 30min in the 
dark, then washed in 5% donkey serum/PBS, followed by PBS only, centrifuging at 
2400g for 4min in between washes and resuspended in 500μl PBS. 
DNA was stained with Propidium Iodide (PI) by adding 50μl of 1mg/ml RNase 
and 50μl of 400μg/ml PI.  The cells were incubated at 37°C for 30min in the dark 
and held in the dark on ice until FACS analysis. 
 
2.9.3 FACS analysis  
Flow cytometric analysis was performed using a BD FACSAriaII SORP (Becton 
Dickinson).  A 488nm laser was used to measure PI fluorescence (685/35nm 
bandpass filter) and FITC fluorescence (525/50nm bandpass filter).  BD FACSDiva 
software (Becton Dickinson, Version 6.1.2) was used for instrument control and data 
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2.10.1 Comparison of published microarray expression data  
The datasets compared by bioinformatics are shown in Table 2.6.  The gene-
names and affymetrix probe symbols in the non-human datasets were converted to 
the names of their human orthologues using Biomart (http://www.biomart.org/).  The 
data was then compiled into a single table in Microsoft Excel of the log2 fold change 
of each gene.  Microsoft Excel software was used to compare correlation between 
datasets. 
 
2.11 Data analysis 
2.11.1 General statistical and quantitative analysis  
Nuclear area datasets were analysed using Mann-Whitney U-tests (MW tests) in 
MiniTab 15 software.  The MW-test is a non-parametric test, so the datasets can 
follow any distribution (unlike the Student’s t-test, which assumes all datasets follow 
a normal distribution), however it assumes that both datasets tested follow a similar, 
but shifted, distribution.  It was chosen because nuclear area datasets tend to follow a 
Rayleigh distribution, with a distinct cut-off at zero at one end of the distribution, 
and tending towards infinity at the other end of the distribution.  Two datasets are 
assumed to be significantly different if p≤0.05. 
Large FISH datasets were first analysed using Analysis of Variance (ANOVA).  
As FISH datasets give a Rayleigh distribution and ANOVA requires data to follow 
Normal distributions, the log10 of each value was first calculated, then ANOVA 
carried out on the group to determine if there was any significant difference between 
all members of the group.  The group was considered to be significantly varied if 
p≤0.05.  A Tukey’s range test was carried out pairwise on the log10 datasets to give 
confidence intervals for each, a pair was considered to be significantly different if the  
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Table 2.6 - Published datasets used for bioinformatics
Species Cell line Method of CdLS modelling Published in Table in paper
Human LCLs CdLS patients Liu et al, 2009 S2 and S3
Mouse Brain Nipbl gene-trap Kawauchi et al , 2009 S4
Mouse MEFs Nipbl gene-trap Kawauchi et al , 2009 S3
Mouse ES Nipbl RNAi Kagey et al , 2010 S3
Mouse ES Smc1 RNAi Kagey et al , 2010 S3
Drosophila BG3 Nipped-B RNAi Schaaf et al , 2009 S4
83
confidence intervals did not overlap.  Pairwise comparisons were then made using 
MW tests on the raw data, as with the nuclear area data.  All of these analyses were 
carried out using MiniTab 15. 
FACS datasets were analysed using χ
2
 tests, as these are much smaller datasets.  
χ
2
 is calculated as: 
χ
2
 = Σ (Observed-Expected)
2
 
         Expected 
The value of χ
2
 was then used to calculate the p-value using the P-value 
Calculator available online from GraphPad Software 
(http://www.graphpad.com/quickcalcs/pvalue1.cfm), using two degrees of freedom, 
as there are three cell cycle stages. 
 
2.11.2 Analysis of fluorescence microscopy images  
2.11.2.1 Analysis of nuclear area 
To study nuclear area, fifty nuclei were selected which were evenly shaped and 
were not touching any adjacent nuclei and imaged in a 100 X objective in bin 2.  The 
area of DAPI staining was measured for each nucleus in pixels, this was converted to 
microns by multiplying by (0.134μm)
2
. 
In the cell cycle nuclear area studies, cells in S-phase and G2 were stained with 
BrdU, and were visualised in red, whilst cells in G1 were not stained.  Fifty nuclei of 
each type were selected and analysed by measuring the area of DAPI staining as 
above.  
 
2.11.2.2 Analysis of chromosome territory area 
For CT area studies, nuclei were selected that were evenly shaped and that were 
not touching another nucleus and imaged in a 100 X objective in bin 2.  The 
chromosome territories had to be bright, easily visible, distinct from one another and 
there had to be only two of them. 
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An IPLab script written by Paul Perry was used to measure the CT area (Figure 
2.1; adapted from Mahy et al, 2002a).  The script first measured the area of DAPI 
staining, giving an estimate of nuclear area.  Each chromosome was then identified 
using a circle tool and the FITC signal was detected within that area.  The area of 
FITC signal above a threshold was then measured.  This threshold was manually set 
each time.  For analysis this area was normalised to the nuclear area. 
 
2.11.2.3 Analysis of looping out from chromosome territories 
For CT looping studies, nuclei were selected that were evenly shaped and that 
were not touching another nucleus and imaged in a 100 X objective in bin 2.  The 
chromosome territories had to be bright, easily visible, distinct from one another and 
there had to be only two of them.  The probe spots had to be bright and easily visible, 
and easy to determine which spot corresponded to which territory. 
An IPLab script written by Paul Perry was used to measure the CT area (Figure 
2.2; Mahy et al, 2002a).  The script first measured the area of DAPI staining, giving 
an estimate of nuclear area.  The chromosomes and their corresponding probes were 
then identified using a circle tool and a paint tool respectively.  The FITC signal was 
detected within the circle tool area and the probe signal was detected within the paint 
tool area.  An expanding circle from the probe signal was used to find the closest CT 
edge based upon a FITC intensity threshold, manually set each time, and the distance 
measured in pixels.  For analysis this was normalised to the nuclear radius, estimated 
by taking the square root of the area divided by pi. 
 
2.11.2.4 Analysis of interphase chromatin compaction in 2D  
For interphase separation studies in 2D, nuclei were selected that were evenly 
shaped and that were not touching another nucleus and imaged in a 100 X objective 
in bin 2.  The probe spots had to be bright and easily visible, there had to be only two 
pairs of the probe spots, as cells had to be diploid, the probe spots had to be single 
round spots rather than chains and the pairs had to be far enough apart to be resolved 
as individual pairs. 
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Image of a nucleus 
labelled with a 
chromosome paint
The image was segmented 
on the basis of DAPI 
staining intensity.  The area 
of the segment was 
measured giving an 
estimate of the nuclear 
area 
The image was split into 
the green colour channel 
and segmented on the 
basis of FITC staining 
intensity
The chromosome territories 
were separately selected 
using a circle tool, and the 
area of FITC staining was 
measured in each one
 17651.00     54.93       63.81
Nuclear 
area
CT 1 CT 2 The script generated a data 
table giving the nuclear area 
and the two CT areas.
Figure 2.1 – Measuring CT areas from images.
An illustration demonstrating the IPLab script, written by Paul Perry, which was used to measure the 
size of CTs in FISH stained nuclei.
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Image of a nucleus 
labelled with a 
chromosome paint 
and a FISH probe
The image was segmented 
on the basis of DAPI 
staining intensity.  The area 
of the segment was 
measured giving an 
estimate of the nuclear 
The image was split into red 
and green channels, and a 
circle tool used to select the CT 
in the green channel and the 
corresponding probe in the red 
channel
The CT and the probe signal 
were found by segmenting on 
the basis of signal intensity.  
The distance between the probe 
signal and the closest edge was 
calculated.
The script generated a data 
table giving the nuclear area, 
the two CT areas and the two 
probe to CT edge distances.







CT 1 area CT 2 area
Figure 2.2 – Measuring the distance of probes from the CT edge from images.
An illustration demonstrating the IPLab script, written by Paul Perry, which was used to measure the 
distance of probes from the edge of CTs in FISH stained stained nuclei.
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An IPLab script written by Paul Perry was used to measure the distance between 
the two probes of a pair (Figure 2.3; Eskeland et al, 2010).  The script first measured 
the area of DAPI staining, giving an estimate of nuclear area.  Pairs of probes from 
the same chromosome were identified using a paint tool; the script then identified the 
spots within the area and defined the centre.  The distance between the centres of the 
two spots was measured in pixels, which could then be converted into microns by 
multiplying by 0.134μm, or normalised to nuclear area. 
 
2.11.2.5 Analysis of interphase chromatin compaction in 3D  
In 3D, stacks of 20 images at 0.25μm intervals were taken.  Nuclei were selected 
on the same basis as 2D nuclei.  The stacks were resolved into a single image using 
IPLab, taking the brightest signal at each spot.  This image was then analysed as with 
the 2D nuclei, giving the distance between the probes in the xy plane.  The distance 
in the z plane was calculated by manually examining the individual images in the 
stacks, and determining in which image the probe was in focus.  The distance 
between pairs of probes in the z plane could then be calculated by counting the 
number of stacks in between the two images, in which the probes were most in focus, 
and multiplying the number of stacks by 0.25μm.  The actual distance between the 
two probes could then be calculated from the xy distance (converted to microns by 
multiplying by 0.134μm) and the z distance, by Pythagoras’ Theorum. 
 
2.11.3 Analysis of FACS data 
2.11.3.1 Analysis of cell cycle stages from FACS data  
Cell cycle analysis of FACS data was carried out using FlowJo (Treestar Inc., 
Version 7.5.5) software.  A DNA content distribution was calculated from the 
fluorescence pulse area (FL2-A) of the 685/35nm PI signal.  A Watson pragmatic 
model was used to fit the DNA content distribution to the three cell cycle stages.  In 
this model, the G1 and G2/M peaks are each assumed to follow a normal distribution 
with a mean at 2n and 4n chromosomes respectively.  No assumptions are made 
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Image of a 
nucleus labelled 
with two FISH 
probes
The image was segmented 
on the basis of DAPI staining 
intensity.  The area of the 
segment was measured 
giving an estimate of the 
nuclear area 







A paint tool was used 
to select regions of 
interest (ROIs) 
containing the pairs of 
FISH probes from the 
same chromosome
The image was split 
into red and green 
colour channels, 
and the ROIs were 
maintained from 
earlier
The probe spots were found within 
each ROI by segmenting on the basis 
of signal intensity.  The coordinates of 
the centre of each probe spot was 
determined and the distance between 
the spots calculated.
The script generated a data 
table giving the nuclear area and 
the two interprobe distances.
Figure 2.3 – Measuring interphase separation of probes from images.
An illustration demonstrating the IPLab script, written by Paul Perry, which was used to measure the 
physical distance between probe pairs in fluorescent images of FISH stained nuclei.
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about the shape of the S-phase distribution, and the Watson model fits the 
distribution exactly (http://www.flowjo.com/v76/en/ccmodels.html). 
 
2.11.3.2 Analysis of nuclear size from FACS data 
Nuclear size was modelled from the fluorescence pulse width (FL2-W) of the 
685/35nm PI signal.  Flowjo (Treestar Inc., Version 7.5.5) software was used to 
calculate the mean fluorescence pulse width. 
 
2.11.3.3 Analysis of immunostaining from FACS data 
Immunostaining was measured from the fluorescence pulse area (FL2-A) of the 
525/50nm FITC signal using Flowjo (Treestar Inc., Version 7.5.5) software.  The 
FITC signal from an unstained control sample was used to set a gate for negative 
staining.  This was then used to find the percentage of cells in each sample that 
scored as negative for FITC staining.  The mean level of FITC staining was also 
calculated. 
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3 General effects of CdLS on the 
nucleus 
 
In this project I wished to discover if, and how, chromatin is altered in CdLS.  
The fly homologue of NIPBL, Nipped-B, is involved in the interactions between 
promoters and enhancers (Rollins et al, 1999), and if NIPBL functions the same way, 
this could be the cause of the developmental phenotype of CdLS patients.  I 
considered that if interactions between promoters and enhancers were physical 
interactions of chromatin, then disruption of a large number of these interactions 
might result in a gross physical change in the organisation of chromatin in CdLS 
cells compared to wildtype.  In mouse ES cells, a large increase in nuclear area is 
observed upon RNAi knockdown of Smc2, a component of condensin, without any 
change in ploidy (Fazzio and Panning, 2010).  As NIPBL, which is mutated in all the 
CdLS cell lines I studied, also loads condensin onto chromatin (D’Ambrosio et al, 
2008), it seemed plausible that CdLS might cause a similar effect on nuclear size.  
The first step was to use human CdLS cell lines to look for gross effects on the 
nucleus compared to wildtype cell lines.  To this end I have studied nuclear area of 
CdLS and wildtype cells, as a possible measure of gross chromatin compaction of 
cells.  It has been shown that addition of HeLa nuclei to Xenopus oocytes resulted in 
a massive increase in the size of the HeLa nucleus, far greater than expected from 
increase in nuclear material suggesting that oocytes contain an agent capable of 
altering HeLa nuclei (Gurdon, 1976).  Addition of certain proteins to nuclei can 
result in a massive compaction of chromatin, giving smaller nuclei (Grigoryev et al, 
1992), whereas deletion of the linker histone, H1, results in an increase in nuclear 
size (Eskeland et al, 2010).  Therefore, measurement of nuclear size appears to be 
one way to measure chromatin compaction. 
Due to the important role of cohesin in the cell cycle I also analysed the cell 
cycle of the same cells by FACS, determining the proportion of cells in each cell 
cycle stage.  Finally, I used BrdU incorporation to determine cell cycle stage in fixed 
cells and measure nuclear area at different stages. 
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3.1 Some CdLS cell lines have increased nuclear area 
compared to wildtype 
3.1.1 Preliminary data suggests increased nuclear size in CdLS 
When I initially started this project in 2007, I had only two CdLS LCLs, AG0805 
and AG0805, which had been kindly sent to us by Professor Tom Strachan at the 
University of Newcastle, named CN1 and CN2 in this thesis, respectively (Tonkin et 
al, 2004).  CN1 has a splice site mutation that causes exon 30 of NIPBL to be 
omitted, however the coding sequence would remain in frame, so that a slightly 
shorter protein is predicted to be produced that lacks part of the HEAT repeats 
domain.  CN2 has a frameshift mutation which results in a stop codon in exon 42, so 
encodes a C-terminally truncated protein.  Both patients, from whom the cell lines 
were derived, were reported to have severe CdLS.  I had a single control to compare 
these cell lines to, the commercially available 575 lymphoblastoid cell line, named 
W1 in this thesis (Figure 3.1; Table 2.3). 
I decided to look for changes in the nuclear size, as this would reflect either a 
gross compaction or decompaction of chromatin.  I fixed the three cell types in 3:1 
methanol:acetic acid (Section 2.8.3.1), then dropped them onto slides and stained 
them with DAPI.  The nuclei were visualised using fluorescence microscopy, and 
100 images of each cell type were captured.  I was then able to analyse the nuclear 
area of the cells using an IPLab script (Section 2.13.2.1) and used Mann-Whitney U-
tests to compare the data from the three cell lines (Section 2.13.1). 
In both CdLS cell lines studied, there was an increase in the average nuclear area 
compared to wildtype of approximately 38% (p<0.0001; Figure 3.1), the mean 
nuclear area of W1 cells being 257.7μm
2





 respectively.  However there was also a significant difference between 
the nuclear areas of the two CdLS lines (p<0.001).  I thought that this increase in 
area might be due to a loss of cohesin-mediated intrachromosomal interactions, 









































































































































































































































































































































































































































































































Figure 3.2 – The nuclear area of some CdLS cell lines is increased 
compared to wildtype.
A, Boxplot showing the distribution of nuclear area measurements 
(µm²; n=100) measured from wildtype LCLs (W1) and two CdLS LCLs 
(CN1 and CN2), including p-values from Mann-Whitney U-tests.  The 
horizontal line represents the median, the boxes the interquartile 
range, the vertical lines the upper and lower limits and the dots the 
outliers.  The upper limit is calculated as the upper quartile value plus 
1.5 times the difference between the two quartiles, whilst the lower 
limit is the lower quartile minus 1.5 times the difference between the 
two quartiles.  B, Sample images of DAPI stained nuclei from wildtype 
and CdLS LCLs.
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effect in CN1 was greater than that in CN2, since mutation in the latter seems to have 
a larger effect on the predicted NIPBL protein (Figure 3.1) 
 
3.1.2 CdLS has a smaller effect on nuclear size in other cell lines 
Later in my project I received a new set of lymphoblastoid cell lines from Dr. 
Matt Deardorff at the Children’s Hospital of Philadelphia.  These included three 
wildtype controls GIA 001 S, CdL 043 S1 and CdL 047 S, and four CdLS lines CdL 
125 P, CdL 186 P, CdL 201 P and CdL 223 P; these cell lines were renamed WP1, 
WP2, WP3, CP1, CP2, CP3 and CP4 respectively for this thesis.  The mutations in 
the CdLS cell lines were much more severe than in the CN1 and CN2 cell lines 
previously used.  CP1 and CP2 both had frameshift mutations that resulted in early 
stop codons in NIPBL, CP3 had an early nonsense mutation and CP4 had a deletion 
of exons 2-17, including the start codon, thus these mutations are likely to result in 
either no protein at all, or severely truncated proteins lacking the PxVxL motif or the 
HEAT repeats (Figure 3.1; Table 2.3).  All patients were reported to have severe 
CdLS. 
I wanted to see if these new cell lines shared the nuclear phenotype found in the 
Newcastle cell lines.  I carried out an identical analysis on the new cells (Figure 3.3). 





), and WP3 (204.1μm
2
) giving a mean wildtype nuclear area of 216.8μm
2
.  
The mean nuclear area of CdLS cells was 11% higher, at 241.2μm
2
, and the means 









).  Note that the actual areas in this second set of cell lines are 
much lower than in the first set, however this does not reflect a biological difference 
between the two groups, as nuclear area of MAA fixed cells can be affected by the 
humidity on the day of the experiment; to control for this, each group of experiments 
were carried out simultaneously.  Pair-wise Mann-Whitney U-tests were carried out 
on the datasets and I found that almost all cell lines, CdLS and wildtype have 
significantly different distributions of nuclear area compared to each other (Figure 




WP1 WP2 WP3 CP1 CP2 CP3 CP4
WP1 1 0 0.0192 0.0008 0 0 0
WP2 0 1 0 0.0004 0.0004 0.1131 0.9698
WP3 0.0192 0 1 0 0 0 0
CP1 0.0008 0.0004 0 1 0.7969 0.0399 0.0004
CP2 0 0.0004 0 0.7969 1 0.0577 0.0003
CP3 0 0.1131 0 0.0399 0.0577 1 0.1295
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Figure 3.3 – The nuclear area of CdLS cell lines is increased compared to most wildtype cells.
A, Boxplot showing the distribution of nuclear areas (µm²) in wildtype and CdLS cells (n>100), as 
Figure 3.2.  B, p-values obtained from Mann-Whitney U-tests, comparing cell lines pair-wise.  
Wildtype cell lines are highlighted in black and CdLS cell lines are not highlighted.  P-values ≤0.05 
that denote a significant difference are highlighted in grey.  C, sample images of nuclei stained with 
DAPI.
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3.2 Cell cycle analysis in CdLS cell lines 
I considered that CdLS cells might have an altered cell cycle compared to 
wildtype, due to the role of cohesin in the separation of chromatids at metaphase.  It 
was important to exclude an effect on cell cycle as a possible explanation for the 
increased nuclear size in CdLS because increasing the DNA content through the cell 
cycle increases the nuclear size (Kang et al, 2010). 
Therefore, I carried out FACS analysis on W1, CN1 and CN2, using PI staining 
as a measure of DNA content (Section 2.9; Figure 3.4).  I firstly noticed that there 
was no evidence for increased ploidy in CdLS cell lines, which would be indicated 
by extra peaks of DNA content to the right of the G2 peak.  I used cell cycle gating 
tools on FlowJo software to determine the percentage of cells in each stage of the cell 
cycle, based on their DNA content (Section 2.12.3).  Both CdLS cell lines had fewer 
cells in S-phase, and more cells in G1 and G2 than the W1 control cell line (Figure 
3.4B).  I carried out χ
2
 statistical tests (Section 2.13.1), comparing the two CdLS cell 
lines to W1 and found that both were significantly different to wildtype (p<0.001). 
When the new cell lines, WP1, WP2, WP3, CP1, CP2, CP3 and CP4, arrived, I 
also analysed them by FACS (Figure 3.5).  The percentage of cells in each cell cycle 
stage was again calculated, and I carried out pair-wise χ
2
 tests, comparing every cell 
line to every other cell line.  I found that no cell line had a significantly different cell 
cycle distribution to any other cell line (Figure 3.5B).  I carried out more χ
2
 tests, 
comparing each of the Philadelphia cell lines to the three Newcastle cell lines, and 
found that the cell cycle of W1 did not significantly differ from any of the new cell 
lines, whereas both CN1 and CN2 had significantly different cell cycles from all the 
new cell lines, both wildtype and CdLS (p<0.001).  I concluded that there is no 
consistent alteration in the cell cycle in CdLS cell lines.  It is possible that CN1 and 
CN2 behave differently to the other CdLS cell lines because they were prepared in a 
different lab (Newcastle), and subtle differences in the EBV transformation 
procedure or cell culture conditions may have resulted in an altered cell cycle 
compared to LCLs prepared by other labs. 
The efficiency of PI staining appeared to differ between the seven cell lines, with 




































Figure 3.4 – FACS analysis of W1, CN1 and CN2.
A, Histogram of DNA content measured by FACS.  Cells were excited at 488nm 
and the fluorescence measured at 562-588nm, the level of fluorescence giving an 
estimate of DNA content in PI stained cells.  B, Bar chart of the percentage of 







































WP1 WP2 WP3 CP1 CP2 CP3 CP4
WP1 1 0.0556 0.6157 0.4449 0.2822 0.2516 0.1054
WP2 0.0724 1 0.1873 0.463 0.2851 0.6126 0.7596
WP3 0.6538 0.2311 1 0.8564 0.8187 0.7047 0.4493
CP1 0.4941 0.4868 0.8521 1 0.8395 0.9371 0.6873
CP2 0.3679 0.3606 0.8437 0.8521 1 0.8564 0.5975
CP3 0.3182 0.644 0.7012 0.9418 0.8437 1 0.8395
CP4 0.1645 0.7634 0.4516 0.7082 0.5655 0.8353 1
Observed
Expected
Figure 3.5 – FACS analysis of WP1, WP2, WP3, CP1, CP2, CP3 and CP4.
A, Histogram of DNA content measured by FACS.  Cells were excited at 488nm and the 
fluorescence measured at 562-588nm, the level of fluorescence giving an estimate of DNA 
content in PI stained cells.  B, bar chart of the percentage of cells in each cell cycle stage, 
calculated from the DNA content.  C, p-values obtained from χ² tests, comparing cell lines 
pair-wise.  Wildtype cell lines are highlighted in black and CdLS cell lines are not 





the histogram does not alter (Figure 3.5A).  It is from the shape of the histogram, and 
not the position of the histogram, that FlowJo creates gates for cell cycle stage.  
CdLS cell lines appear to have taken up proportionately more PI than wildtype; as PI 
is a dye that intercalates with the DNA, this may in itself indicate that the chromatin 
structure of CdLS cell lines is altered in CdLS cell lines. 
 
3.3 The increase in nuclear area is not due to cells 
spending more time in G2 
Nuclear area increases as DNA content increases, so a higher percentage of cells 
in G2 (Figure 3.4) might have accounted for the increase in nuclear area observed in 
CN1 and CN2. 
To determine if the nuclear area change was due to the cell cycle change in CdLS 
cells, I decided to study the nuclear area at each cell cycle stage.  I carried out a two-
hour BrdU incorporation on the four control cell lines (Section 2.6.6), W1 GIA 001S, 
WP3 and WP2, and five of the CdLS cell lines, CN2, CP1, CP2, CP3 and CP4, then 
fixed the cells in MAA.  The cells were dropped onto slides as with the previous 
nuclear area analysis, then treated with RNase and denatured before detection of 
BrdU using a mouse anti-BrdU antibody, followed by a Texas-red conjugated anti-
mouse antibody.  The slides were then mounted in DAPI and examined using 
fluorescence microscopy. 
Cells which I judged as positive for BrdU staining were considered to have 
undergone DNA replication at some point within the two hour period of treatment, so 
I judged these cells to be in S-phase or G2 (Figure 3.6A).  Those that were negative 
for BrdU staining were judged to be in G1 as their DNA had not replicated within the 
time point (Figure 3.6A).  Of the few metaphase spreads that I observed, most were 
negative for BrdU staining, though some had a few loci with BrdU staining, most 
likely the late replicating loci.  Because of this I thought it unlikely that any nuclei 
with BrdU incorporation had progressed through mitosis into G1, and similarly 
unlikely that any G2 cells had replicated their DNA prior to the BrdU incorporation, 
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and 50 S-G2 images for further study.  I analysed the nuclear area as before, (Section 
3.1), to compare the nuclear area of G1 cells to S-G2 cells.  I also examined 100 
images of each cell line without looking for BrdU staining, so that I could compare 
each cell cycle stage to a mixed cell stage population (asynchronous), that would 
reflect all cell cycle stages in their normal proportions, and would also allow me to 
repeat analysis of nuclear size between the old and new cell lines.  Within each cell 
cycle stage, I compared all the cell lines pair-wise using Mann-Whitney U-tests. 
The asynchronous population did not follow the same pattern as the previous data 
on nuclear area (Figure 3.6B; Figure 3.2; Figure 3.3).  Mostly, the wildtype cell lines 
did not have significantly different nuclear areas to one another.  However the CdLS 
cell lines varied in nuclear area, with some significantly larger than wildtype (CP1 
and CP2) and some with a similar size to, or even smaller than wildtype (CN2, CP3 
and CP4).  It is unclear why these results differ from those previously gathered 
(Figure 3.2; Figure 3.3). 
The G1 population follows a similar pattern to the asynchronous population 
(Figure 3.6C).  There is more variation within the wildtype cell lines than in the 
mixed population.  In the G1 population CN2 has similar nuclear area to all wildtype 
cell lines and CP4 has statistically smaller nuclei than all cell lines, except WP2.  
CP1, CP2 and CP3 have large nuclei, which are mostly statistically different to 
wildtype. 
The S-G2 population also shows a similar pattern to the asynchronous and G1 
populations (Figure 3.6D).  Three of the wildtype cell lines, W1, WP1 and WP2, plus 
two CdLS lines, CN2 and CP4 do not have significantly different nuclear areas.  
CP1, CP2 and CP3 have significantly larger nuclei than all members of the other 
group, but of these three, only CP2 and CP3 are significantly different to each other. 
In this experiment CN2, CP3 and CP4 behaved more like wildtype cell lines than 
CdLS, however CP1 and CP2 had consistently larger nuclei than wildtype, in the 
mixed population and in both cell cycle stages.  Although the data in this experiment 
were not consistent with data from previous experiments, the data are consistent 
between the cell cycle stages in this experiment, so we can consider that any change 
in nuclear area in CdLS is independent of the change in the cell cycle of CdLS.  
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Despite this, I conclude that gross nuclear area, as assessed cytologically, is too 
irreproducible to explore further. 
 
3.4 Analysis of nuclear size by FACS 
As I was not able to reproduce the change in nuclear size in CdLS cell lines in the 
BrdU experiment, I wanted to assess nuclear size by a different method.  Nuclear 
size can also be estimated from FACS data, by measuring the width of the PI signal, 
with larger nuclei giving a higher relative width.  This method is able to identify the 
size of nuclei, rather than the size of cells, as it relies upon the PI signal, which 
intercalates with the DNA (Sharpless and Melamed, 1976; Kang et al, 2010). 
I measured the fluorescence width from my previous FACS data, looking at 
asynchronous, G1 and G2 populations, in all the CdLS and wildtype cell lines 
previously studied.  I found that in neither the Newcastle nor the Philadelphia cell 
lines, was there a difference in PI signal width between the CdLS and wildtype cell 
lines, and that this was consistent through the cell cycle (Figure 3.7).  Due to the 
much higher sample sizes used in FACS analysis, and the lack of human 
involvement in choosing cells to analyse, I believe that that FACS PI signal width 
gives a much more accurate measure of nuclear size than microscopic analysis.  
Based on this assumption, I suggest that there is no change in nuclear size in CdLS 
cells compared to wildtype. 
 
3.5 Discussion 
The CdLS cell lines I have examined do not show such a consistent increase in 
nuclear area as was seen when the condensin subunits SMC2 and SMC4 were 
knocked down in mouse ES cells.  However SMC1A was also tested in this RNAi 
screen, and a change in nuclear size was not detected (Fazzio and Panning, 2010).  It 
is important to consider the protein levels in the two experiments, knockdown of 
Smc2 in the published experiment is almost complete, whereas CdLS cells show only 

















































Figure 3.7 - Nuclear size as shown by PI staining width.
Histograms of PI staining width, measured by FACS.  Cells were excited at 488nm and 
the fluorescence measured at 562-588nm, the width of fluorescence giving an estimate of 
nuclear size in PI stained cells.  A, Fluorescence width in seven CdLS LCLs and four 
wildtype LCLs, in asynchronous, G1 and G2 cells.  B, Mean PI width of the seven CdLS 
LCLs and four wildtype LCLs
            Asynchronous                                G1                                                                 G2
A
B
Cell line Asynchronous G1 G2
W1 88.07 76.53 119.76
CN1 83.84 72.98 106.95
CN2 79.73 70.79 112.39
WP1 279.28 274.76 289.35
WP2 276.49 271.52 284.24
WP3 280.33 275.86 289.32
CP1 282.05 275.94 294.22
CP2 279.53 275.13 291.1
CP3 280.4 274.99 292.8
CP4 282.48 275.8 292.04
Mean PI width
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Because I could detect no overall gross change in chromatin compaction, as 
assessed by nuclear size, I next analysed chromatin compaction at specific loci. 
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4 Chromatin condensation at specific 
regions in CdLS 
 
In the previous chapter, analyses using the cell lines W1, CN1 and CN2, had 
suggested that mutation of NIPBL in CdLS may cause a general decompaction of 
chromatin.  To determine if chromatin compaction was altered at specific genomic 
regions with differing characteristics in these cells, I then set out to examine defined 
genomic locations via study of chromosome territories and extensive 2D FISH 
analysis.  I also examined some of these regions at different stages of the cell cycle, 
and via 3D FISH. 
 
4.1 Chromosome territory size in CdLS 
I was interested in the sizes of the CTs in CdLS as it has been shown that changes 
in compaction of the chromatin result in an alteration of the size of the CTs.  For 
example, knockdown of BAF53, which is a component of a number of chromatin 
remodelling complexes, including SWI/SNF and TIP60, causes decompaction of 
chromatin and enlargement of CTs (Lee et al, 2007). 
I measured CT area by hybridising a DIG-11-dUTP-labelled chromosome paint 
to MAA fixed nuclei and detecting the CTs in FITC, with the nuclei in DAPI.  I was 
then able to measure the size of the CTs and nuclear area using an IPLab script 
(Section 2.11.2.2; Figure 2.1).  I normalised the CT area to the nuclear area, then 
compared wildtype to CdLS cells using Mann Whitney U-tests, and considered data 
to be significantly different where p≤ 0.05.  
I measured the CT size of four chromosomes, 11, 13, 17 and 18; chromosome 11 
area was measured in W1 (wt) cells compared to CN1 (CdLS) and CN2 (CdLS) and 
the areas of chromosomes 13, 17 and 18 were compared between W1 and CN1 cells.  
I was interested in chromosomes 13 and 18 because both are gene-poor 
chromosomes that are located close to the nuclear periphery and have compact 
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chromatin (Gilbert et al, 2004).  In contrast, chromosome 17 is gene-rich, has open 
chromatin and located towards the nuclear centre (Boyle et al, 2001).  Chromosome 
11 was of interest because it locates towards the nuclear periphery, although it is 
gene-rich (Boyle et al, 2001).  I was also carrying out other studies on looping out 
from chromosome 11 (Section 4.2), and looking at compaction at a specific region on 
chromosome 11, 11q13, by 2D FISH (Section 4.3.1).  It is important to carry out 
these studies on a number of different chromosomes, with varied characteristics, as 
CT size varies, not just with chromosome size, but also with compaction of the CT 
due to histone acetylation and other factors (Croft et al, 1999).  
I looked at the CTCF and cohesin binding density of each of the chromosomes 
studied (Figure 4.1A; Figure 4.1B; Barski et al, 2007; Liu et al, 2009).  I found that 
chromosome 11 had a higher than average CTCF binding density but lower than 
average cohesin binding density, chromosome 17 had higher than average CTCF and 
cohesin binding densities and chromosomes 13 and 18 had lower than average CTCF 
and cohesin binding (Figure 4.1B). 
I found that the CT size of chromosome 11 was significantly increased in both 
CN1 and CN2 compared to W1 (p<0.02; Figure 4.2C).  The CT area of chromosome 
13 did not significantly alter in CN1 compared to W1 (p=0.8288; Figure 4.2C).  The 
CT areas of chromosomes 17 and 18 both significantly decreased in CN1 compared 
to W1 (p=0.001 and p=0.035 respectively; Figure 4.2C).  There appeared to be no 
correlation between the binding density of CTCF and cohesin, and the change in CT 
size in CdLS. 
I then looked at the physical size of the CTs compared to the genomic length of 
the chromosomes (Figure 4.2B).  I considered that there would be a correlation 
between the physical size of the chromosome and the genomic length, but that many 
chromosomes would deviate strongly from this relationship based upon gene density 
and chromatin topographical features.  I therefore compared the mean CT sizes 
normalised to nuclear area that I measured, to the genomic size of the chromosome 
normalised to the size of the whole genome (Croft et al, 1999).  I found that there 
was some correlation between chromosome size and CT size in W1 cells, but a much 














































Figure 4.1 - CTCF and cohesin binding on human chromosomes 11, 13, 17 and 18.
A, UCSC tracks of the four chromosomes studied (GRCh37/h19 assembly; Kent et al, 
2002; http://genome.ucsc.edu/).  The position in bp is indicated at the top.  CTCF binding 
across the chromosome is indicated as a bar chart in black (Barski et al, 2007).  Cohesin 
binding across the chromosome is indicated below in black (Liu et al, 2009).   The genes 
are in blue, and genes that are misregulated in CdLS LCLs are highlighted in red and 
green below (Liu et al, 2009).  B, Bar-chart showing the CTCF and Rad21 binding density 






























W1           CN1        CN2 W1      CN1              W1 CN1         W1             CN1
C11                                         C13                                             C17                                             C18 
Figure 4.2 - Chromosome territory size in W1, CN1 and CN2.
A, sample fluorescence microscopy images of chromosome territories in nuclei.  DNA is stained with 
DAPI and chromosome territories are stained in green.  B, Scatter-plot showing the relationship 
between the normalised CT area in W1, CN1 and CN2 and the proportion of the genome that that 
chromosome makes up, for chromosomes 11, 13, 17 and 18.  C, Boxplots showing the territory size 
of chromosome 11 in W1, CN1 and CN2 , and chromosomes 13, 17 and 18 in W1 and CN1, normal-
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CdLS is to homogenise the chromatin such that on a large scale, all chromatin will 
tend towards having a linear relationship between genomic length and space taken 
up. 
 
4.2 Intra-chromosome territory organisation in CdLS 
I then measured the intra-chromosome territory organisation of two regions of 
chromosome 11 from the CT.  It has been shown on various chromosomes that genes 
loop out of their CT upon activation (Mahy et al, 2002b; Chambeyron and Bickmore, 
2004; Morey et al, 2007).  It is thought that this reflects their association with 
transcription factories, forming ACHs (Kurukuti et al, 2006; Chernukhin et al, 2007; 
Mitchell and Fraser, 2008; Heard and Bickmore, 2007); it is possible that the 
formation of these ACHs may be mediated by cohesin.  It is important to note that 
looping out is not sufficient to activate transcription (Morey et al, 2009). 
Looping out from CTs was measured by hybridising a DIG-11-dUTP-labelled 
paint to the CT (as Section 4.1) and hybridising a biotin-16-UTP-labelled probe to a 
specific region, then detecting the CT in FITC and the probe in Texas Red.  The 
shortest distance to a chromosome territory edge was then measured using an IPLab 
script, giving negative values for probes outside the CT, and positive values for 
probes inside the CT.  The distance between the probe and CT edge was normalised 
to the nuclear radius, estimated from the measured nuclear area (Section 2.11.2.3; 
Figure 2.2).  I then compared CdLS cell line datasets to wildtype using Mann-
Whitney U-tests, and considered datasets to be significantly different where p≤ 0.05. 
I measured the intra-territory organisation of two regions of chromosome 11, 
11p13 and 11q13, measured in W1, CN1 and CN2 at 11q13 and in W1 and CN1 only 
at 11p13 (Figure 4.3A).  11p13 has been shown to be gene-poor and normally 
located well within the CT (Mahy et al 2002a; Mahy et al, 2002b).  Previous work in 
the lab had demonstrated that 11q13 is a very open chromatin region that is 
frequently located outside the chromosome territory (Gilbert et al, 2004; Mahy et al, 
2002b).   This region is both gene dense and very transcriptionally active, and is 
considered to be a region of increased gene expression (ridge) of irregularly-shaped, 





Figure 4.3 - Looping out of chromosome 11 in W1, CN1 and CN2.
A, UCSC track of  human chromosome 11 (GRCh37/h19 assembly; Kent et al, 2002; 
http://genome.ucsc.edu/).  The position in bp is indicated at the top.  CTCF binding across the 
chromosome is indicated as a bar chart in black at the (Barski et al, 2007).  Cohesin binding across 
the chromosome is indicated below in black (Liu et al, 2009).   The genes are in blue, and genes that 
are misregulated in CdLS LCLs are highlighted in red and green below (Liu et al, 2009).  The two 
probes used are indicated below in green, RP1-61M11 at 11p13 and WI2-671I21.  B, sample 
fluorescence microscopy images, the DNA is labelled with DAPI, the CTs in green and the probes in 
red  C, Boxplots showing distance from the FISH probes to the chromosome territory edge 
normalised to the nuclear radius, negative values indicate that the probe is outside the chromosome 
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Gierman et al, 2007).  More recently, looping out of this region was shown to be 
dynamic (Müller et al, 2010).  I used a cosmid, RP1-61M11, to study looping out at 
11p13 and the fosmid probe, WI2-671I21, to study looping at 11q13 (Figure 4.3A). 
RP1-61M11 at 11p13 is mostly found inside the CT in both W1 and CN1, but is 
found closer to the territory edge, and even outside the CT in CN1 (p<0.002).  I 
found that WI2-671I21 at 11q13, which is mostly found outside the CT in all three 
cell lines, is located closer to the CT edge in CN1 compared to W1 (p<0.001) but 
that there is no difference in the localisation of WI2-671I21 compared to the CT 
between W1 and CN2 (p=0.342; Figure 4.3B).  These data also suggest that CdLS 
homogenises the chromatin organisation, and that the organisation of chromatin 
within a CT is tending towards a more random state, as control of large scale looping 
is lost. 
 
4.3 2D FISH to study CdLS at specific chromatin 
regions 
2D FISH can be used to give a measure of chromatin compaction over a specific 
region of the genome.  It is a well-established technique in the Bickmore lab, as well 
as others, and has been used to demonstrate changes and variation in compaction.  It 
has been used to compare compaction between different genomic regions in the same 
cells (Yokota  et al, 1997; Gilbert et al, 2004), to compare the same genomic region 
through cell differentiation (Chambeyron et al, 2004) and to compare the same 
region in wildtype versus mutant cells (Eskeland et al, 2010).  
2D FISH has been shown to be a robust method for determining compaction of 
chromatin that accurately reflects the 3D structure of chromatin, though compared to 
3D FISH, 2D FISH generally gives greater distances (Morey et al, 2007; Eskeland et 
al, 2010).  It is more suitable for examining large datasets than 3D FISH, as imaging 
in 2D is faster and algorithms for measuring distances are well established.  
Therefore I only used 3D FISH to confirm my 2D FISH data, and not to carry out 
initial analysis. 
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The physical distance between genomic regions of known genomic separation 
(kb) was measured using pairs of fosmid clones that correspond to a region of 
interest and that are of known distance apart.  The probes are selected by examining 
the region of interest on the UCSC browser, and choosing fosmid probes from the 
fosmid end pairs track on the March 2006 human genome assembly (Kent et al, 
2002; http://genome.ucsc.edu/).  One of the clones is labelled with DIG-11-dUTP 
and the other with biotin-16-dUTP, then hybridised to MAA fixed cells on slides.  I 
then detected DIG-11-dUTP with fluorescein-conjugated antibodies and biotin-16-
dUTP with Texas Red-conjugated antibodies (Section 2.8; Figure 4.4B, 4.6B, 4.8B 
and 4.10B).  I measured the physical distance between the two probes (Figure 2.3) 
and determined the mean squared separation (r²), as there is a linear relationship 
between this and the genomic distance (Figure 4.4).  The r² gives an estimate of the 
chromatin compaction, as larger values at the same genomic distance suggests that 
the chromatin is less compact.  It is possible to use 2D FISH to measure chromatin 
compaction at genomic distances of <1Mb, as chromatin appears to act as a polymer 
that follows a random-walk giant-loop model, with loops above 1.5Mb (Sachs et al, 
1995; van den Engh et al, 1992).  The data is also normalised to the nuclear area 
(r²/a), as nuclear size varies based not only on the cell type, as seen in the previous 
chapter, but on the humidity on the day of preparation.  The distribution of r values 
should follow a Rayleigh distribution, where the data have a discrete cut-off at zero 
to the left of the distribution, but extend towards infinity to the right of the 
distribution.  As a result the ratio of median to mean is ~0.9 and the ratio of standard 
deviation to mean is ~0.5 (Figure 1.6; Figure 4.4).  For a more linear confirmation 
the median to mean ratio is approximately 1, and the ratio of standard deviation to 
mean is around 0.25. 
I first studied chromatin compaction by FISH in the three original cell lines, W1, 
CN1 and CN2, and at four regions of the genome.  Analysis of Variance (ANOVA) 
was carried on log10 of r² or r²/a on each single experiment, comparing datasets from 
W1, CN1 and CN2 under each condition to give an indication of whether there was 
variation between the three datasets.  Variation was considered significant when this 
gave a p value ≤ 0.05.  This analysis also generated pairwise Tukey’s confidence 
intervals, and pairs of datasets were considered to be significantly different when 
113
Short genomic distance Large genomic distance
Figure 4.4 - Mean r² is proportional to genomic distance.
An illustration showing how the mean r² measured in a FISH experiment is proportional to 
the genomic distance.  If we compared mean r to genomic distance, we would find that over 
large genomic separations the small values of r that occur by chance because of the 
random folding fibre would significantly reduce the mean r.  However if we compare the 
mean r² we find that the larger r² values in the dataset are sufficiently high to increase the 
mean.  At shorter genomic separations, r is small and varies very little, and squaring it 








these confidence intervals did not overlap one another.  I then carried out Mann 
Whitney U-tests comparing the datasets from the two CdLS cell lines to the W1 
dataset, and considered data to be significantly different where p≤ 0.05. 
 
4.3.1 Chromatin decompaction at regions of high CTCF binding 
density in CdLS cell lines 
I first selected a candidate region at 11q13 for studying chromatin compaction, 
where I had studied looping-out of the CT (Section 4.2).  This is a gene-rich ridge 
region, located outside the chromosome territory and towards the nuclear centre 
(Figure 4.5A; Gilbert et al, 2004; Mahy et al, 2002b; Goetze et al, 2007; Gierman et 
al, 2007).  Since cohesin and CTCF co-localise (Wendt et al, 2008; Parelho et al, 
2008; Stedman et al, 2008), I examined CTCF binding at 11q13 from published data 
(Barski et al, 2007) and found that it binds very densely, at approximately 2798 
sites/Mb, compared to the global average binding of 906 sites/Mb estimated from the 
same dataset.  Also, after selecting the region for study, it was subsequently revealed 
that this region also contains a small number of genes that are misregulated in CdLS 
LCLs and that there are 11 cohesin binding sites across the 1Mb region studied in 
LCLs as identified by ChIP-chip for Rad21 (p=1 x 10
-6
 compared to an input sample; 
Liu et al, 2009; Figure 4.5A). 
Probe pairs were selected at separations of ~250kb, ~500kb, ~750kb and ~1Mb; 
WI2-671I21 was selected as an anchor probe at the centromere proximal end of the 
region and labelled with DIG-11-dUTP whilst WI2-1737E8, WI2-412A22, WI2-
2372A13 and WI2-3325E18 were 249kb, 517kb, 750kb and 996kb away respectively 
and labelled with biotin-16-dUTP (Table 2.7; Figure 4.5A; Figure 4.5B).  1Mb was 
chosen as the maximum distance as this would represent a separation where the 
random-walk model would hold (van den Engh et al, 1992) and ~250kb was selected 
as a minimum distance as below this distance probes may have been hard to resolve 
by light microscopy. 
There is an increase in interphase separation observed with the increase in 
genomic distance at the 11q13 region.  The relationship between r² and genomic 





Figure 4.5 – Chromatin is decompacted at 11q13 in CdLS. 
A, UCSC track of 11q13 (chr11:64,500,000-65,900,000; GRCh37/h19 assembly; Kent et al, 2002; 
http://genome.ucsc.edu/).  CTCF binding across the region is indicated as a bar chart in black at the top of 
the track (Barski et al, 2007).  Cohesin binding across the region is indicated below in black (Liu et al, 
2009).  The positions of the FISH probes used are indicated below, the reference probe is indicated in 
green and the different distance probes are indicated in red.  The genes in the region are in blue, however 
those that are upregulated in CdLS LCLs compared to wildtype are highlighted in green, and those 
downregulated in red (Liu et al, 2009).  B, sample fluorescence microscopy images of nuclei hybridised 
with probes separated by ~500kb.  C,The mean interphase separation squared is plotted against the 
genomic distance as  measured in W1, CN1 and CN2 cell lines.  The error bars represent the standard 















































































































































   







































































   











   











   







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































separation.  However in the CdLS cell line CN1 there is still a linear relationship up 
to 1Mb (Figure 4.5C).  This may suggest that a specific cohesin mediated chromatin 
interaction takes place in between WI2-2372A13 and WI2-3325E18, which is 
disrupted in CN1 (Figure 4.5A).  Despite this none of the datasets significantly 
deviate from a Rayleigh distribution, suggesting that in all cases the chromatin 
conforms to a random walk path model (Table 4.1). 
At the 11q13 region there is evidence that CN1 has significantly decompacted 
chromatin for the 249kb stretch between the probes WI2-671I21 and WI2-1737E8 
compared to wildtype, but that CN2 does not.  The 517kb stretch of chromatin 
between WI2-671I21 and WI2-412A22 is significantly decompacted in both of the 
CdLS cell lines compared to wildtype.  There is no evidence of change in the 
compaction of chromatin between WI2-671I21 and WI2-2372A13, a 750kb stretch, 
in CdLS compared to wildtype.  At the 996kb separation between WI2-671I21 and 
WI2-3325E18, chromatin is significantly decompacted in CN1 compared to 
wildtype, however this is no greater than the general decompaction in chromatin as 
indicated by nuclear area, and there is no change in the chromatin compaction for 
this region in CN2 compared to wildtype (Figure 4.5C; Figure 4.6; Table 4.1; Table 
4.2). 
There does appear to be some decompaction of chromatin at 11q13 in CdLS 
compared to wildtype, however it is variable in two ways.  Firstly, CN1 seems to 
show more chromatin decompaction than CN2 at this region, with CN1 giving more 
significant differences to W1 than CN2, and the increase in mean compared to W1 
being much larger.  This suggests variability between CdLS cell lines, perhaps 
explaining the variability in phenotype severity between patients.  Secondly the 
chromatin appears to decompact more at the smaller separations in CdLS compared 
to wildtype, perhaps due to more noise at the larger separations which will have more 
flexibility than the smaller separations anyway, or perhaps this reflects the scale over 
which cohesin mediated structures have their effect.  To understand this further, I 
considered another region with similar properties to 11q13. 
Like 11q13 the epidermal differentiation complex (EDC) on chromosome 1 is a 
region that has also been studied for chromatin compaction in the lab (D. Sproul, 
122
PhD Thesis, 2008), is also very open and gene-rich (Figure 4.7A).  It has been shown 
that this region is located external to chromosome 1 in keratinocytes, where the 
genes are active, but close to the CT periphery in other cells, where the EDC is 
inactive (Williams et al, 2002).  Later analysis of CTCF binding and genes 
misregulated in CdLS revealed that this region also has a high density of CTCF 
binding, 1554 sites/Mb (Barski et al, 2007), has a 14 cohesin binding sites across the 
1Mb region studied and contains a small number of genes misregulated in CdLS 
LCLs (Liu et al, 2009). 
Because this region has similar properties as 11q13, it was similarly studied using 
pairs of probes ~250kb, ~500kb, ~750kb and ~1Mb apart.  In this case the anchor 
probe, WI2-2080I19, labelled in DIG-11-dUTP, was at the telomeric end of the 
region, compared to the four biotin-16-dUTP--labelled distance probes, WI2-2423D6 
(262kb), WI2-553L9 (552kb), WI2-3057F14 (741kb) and WI2-784N16 (1055kb; 
Figure 4.7A; Figure 4.7B; Table 2.7). 
At the EDC region, interphase separation increases with genomic distance, and 
there is a linear relationship between the r² and the genomic distance (Figure 4.7C).  
All of the datasets conform to a Rayleigh distribution, having a ratio of median to 
mean of ~0.9, and a ratio of standard deviation to mean of ~0.5 (Table 4.1). 
The 262kb stretch of chromatin between WI2-2080I19 and WI2-2423D6 and the 
741kb stretch between WI2-2080I19 and WI2-3057F14 at the EDC region are both 
significantly decompacted in both of the CdLS cell lines compared to wildtype.  At 
552kb separation (WI2-2080I19 and WI2-553L9) and the 1055 separation (WI2-
2080I19 and WI2-784N16) chromatin is significantly decompacted in CN1 
compared to wildtype, but this is no greater than the general decompaction in 
chromatin as indicated by nuclear area.  Despite this there is no change in the 
chromatin compaction for this region in CN2 compared to wildtype (Figure 4.8; 
Table 4.1; Table 4.2). 
Similarly to 11q13, the EDC region does show decompaction of chromatin in 
CdLS compared to wildtype, but, as with 11q13, this is highly variable.  Again, the 
effect is stronger in CN1 compared to CN2.  However, there is no indication that this 






Figure 4.7 – Chromatin is decompacted the EDC in CdLS.
A, UCSC track of the human EDC (chr1:150,000,000-151,900,000; GRCh37/h19 assembly; 
Kent et al, 2002; http://genome.ucsc.edu/) as Figure 4.5.  B, sample fluorescence microscopy 
images of nuclei hybridised to probes separated by ~500kb.  C, The mean interphase separation 
squared is plotted against the genomic distance as  measured in W1, CN1 and CN2 cell lines.  The error 













































































































































   
   






































































   
   











   
   











   
   





4.3.2 Chromatin compaction at regions of lower CTCF binding 
density in CdLS cell lines 
The mouse HoxD is another region that has been well studied in the Bickmore 
lab, and is found to decondense and loop out of its chromosome territory upon 
activation in mouse ES cell differentiation and embryogenesis (Morey et al, 2007).  
Chromatin compaction at this region in ES cells is shown to be mediated by 
polycomb repressive complexes (Eskeland et al, 2010).  Because of this I decided to 
study this region, which is on human chromosome 2, in CdLS cell lines.  The region 
around HoxD is relatively gene poor, containing few genes other than the HoxD 
cluster itself.  The CTCF binding density of the region is fairly representative of the 
genome as a whole, at 883 sites/Mb (Barski et al, 2007) and there are seven cohesin 
binding sites within the 1Mb region studied (Liu et al, 2009; Figure 4.9A). 
I was also interested in the HoxD locus for two other reasons.  Firstly HoxD is 
known to be regulated by enhancers and as such is a region likely to be affected by a 
disorder that disrupts promoter/enhancer interactions.  The global control region 
(GCR) is found 240kb upstream of the HoxD cluster and contains a number of 
enhancers that regulate HoxD expression in limbs and in the CNS (Figure 4.9A; 
Gérard et al, 1993; Spitz et al, 2003).  Secondly the limb phenotype observed in 
CdLS (OMIM 122470) is reminiscent of the limb phenotype observed upon HoxD 
mutation (del Campo et al, 1999), suggesting that HoxD may be misregulated in 
CdLS.  I had already studied the region by the time data came out showing that 
HoxD genes are not misregulated in CdLS LCLs (Liu et al, 2009), but it is more 
likely that HoxD genes are only misregulated in the limb bud cells and not LCLs.  As 
developmental patterning genes, HoxD genes are not expressed in LCLs (Liu et al, 
2009). 
Like 11q13 and EDC, I chose separations of ~250kb, ~500kb, ~750kb and ~1Mb, 
but I also chose to study a separation of ~375kb as I hypothesised that this region 
would be more compact than 11q13 and the EDC so I wanted to have another small 
separation to find the more subtle changes at small separations.  My DIG-11-dUTP-
labelled anchor probe was WI2-3163O19 and my biotin-16-dUTP-labelled distance 







Figure 4.9 – Chromatin is not decompacted at HoxD in CdLS.
A, UCSC track of the human HoxD cluster (chr2:176,500,000-177,700,000; GRCh37/h19 assembly; Kent 
et al, 2002; http://genome.ucsc.edu/) as Figure 4.5.  The position of the GCR is shown in turquoise.  B, 
sample fluorescence microscopy images of nuclei hybridised to probes separated by ~500kb.  
C, The mean interphase separation squared is plotted against the genomic distance as  measured in W1, 






















WI2-1957H23 (742kb) and WI2-1241H8 (1007kb; Table 2.7; Figure 4.9A).  The 
GCR is located in between my reference probe WI2-3163O19 and my 253kb probe 
WI2-1038D9. 
This region is more condensed than both the EDC and 11q13 in all three cell 
lines: the mean and median r²/a at the ~1Mb for the HoxD cluster is around half 
those of the EDC and 11q13 for all cell lines (Figure 4.6; Figure 4.8; Figure 4.10; 
Table 4.1; Table 4.2).  This is because the HoxD cluster is compacted when it is 
inactive (Morey et al, 2007; Eskeland et al, 2010), as it is in LCLs. 
There is some increase in r² with genomic distance at the HoxD locus, but there is 
deviation from a linear relationship (Figure 4.9C).  Despite this, most datasets follow 
a Rayleigh distribution, with the ratio of median to mean of ~0.9 and a ratio of 
standard deviation to mean of ~0.5, except at the ~250kb separation, where the 
median is significantly lower than the mean, and the standard deviation is higher than 
the mean in W1 cells (Table 4.1).  This suggests that there may be some specific 
interactions that take place within this region, that interfere with any direct 
correlation between r² and genomic distance and disrupt the random walk. 
The data obtained with the 253kb separated probes (WI2-3163O19 and WI2-
1038D9) suggests that there is a complex interaction that is disturbed by CdLS 
within this region, as CN1 appears to have condensed chromatin compared to 
wildtype whilst CN2 appears to have decondensed chromatin compared to wildtype.  
The distribution of r² values results in means are significantly higher than the 
medians for this separation, so whilst the mean r² for this region is significantly 
lower in CN2 than in W1 (Figure 4.9C), the distribution of data is such that most 
CN2 cells had higher r² values than W1 cells.  The GCR is contained between these 
two probes and this locus may interact with other regions, disruption of which in 
CdLS could cause the complex phenotype observed here (Figure 4.8A; Barski et al, 
2007).  There is no evidence of change in the compaction of chromatin at the 396kb 
(WI2-3163O19 and WI2-2744M3) and 491kb (WI2-3163O19 and WI2-1919C15).  
At the 742kb separation (WI2-3163O19 and WI2-1957H23) chromatin is 
significantly decompacted in CN1 compared to wildtype, however this is no greater 













































































































































































































































there is no change in the chromatin compaction for this region in CN2 compared to 
wildtype.  There is no change in the compaction of chromatin between WI2-
3163O19 and WI2-1241H8, a stretch 1007kb long, in CN1 compared to W1, but 
some decompaction of CN2 (Figure 4.10; Table 4.1; Table 4.2). 
The link between CdLS and chromatin compaction is not clear at HoxD, a region 
with a CTCF binding density not dissimilar to the average genomic density.  The 
HoxD gene cluster is tightly regulated and if cohesin is involved in this regulation, it 
is likely that its interaction here is complex.  Cohesin may be linked to the 
interactions of the GCR with other regions, causing complex changes in CdLS at the 
253kb separation which contains the GCR.  Even though the GCR is also included in 
the larger separations, the effect of having more chromatin within the region may 
dilute out the effects of the GCR.  If this is the case, then FISH may be too crude an 
assay to delineate these interactions. 
I wanted to find a gene desert to contrast with the three regions I had already 
studied, which all contained some genes and had some CTCF and cohesin binding, 
so I chose a region at 18q22, which contained a 500kb gene-free region (Figure 
4.11A).  This region also has a very low CTCF binding density (788 sites/Mb; Barski 
et al, 2007), no cohesin binding sites identified by ChIP-chip (Liu et al, 2009) and 
the only two genes in the vicinity are not misregulated in CdLS (Liu et al, 2009). 
In order to keep all my probes within the gene desert, I only used separations of 
~250kb, ~375kb and ~500kb.  The probes used were WI2-1702P7 as my anchor 
probe, WI2-502C21 (239kb), WI2-1735D16 (376kb) and WI2-1708L7 for (486kb; 
Table 2.7; Figure 4.11A). 
At 18q22, interphase separation increases with genomic distance, and there is an 
approximately linear relationship between the r² and the genomic distance in all three 
cell lines (Figure 4.11; Table 4.1).  Like HoxD, this region is more compacted than 
11q13 and the EDC, due to this regions being a gene desert, which tend to be more 
compact than gene-rich regions (Gilbert et al, 2004). 
For neither the 239kb stretch (WI2-1702P7 and WI2-502C21), nor the 376kb 
stretch (WI2-1702P7 and WI2-1735D16), is there any change in chromatin 




Figure 4.11 – Chromatin is not decompacted at 18q22 in CdLS.
A, UCSC track of 18q22 (chr18:63,450,000-64,300,000; GRCh37/h19 assembly; Kent et al, 2002; 
http://genome.ucsc.edu/) as Figure 4.5.  B, sample fluorescence microscopy images of nuclei 
hybridised to probes separated by ~500kb.  C, The mean interphase separation squared is plotted 































































































































































































































1702P7 and WI2-1708L7, there is evidence that the chromatin is more compacted in 
CdLS than in wildtype (Figure 4.12; Table 4.1; Table 4.2).  
The absence of any CTCF- or cohesion-binding sites in 18q22 makes it 
unsurprising that at the ~250kb and ~375kb separations there is no change in 
chromatin compaction.  However the apparent compaction of chromatin in CdLS at 
the ~500kb separation is an unexpected result. 
 
4.3.3 How CdLS affects different genomic regions 
The effects of CdLS differ at different regions.  At both the EDC and 11q13 the 
chromatin is generally less compact in CdLS cells compared to wildtype, whereas at 
18q22 the chromatin is more compact, and at HoxD this relationship is more 
complex.  To understand this, we must think in terms of chromosome topology, and 
not compaction of chromatin itself.  If cohesin is indeed able to regulate gene 
expression by tethering chromatin loops together, it is this that may cause the 
difference in interphase distances observed, and not compaction of the 30nm fibres. 
Both the EDC and 11q13 are gene-rich regions with dense cohesin binding 
(Figure 4.5A; Figure 4.7A).  A number of genes within these two regions are likely 
to be regulated by cohesin mediated looping as a number of genes in each region are 
misregulated in CdLS LCLs (Liu et al, 2009), and loops within these two regions 
will result in an apparent compaction of the chromatin.  Hence reduction in cohesin 
in CdLS will result in loss of these loops and an apparent chromatin compaction. 
Genes of the HoxD cluster are unlikely to be expressed in LCLs, however the 
tight and complex regulation of these genes means that this region is still affected in 
CdLS.  The cohesin binding sites within this region, particularly those associated 
with the GCR (Figure 4.9A), may hold the HoxD in a complex structure that is 
disturbed in CdLS.  A 5C study of this region could delineate this structure to further 
understand how HoxD is affected by CdLS. 
The gene-poor, cohesin-poor 18q22 region is more compacted in CdLS 
compared to wildtype.  However on either side of the region studied, 600kb 
telomeric and 400kb centromeric, are two cohesin binding sites and a cohesin 
133
binding site cluster 1.6Mb centromeric to the region, identified by ChIP (Liu et al, 
2009).  It is plausible that the interactions of these sites with other genomic loci leads 
to a stretching of the 18q22 region in wildtype cells, which is abrogated in CdLS, 
giving compaction of this region. 
Chromatin compaction in CdLS may also be affected by chromatin 
modifications.  NIPBL has been shown to recruit HDAC1 and HDAC3, leading to 
repression of reporter genes; CdLS mutations result in loss of this repression (Jahnke 
et al, 2008).  Presumably, this effect could lead to the conversion of all chromatin to 
an active and decompacted state, with an increase in nuclear size.  However, the 
decompaction I have observed in CdLS is not universal, suggesting that this is not 
the mechanism by which cohesin regulates cohesin structure.  If any changes in 
histone acetylation are occurring in CdLS, instead of having a knock-on effect on 
other histone modifications and DNA methylation that can influence chromatin 
compaction, these other modifications may maintain correct compaction.  Indeed, 
there is no alteration in the DNA methylation state of autosomal chromatin in CdLS 
(Liu et al, 2010). 
 
4.4 Confirmation of 2D FISH data by 3D FISH 
Whilst 2D FISH has been shown to be a robust method for determining 
compaction of chromatin (Morey et al, 2007; Eskeland et al, 2010), it is important to 
replicate the data in 3D nuclei, to confirm that the changes observed in chromatin are 
not an artefact of the fixation process.  The method for 3D FISH differs from that for 
2D FISH in the method used to fix the nuclei; in the latter MAA fixation dehydrates 
the nucleus and extracts many proteins.  In 3D FISH it is important to maintain the 
3D structure of the nucleus so live cells are adhered to the slides by cytospinning 
then fixed with pFA (Section 2.8).  To image 3D nuclei, I used a moving objective to 
image the nucleus as sections across the z-axis at known intervals.  The technology 
was not available for me to construct 3D maps of the nuclei, so I could not directly 
measure the 3D distance between FISH probes.  Instead I measured the xy distance 
from a maximal projection of the stacks and counted the number of stacks between 
the probes to calculate the z distance; I could then calculate the xyz distance (Figure 
134
1 2 3 4 5
6 8 9 10
11 13 14 15
7
12




Figure 4.13 - Analysis of 3D FISH image stacks.
A, A mosiac of the 20 image stacks taken for 3D FISH analysis, at 0.25µm z axis intervals.  B, A 
merged 2D image made from a maximal projection of the 3D stack.  To analyse 3D FISH images the 
xy distance between probes is calculated from this image using the 2D FISH distance script (Figure 
2.3); in this image, this gives a distance of 0.36µm for the bottom probe pair.  The z distance is 
calculated by identifying the images in the 3D stack in which the probe can be seen the most clearly, 
and are the most in focus; in this image stack the green signal in the bottom probe pair is most in 
focus in image 8, and the red signal of the bottom probe pair is most in focus in image 6, giving a z 
distance of 0.5µm.  The xyz distance can now be calculated from these two values using 
Pythagoras Theorum.  Distance = √(0.36² + 0.5²) = 0.62µm.
135
4.13).  This method of calculation of physical distances means that 3D FISH is more 
labour intensive than 2D and gains less accurate results, as it relies upon human 
judgement and less detailed measurement.  Therefore 3D FISH is mostly suitable for 
confirmation of 2D FISH data, and not for collection of large-scale datasets, and 3D 
FISH was only carried out using two pairs of probes. 
 
4.4.1  Chromatin is decompacted at regions of high CTCF 
binding density in CdLS 
I decided to use 3D FISH to confirm the data I found at 11q13 with a ~500kb 
separation, as at this region and separation both CN1 and CN2 CdLS cell lines 
showed a significant decompaction of chromatin compared to W1 control cells.  I 
used the probes WI2-671I21 and WI2-412A22 that I had used earlier to study this 
region in 3D (Figure 4.14A). 
As with the ~500kb separation studied at 11q13 in 2D, CN1 has significantly 
decompacted chromatin compared to W1, however unlike the 2D data, CN2 does not 
(Figure 4.14B; Table 4.3).  Furthermore, across the region in the 2D study, CN2 did 
not have decompacted chromatin as consistently as CN1.  The distances measured in 
3D are smaller than those measured in 2D (Figure 4.14B); this is due to differences 
in the fixing method and have been previously observed in similar experiments 
(Morey et al, 2007; Eskeland et al, 2010).  These data, therefore, do support the data 
collected in 2D, and show that the 2D data is reflective of the chromatin compaction 
in 3D fixed cells. 
 
4.4.2  Chromatin maintains its compaction at regions of low 
CTCF binding density in CdLS 
I also carried out 3D FISH at 18q22 using the ~500kb separation as this region 
showed an opposite effect to 11q13 in CdLS, with both CN1 and CN2 having more 
compact chromatin compared to W1 at this region and separation.  I also felt that 












Figure 4.14 – Chromatin decompaction at 11q13 in CdLS can be confirmed in 3D.
A, UCSC track of 11q13 (chr11:64,500,000-65,900,000; GRCh37/h19 assembly; Kent et al, 2002; 
http://genome.ucsc.edu/) as Figure 4.5.  B, Boxplots showing the normalised interphase separation 
squared (r²/a) of the region as measured in 2D and 3D, as Figure 3.2.






























































































































































































































































































































































































































































































































































































































































of data.  I used the probes WI2-1702P7 and WI2-1708L7 for this study as before 
(Figure 4.15A). 
There is no evidence of a statistically significant change in the compaction of 
chromatin between WI2-1702P7 and WI2-1708L7 in CdLS compared to wildtype 
when studied in 3D.  Visually, it would appear that this region is more compact in 
CN1 than in W1 and CN2, however this is not statistically significant (Figure 4.15B; 
Table 4.3).  These data are more similar to the data collected for the ~250kb and 
~375kb separation in 2D, suggesting that the apparent decompacted chromatin at 
~500kb in W1 in 2D was an anomaly, however the rest of the data collected in 2D is 
reflective of living cells. 
 
4.5 The effect of CdLS on chromatin is not dependant 
on the cell cycle 
Given the importance of cohesin in the cell cycle, it was important to show that 
the effects I observed were not specific to one stage of the cell cycle.  To this end, I 
fractioned cells based on size using centrifugal elutriation, as cells are larger in later 
stages of the cell cycle.  Centrifugal elutriation combines a pump with a centrifuge, 
pumping cells in the opposite direction to the centrifugal force.  As the pump speed 
increases, larger cells are able to escape the centrifugal force and be pumped out, so 
by moving up the pump speed in measured increments, fractions of cells of different 
sizes can be collected (Section 2.6.4).  I was then able to analyse the DNA content of 
the cells using FACS, and choose the fractions that best represented each stage of the 
cell cycle. 
As seen in the previous chapter, we already know that in a mixed population of 
cells, CN1 and CN2 will have a larger number of cells in the two growth phases of 
the cell cycle than W1.  By centrifugal elutriation, I succeeded in producing 
populations that were enriched for G1 cells, with all cell lines with over 70% of cells 
with 2n chromosomes in the G1 populations as judged by FACS.  I was able to 
produce G2 populations that were enriched for cells with 4n chromosomes, 













Figure 4.15 – The lack of chromatin decompaction at 18q22 in CdLS can be confirmed in 3D.
A, UCSC track of 18q22 (chr18:63,450,000-64,300,000; GRCh37/h19 assembly; Kent et al, 2002; 
http://genome.ucsc.edu/) as Figure 4.5.  B, Boxplots showing the normalised interphase separation 
squared (r²/a) as measured in 2D and 3D, as Figure 3.2.
W1         CN1           CN2 W1         CN1           CN2
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W1, and over 30% in CN2 (Figure 4.16).  Although my G2 populations do not 
contain a majority of G2 cells, they contain a sufficient proportion of G2 cells to show 
a difference to a mixed population. 
 
4.5.1 Chromatin is decompacted at regions of high CTCF 
binding density in CdLS throughout the cell cycle 
I again used the 500kb separation at the 11q13 region for this analysis, using 
probes WI2-671I21 and WI2-412A22 (Figure 4.17A).  In the G1 population, 
chromatin is significantly decompacted in CN1 compared to wildtype at this region, 
however this is no greater than the general decompaction in chromatin as indicated 
by nuclear area, and there is no change in the chromatin compaction for this region in 
CN2 compared to wildtype (Figure 4.17B; Table 4.4).  The G2 population has a 
similar effect, the chromatin of CN2 is unaffected but the chromatin of CN1 appears 
to decondense, but this effect is erased upon normalisation to nuclear area (Figure 
4.17C; Table 4.4).  Comparing the G1 and G2 datasets, we can see that r² 
measurements are much higher in G2 than in G1, reflecting the decompaction of 
chromatin through the cell cycle, but r²/a measurements do not differ between G1 and 
G2 suggesting that this is a general decompaction of all chromatin through the cell 
cycle, not of specific regions (Table 4.4; Figure 4.17B). 
The cell cycle specific data at 11q13 does not completely support the data in the 
mixed population, where chromatin was shown to decompact in CdLS, as the 
chromatin does not decompact more than the general decompaction of the nucleus in 
either G1 or G2.  However I have already observed that the phenotypes in CdLS are 
often inconsistent and variable.  Also, the G1 and G2 populations behave the same as 
each other, showing that any effect we observe is not restricted to G2, when cohesin 
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Figure 4.17 - Chromatin decompaction at 11q13 in CdLS occurs throughout the cell cycle.
A, UCSC track of 11q13 (chr11:64,500,000-65,900,000; GRCh37/h19 assembly; Kent et al, 2002; 
http://genome.ucsc.edu/) as Figure 4.5.  B, Boxplots showing the normalised interphase separation 
squared (r²/a) in the unsorted cells and the G1 and G2 fractions, as Figure 3.2.



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.5.2 Chromatin maintains its compaction at regions of low 
CTCF binding density in CdLS throughout the cell cycle 
I again used the 500kb separation at the 18q22 region for this analysis, using 
probes WI2-1702P7 and WI2-1708L7 (Figure 4.18A). 
In the G1 population there is some evidence that CN1 may have condensed 
chromatin at 18q22 compared to W1, but CN2 does not (Figure 4.18B; Table 4.4).  
Surprisingly, both CdLS cell lines have decondensed chromatin compared to 
wildtype at 18q22 in G2 (Figure 4.18C; Table 4.4).  In all three cell lines, the r² 
measurements in the G2 fraction are significantly smaller than those in G1 fraction, 
whilst the r²/a measurements decrease in G2 compared to G1 in W1, but there is little 
difference between G1 and G2 r²/a measurements in CN1 and CN2 (Table 4.5; Figure 
4.18). 
I previously suggested that chromatin at 18q22 may be stretched out in wildtype 
cells by the interactions of two cohesin binding sites that flank the region.  These 
data suggest that upon DNA replication the effect is lost in wildtype cells, perhaps 
due to altered gene expression through the cell cycle, and the region compacts.  In 
CdLS there is no stretching in G1 and no compaction in G2, giving consistent 
compaction of this region through the cell cycle. 
 
4.6 The effect on chromatin compaction does not 
occur with all CdLS cell lines 
Having conducted extensive analysis of chromatin compaction with the CdLS 
cell lines CN1 and CN2, compared to the wildtype W1, I then began analysis on the 
new cell lines from Philadelphia, the wildtype lines WP1, WP2 and WP3 and the 
CdLS lines, CP1, CP2, CP3 and CP4.  I decided to analyse just the 500kb separations 
at 11q13 and 18q22, as I had done with 3D FISH and with the cell cycle fractions, 
using WI2-671I21 and WI2-412A22 at 11q13 (Figure 4.19A) and WI2-1702P7 and 













Figure 4.18 – The lack of chromatin decompaction at 18q22 in CdLS occurs throughout the cell 
cycle.
A, UCSC track of 18q22 (chr18:63,450,000-64,300,000; GRCh37/h19 assembly; Kent et al, 2002; 
http://genome.ucsc.edu/) as Figure 4.5.  B, Boxplots showing the normalised interphase separation 
squared (r²/a) in the unsorted cells and the G1 and G2 fractions, as Figure 3.2.
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Figure 4.19 – Chromatin is not decompacted at 11q13 in all CdLS cell lines.
A, UCSC track of 11q13 (chr11:64,500,000-65,900,000; GRCh37/h19 assembly; Kent et al, 2002; 
http://genome.ucsc.edu/) as Figure 4.5.  B, Boxplots showing the normalised interphase separation 




Table 4.5 - 11q13 statistics
r²
WP1 WP2 WP3 CP1 CP2 CP3 CP4
mean  (µm²) 1.14 1.09 1.34 1.86 1.67 1.35 1.34
median  (µm²) 0.42 0.63 0.68 1.11 0.73 0.89 0.66
Compared to WP1 MW 1 0.079 0.021 0.000 0.006 0.003 0.129
Tukey's CI yes no no no no yes
WP2 MW 0.079 1 0.638 0.001 0.152 0.077 0.970
Tukey's CI yes yes yes yes yes yes
WP3 MW 0.021 0.638 1 0.005 0.434 0.204 0.643
Tukey's CI no yes yes yes yes yes
CP1 MW 0.000 0.001 0.005 1 0.136 0.068 0.002
Tukey's CI no yes yes yes yes yes
CP2 MW 0.006 0.152 0.434 0.136 1 0.996 0.162
Tukey's CI no yes yes yes yes yes
CP3 MW 0.003 0.077 0.204 0.068 0.996 1 0.112
Tukey's CI no yes yes yes yes yes
CP4 MW 0.129 0.970 0.643 0.002 0.162 0.112 1
Tukey's CI yes yes yes yes yes yes
r²/a
WP1 WP2 WP3 CP1 CP2 CP3 CP4
mean 0.0057 0.0047 0.0056 0.0074 0.0082 0.0049 0.0069
median 0.0021 0.0029 0.0028 0.0044 0.0036 0.0031 0.0029
Compared to WP1 MW 1 0.431 0.177 0.002 0.015 0.161 0.322
Tukey's CI yes yes yes yes yes yes
WP2 MW 0.431 1 0.544 0.002 0.042 0.400 0.713
Tukey's CI yes yes yes yes yes yes
WP3 MW 0.177 0.544 1 0.012 0.156 0.750 0.937
Tukey's CI yes yes yes yes yes yes
CP1 MW 0.002 0.002 0.012 1 0.534 0.016 0.018
Tukey's CI yes yes yes yes yes yes
CP2 MW 0.015 0.042 0.156 0.534 1 0.185 0.133
Tukey's CI yes yes yes yes yes yes
CP3 MW 0.161 0.400 0.750 0.016 0.185 1 0.804
Tukey's CI yes yes yes yes yes yes
CP4 MW 0.322 0.713 0.937 0.018 0.133 0.804 1
Tukey's CI yes yes yes yes yes yes
The statistics of every r² and r²/a dataset studied at 11q13 by 2D FISH with the 












Figure 4.20 - Chromatin is not decompacted at 18q22 in CdLS cell lines.
A, UCSC track of 18q22 (chr18:63,450,000-64,300,000; GRCh37/h19 assembly; Kent et 
al, 2002; http://genome.ucsc.edu/) as Figure 4.5.  B, Boxplots showing the normalised 
interphase separation squared (r²/a), as Figure 3.2.  Wildtype cell lines are highlighted in 
black.
WP1    WP2       WP3         CP1            CP2             CP3               CP4
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Table 4.6 - 18q22 statistics
r²
WP1 WP2 WP3 CP1 CP2 CP3 CP4
mean  (µm²) 0.77 0.56 0.46 0.41 0.70 0.90 0.98
median  (µm²) 0.19 0.26 0.14 0.20 0.22 0.21 0.56
Compared to WP1 MW 1 0.971 0.027 0.265 0.954 0.954 0.001
Tukey's CI yes yes yes yes yes no
WP2 MW 0.971 1 0.025 0.219 0.861 0.941 0.001
Tukey's CI yes yes yes yes yes no
WP3 MW 0.027 0.025 1 0.171 0.018 0.029 0.000
Tukey's CI yes yes yes yes yes no
CP1 MW 0.265 0.219 0.171 1 0.211 0.275 0.000
Tukey's CI yes yes yes yes yes no
CP2 MW 0.954 0.861 0.018 0.211 1 0.961 0.002
Tukey's CI yes yes yes yes yes yes
CP3 MW 0.954 0.941 0.029 0.275 0.961 1 0.003
Tukey's CI yes yes yes yes yes no
CP4 MW 0.001 0.001 0.000 0.000 0.002 0.003 1
Tukey's CI no yes no no yes no
r²/a
WP1 WP2 WP3 CP1 CP2 CP3 CP4
mean 0.0049 0.0024 0.0033 0.0023 0.0032 0.0049 0.0040
median 0.0012 0.0009 0.0009 0.0009 0.0010 0.0010 0.0022
Compared to WP1 MW 1 0.065 0.207 0.100 0.329 0.380 0.177
Tukey's CI yes yes yes yes yes yes
WP2 MW 0.065 1 0.591 0.849 0.390 0.411 0.001
Tukey's CI yes yes yes yes yes yes
WP3 MW 0.207 0.591 1 0.783 0.689 0.761 0.012
Tukey's CI yes yes yes yes yes yes
CP1 MW 0.100 0.849 0.783 1 0.513 0.507 0.002
Tukey's CI yes yes yes yes yes yes
CP2 MW 0.329 0.390 0.689 0.513 1 0.988 0.019
Tukey's CI yes yes yes yes yes yes
CP3 MW 0.380 0.411 0.761 0.507 0.988 1 0.034
Tukey's CI yes yes yes yes yes yes
CP4 MW 0.177 0.001 0.012 0.002 0.019 0.034 1
Tukey's CI yes yes yes yes yes yes
The statistics of every r² and r²/a dataset studied at 18q22 by 2D FISH with the 
Philadelphia cell lines, with pairwise statistical comparisons. Statistical differences are 
highlighted in grey.
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At the 11q13 region, the chromatin compaction in the wildtype WP1 differs 
significantly to that of many of the other cell lines, including the wildtype WP3 and 
the CdLS lines, CP1, CP2, CP3 and CP4 in the r² dataset, but not in the r²/a dataset.  
In the r²/a datasets, CP1 and CP2 have significantly decompacted chromatin 
compared to all of the wildtype cell lines, except CP2 and WP3 which are not 
significantly different, as shown by Mann-Whitney tests but not by Tukey’s 
confidence intervals.  Other than this, there is little indication of any significant 
difference between the chromatin compaction of any of the cell lines studied, and no 
indication of a particular difference between wildtype and CdLS cell lines (Figure 
4.19; Table 4.5). 
At the 18q22 region it is suggested that the CdLS cell line, CP4, may have 
significantly decompacted chromatin compared to all other cell lines studied in both 
the r² and r²/a datasets.  However there is no evidence of a particular difference in the 
chromatin compaction at this region between wildtype and CdLS cell lines (Figure 
4.20; Table 4.6). 
As with the results in the previous chapter, there is a contrast between the results 
found when studying the cell lines from Professor Tom Strachan, CN1 and CN2 
compared to commercially available W1, and those from the cell lines from Dr Matt 
Deardorff, the wildtypes WP1, WP2 and WP3, and the CdLS lines CP1, CP2, CP3 
and CdL 223P.  CN1 and CN2 have decompacted chromatin at regions of high CTCF 
and cohesin binding compared to W1, whilst CP1, CP2, CP3 and CdL 223P do not 
have decompacted chromatin at the same regions compared to WP1, WP2 and WP3. 
One possible explanation may be the severity of the mutations in these cell lines 
(Figure 3.1).  CN1 has a mutation that skips exon 30 of NIPBL, however the protein 
remains in frame, whilst CN2 has a nonsense mutation in exon 43 of 46 (Tonkin et 
al, 2004).  Both of these mutations give a long mRNA which may not be degraded 
by the nonsense-mediated decay machinery of the cell, resulting in a large, non-
functioning protein.  In contrast the CdLS cell lines from Philadelphia all have much 
more severe NIPBL mutations giving short mRNAs that would be predicted to be 
subject to nonsense-mediated decay, therefore giving no peptide: CP4 has a 
microdeletion that deletes exons 2-17, which includes the start codon; CP2 has an 
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out-of-frame deletion in exon 3 that results in a premature stop codon; CP1 and CP3 
both have mutations in exon 10, 2bp deletion and a point mutation respectively, both 
of which result in a stop codon.  The Newcastle CdLS cell lines could still give a 
large non-functioning NIPBL protein, whilst the Philadelphia CdLS lines would only 
give a small non-functioning peptide, if anything.  This large non-functioning protein 
may have a dominant negative effect, whereas the small non-functioning peptide, or 
no protein, would only give a haploinsufficient effect.  Perhaps the decompaction of 
chromatin I observed in CN1 and CN2 was due to interference of non-functional 
NIPBL on the activity of the one functioning copy, whilst in the Philadelphia cell 
lines, the functioning NIPBL was able to act unhindered.  Indeed, complete knockout 
of one copy of NIPBL gives a very different phenotype to CdLS (Reeves et al, in 
preparation), suggesting that CdLS is caused by dominant negative effects, not 
haploinsufficiency.  However, all of the cell lines came from patients diagnosed with 
severe CdLS, suggesting that any differences that can be seen at a cellular level are 
not apparent at a patient level. 
An alternative explanation is that natural variation is responsible for the cellular 
phenotype observed in CN1 and CN2, but not in CP1, CP2, CP3 and CP4.  The 
wildtype cell lines WP1, WP2 and WP3 were matched controls, obtained from 
siblings of CdLS patients (though not the same patients as any of the cell lines in this 
thesis). It is possible that the cellular phenotype I observed in CN1 and CN2 was due 
to a genetic background effect, and I did not observe it in CP1, CP2, CP3 and CP4 




There is evidence that CdLS is able to affect the compaction of chromatin in 
different ways at different regions.  At a large scale, chromatin in CdLS behaves as if 
its topology were more homogenous than in wildtype, as tight controls on looping 
are lost.  At a smaller scale, we can see how the complex cohesin interactions at 
specific regions can result in subtle changes in the compaction of chromatin that 
differ between CdLS cell lines. 
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5 RNAi manipulation to replicate the 
cellular phenotype of CdLS 
 
It was unclear from the experiments I did in the CdLS cell lines, described in 
Chapter 4, whether the chromatin condensation phenotypes observed in the first set 
of CdLS cell lines from Newcastle, but not in the second set from the USA, were 
genuinely due to CdLS or due to some other factor, such as differences in the way 
cell lines were established in different donor labs.  For this reason, I decided to use 
RNA interference (RNAi) to see if I could replicate these phenotypes by knocking 
down genes that are involved in CdLS and in cohesin, or that have been implicated in 
cohesin function. 
I chose to knockdown NIPBL, SMC1 and CTCF by RNAi.  I considered NIPBL 
to be the most important choice for knockdown, as this is mutated in 50% of all 
CdLS cases and was mutated in all of the CdLS cell lines that I studied.  NIPBL 
expression is reduced by 30% in CdLS patients with a NIPBL mutation (Liu et al, 
2009) so I felt that reduction in NIPBL levels by RNAi might replicate the cellular 
effect of CdLS.  I chose to knockdown SMC1 as this is a component of the cohesin 
complex itself, and is also mutated in some cases of CdLS (Musio et al, 2006).  I was 
interested in knocking down CTCF because it is reported to colocalise with cohesin 
around the genome and is involved in chromosome topology, interacting with 
cohesin (Section 1.5), therefore the mechanism of disrupted chromatin condensation 
in CdLS may be through cohesin-CTCF mediated chromatin looping (Wendt et al, 
2008; Stedman et al, 2008; Parelho et al, 2008; Zhao et al, 2006; Kurukuti et al, 
2006; Splinter et al, 2006; Nativio et al, 2006; Degner et al, 2009; Hadjur et al, 
2009; Mishiro et al, 2009; Hou et al, 2010). 
 
5.1 RNAi knockdown of NIPBL , SMC1 and CTCF  
I knocked down the three genes in HT1080 human fibroblast cells, as LCLs, 
which I had used for previous experiments, do not transfect well.  HT1080 cells were 
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derived in 1974 by Rasheed et al from a fibrosarcoma from a 35-year old male.  
These cells have a modal chromosome number of 46, however it is known that 80% 
display rearranged karyotypes and pseudodiploidy is common.  Despite this, the 
karyotype is stable enough to provide an accurate model of human fibroblasts. 
The genes were knocked down for two days using 100nM ON-TARGETplus 
short interfering RNA (siRNA) SMART-pools ordered from Dharmacon (Section 
2.7; Figure 5.1).  As well as the three siRNAs targeted to the genes of interest, in 
each experiment I treated samples of cells with two negative controls, a non-coding 
SMART-pool from Dharmacon which did not correspond to any endogenous 
mRNAs, and a mock transfection, using siRNA buffer but no siRNA.  It was 
important to compare coding siRNAs to a non-coding control, because siRNA 
treatment itself has been shown to affect gene expression in HT1080 cells, 
particularly genes involved in the immune response, and these changes may also 
affect compaction (Tagami et al, 2005).  After 48h, cells were harvested to detect 
knockdown. 
As I was not able to detect NIPBL protein by western blot, perhaps due to its 
large size (more than 300kDa), I detected knockdown of NIPBL mRNA by reverse-
transcriptase polymerase chain reaction (RT-PCR; Section 2.4).  I was able to 
demonstrate a qualitative knockdown of NIPBL RNA in the NIPBL targeted siRNA 
treated cells compared to the cells treated with a non-coding control pool siRNA and 
those mock transfected, by running the PCR products on a 1% agarose gel.  qPCR 
showed that NIPBL RNA levels were reduced by more than 90% in the NIPBL-
targeted siRNA treated cells compared to the non-coding siRNA treated and the 
mock transfected cells (Figure 5.2A).  In CdLS caused by mutations of NIPBL, there 
is only a loss of 30% of the NIPBL RNA (Liu et al, 2009) therefore I have reduced 
NIPBL expression to below that in CdLS cells, so my model may give a more 
extreme phenotype than in CdLS. 
I was able to detect SMC1 and CTCF proteins by western blot using antibodies 
from Upstate and Bethyl laboratories respectively, and using a GAPDH antibody 
from Abcam as a loading control (Section 2.5).  SMC1 protein was detected close to 
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Figure 5.2 – Knockdown of NIPBL, SMC1 and CTCF by RNAi.
A, levels of NIPBL RNA after RNAi in HT1080 cells, shown by RT-PCR.  On the top PCR products are 
shown on a 1% agarose gel.  The graph shows the mean NIPBL mRNA level of three qPCR technical 
replicates relative to GAPDH, the error bars indicate the standard deviation.  B, levels of SMC1 protein 
after RNAi in HT1080 cells, shown by Western Blot and by immunofluorescence FACS.  For FACS SMC1 
levels were detected in FITC and the FITC levels measured by FACS, shown on a log10 scale; the 
percentage of FITC negative cells and the mean FITC level were calculated  C, levels of CTCF protein 
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known to migrate at 130kDa in extracts from mammalian cells (Farrar et al, 2010).  
By western blot, I showed a knockdown of both SMC1 (Figure 5.2B) and CTCF 
(Figure 5.2C) protein levels in the cells treated with the respective siRNAs compared 
to the non-coding siRNA treated and mock transfected cells.  From these westerns, I 
estimate that I have reduced SMC1 and CTCF proteins levels by 90%.  I then carried 
out FACS analysis of immunofluorescent cells, treating with antibodies against 
SMC1 and CTCF proteins and staining with FITC, then measured the FITC levels in 
all cells (Section 2.9.2).  There was a general decrease in both SMC1 and CTCF 
upon knockdown in all cells, not loss of the proteins in some cells and maintained 
protein levels in other cells, as the histogram of FITC staining was shifted to the left, 
and not split into two peaks (Figure 5.2B; Figure 5.2C). 
 
5.2 General nuclear phenotype of NIPBL, SMC1 and 
CTCF knockdown cells 
I analysed the RNAi treated cells as I had analysed the CdLS LCLs previously to 
determine the general nuclear phenotype of the cells.  For each experiment I 
transfected the HT1080 cells with the siRNA of interest (targeted to NIPBL, SMC1 
or CTCF) and the non-coding siRNA, and carried out a mock transfection.  These 
cells were harvested after 48h. 
 
5.2.1  Cell cycle analysis of NIPBL, SMC1 and CTCF knockdown 
cells 
I carried out FACS analysis after siRNA mediated knockdown of NIPBL, SMC1 
and CTCF, compared to the negative controls, using PI staining as a measure of 
DNA content (Section 2.9). 
There was no significant difference in the cell cycle of the NIPBL knockdown 
cells compared with either of the two controls (χ
2
, p>0.6; Figure 5.3).  Similarly the 
cell cycle of the SMC1 knockdown cells was no different to the two controls (χ
2
, 
p>0.24; Figure 5.3).  In contrast, CTCF knockdown resulted in an increase in the 


























































































Figure 5.3 – The effect of RNAi knockdown of NIPBL, SMC1 and CTCF on the cell cycle.  
FACS analysis of three test siRNAs, to NIPBL, CTCF and SMC1, compared to two controls, a 
non-coding siRNA and a mock transfection.  A, histograms of DNA content.  Cells were excited at 
488nm and the fluorescence measured at 562-588nm, the level of fluorescence giving an estimate of 
DNA content in PI stained cells.  B, bar charts of the percentage of cells in each cell cycle stage, 


















phase compared to both of the controls (Figure 5.3).  χ
2
 statistical tests suggest that 
this change was significantly different, at p=0.0001 when comparing CTCF siRNA 
treatment to both non-coding siRNA treatment and mock transfection.  In all three 
experiments there is evidence of an aneuploid population with a DNA content greater 
than 2n, which is commonly seen in HT1080 cells, however there was no evidence of 
increased aneuploidy in any of the three knockdowns compared to controls (Figure 
5.3). 
It is surprising that SMC1 knockdown does not affect the cell cycle, nor result in 
increased aneuploidy, given the importance of sister chromatid cohesion in cell cycle 
progression through mitosis.  It may be that residual levels of SMC1 are sufficient 
for this process. 
These data suggest that loss of CTCF may act to trigger a G1/S checkpoint.  It is 
unlikely that this is due to the putative role of CTCF in positioning cohesin as a 
similar effect is not observed upon SMC1 knockdown, so it may also be due to other 
factors, as CTCF is known to interact with a large number of other proteins and to 
participate in a range of chromatin functions.  Conditional knockout of CTCF in T-
cells results in cells that are small and do not progress through the cell cycle due to 
increased expression of cyclin-CDK inhibitors p21 and p27 (Heath et al, 2008).   
Also CTCF knockdown has been previously shown to alter epigenetic marks 
(Splinter et al, 2006; Kurukuti et al, 2006), increasing DNA methylation and 
H3K9me2 and H3K27me2, which may delay S-phase as inactive chromatin tends to 
replicate later than active chromatin (Hiratani et al, 2008).  Since similar effects are 
not seen upon NIPBL or SMC1 knockdown, it is likely that this function of CTCF is 
independent of cohesin. 
 
5.2.2  Nuclear size of the NIPBL, SMC1 and CTCF knockdown 
cells 
I also analysed the nuclear area after siRNA mediated knockdown to search for 
evidence of gross changes in nuclear compaction.  I fixed the cells in MAA, and 
visualised the DAPI-stained nuclei using fluorescence microscopy.  I analysed the 
nuclear area of the cells using an IPLab script.  It was important to carry out each 
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experiment simultaneously to control for the effect of humidity on the results.  I 
carried out each experiment twice.  The effect of the different treatments on nuclear 
area in each experiment was compared using Mann-Whitney U-tests. 
There is some increase in nuclear area in NIPBL knockdown cells compared to 
the two controls (Figure 5.4).  In the first experiment the mean nuclear area in the 
NIPBL siRNA treated cells (443.2μm²) was no different than that of the non-coding 
siRNA treated cells (444.7μm²; p=0.3218) but larger than that of the mock 
transfection (404.4μm²; p=0.0263). In the biological replicate the mean nuclear area 
for the NIPBL siRNA treated cells (485.9μm²) was greater than the two controls, 
non-coding siRNA (422.1μm²; p=0.0055) and mock transfection (357.1μm²; 
p<0.0001).  
SMC1 knockdown also resulted in an increase in nuclear area compared to the 
two negative controls (Figure 5.4).  In the first experiment the mean nuclear area of 
the SMC1 knockdown cells (530.8μm²) was greater than that of the non-coding 
siRNA treated cells (522.1μm²) and of the mock transfected cells (395.2μm²), whilst 
in the second experiment the mean nuclear areas were 460.0μm², 385.9μm² and 
386.7μm² respectively.  In the first experiment there was no significant difference 
between the nuclear areas after the SMC1 targeted siRNA and non-coding siRNA 
treatments at p=0.7985, but the mock transfected cells had nuclear areas significantly 
different to both at p<0.0001.  In contrast, in the second experiment, SMC1 
knockdown resulted in a significant difference in nuclear area to the two other 
treatments at p<0.0001. 
There is also evidence that CTCF knockdown increases nuclear size (Figure 5.4).  
The mean nuclear area of the CTCF knockdown cells (303.9μm² in the first 
experiment and 480.0μm² in the second), was larger than that of the non-coding 
siRNA treatment (278.1μm² and 478.8μm²), and mock transfection (256.7μm² and 
431.8μm²).  This is significant at p<0.0001 compared to both controls in the first 
experiment, however in the second experiment CTCF knockdown gives a significant 
increase compared to the mock transfection at p<0.0001, but not compared to the 
non-coding siRNA at p=0.9631.  The increase in the nuclear area of CTCF 
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Figure 5.4 – RNAi treatment causes variation in nuclear area as measured by fluorescence 
microscopy
Boxplots showing the area (µm²) of DAPI staining of MAA fixed cells after RNAi treatment, as boxplots in 
Figure 3.2, n=100.  Three test siRNAs, to NIPBL, CTCF and SMC1, were compared to two controls, a 
non-coding siRNA and a mock transfection in each experiment.  Each experiment was carried out twice.
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knockdown cells is even more significant when you consider that CTCF knockdowns 
have a greater proportion of cells in G1 (Figure 5.3). 
There is evidence that knockdown of all three genes results in an increase in 
nuclear area compared to the mock transfection and sometimes to the non-coding 
control.  However, in all experiments, except the second SMC1 knockdown, the non-
coding siRNA also increased nuclear size compared to mock transfection, suggesting 
that the presence of siRNAs per se has some effect on the nuclear area.  However, 
there was an increase in area over and above the increase in the non-coding siRNA 
treated cells in the NIPBL siRNA, SMC1 siRNA and CTCF siRNA treated cells, 
suggesting that knockdown of all three results in a gross change in nuclear 
architecture. 
I then analysed nuclear size of siRNA treated cells by width of PI staining in 
FACS analysis as in Chapter 3.  I found no change in PI width after NIPBL and 
SMC1 siRNA treatments, in neither the asynchronous population nor in G1 or G2 
only populations.  After CTCF knockdown, there appears to be a small increase in 
the number of larger nuclei in G2 (Figure 5.5). 
 
5.3 Chromatin compaction at specific chromatin 
regions in NIPBL, SMC1 and CTCF knockdown 
cells 
To search for more specific changes in chromatin architecture, I decided to study 
the same regions that I previously analysed in the CdLS cell lines to determine if 
siRNA knockdown gave the same phenotypes as I observed in some of these cell 
lines.  I chose the CTCF-rich region at 11q13 which showed decompaction in some 
CdLS lines and the CTCF-poor gene desert at 18q22 which mostly did not differ in 
compaction between the CdLS and wildtype cell lines, but this region may be even 
more compact in CdLS than in wildtype (Figure 5.6).  I studied these regions by 
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Figure 5.5 - RNAi treatment does not affect nuclear size, measured by FACS.
Cells were excited at 488nm and the fluorescence measured at 562-588nm, the width of 
fluorescence giving an estimate of nuclear size in PI stained cells.  Histograms of 
fluorescence width and mean fluorescence width is shown upon NIPBL, SMC1 and CTCF 
knockdown, in asynchronous, G1 and G2 cells.
siRNA Asynchronous G1 G2
NIPBL 295.91 281.16 300.16
Non-coding 293.17 277.8 296.14
Mock 294.69 278.57 297.31
Mean PI width
siRNA Asynchronous G1 G2
SMC1 316.88 307.21 328.37
Non-coding 321.88 309.44 339.59
Mock 318.46 307.93 334.55
Mean PI width
siRNA Asynchronous G1 G2
CTCF 309.96 300.19 331.56
Non-coding 306.93 297.22 317.63



















































































































































































































































































































































































5.3.1 Chromatin compaction of a CTCF-rich chromatin region 
upon knockdown of NIPBL, SMC1 or CTCF 
In the previous chapter, I showed that in some CdLS cell lines, the chromatin at 
11q13 is significantly decompacted compared to wildtype cells, although this is not 
the case in all CdLS lines.  This region is gene-rich, cohesin-binding rich (Liu et al, 
2009) and CTCF-binding rich (Barski et al, 2007).  In addition some of the genes 
within this region have been shown to be misregulated in CdLS LCLs (Liu et al, 
2009; Figure 5.6A).  None of the genes in this region were shown to be misregulated 
upon non-coding siRNA treatment in HT1080 (Tagami et al, 2008). 
Upon NIPBL knockdown there is an increase in r² at 11q13 in both biological 
replicates compared to the two controls, however these increases are not statistically 
significant by Tukey’s confidence intervals, and only compared to the non-coding 
siRNA in the first experiment by Mann-Whitney U-test, and compared to the mock 
transfection in the second experiment by Mann-Whitney U-test.  However this may 
be due to a general decompaction of the nucleus as previously observed by this 
method (Figure 5.4), as in the r²/a datasets no significant differences between NIPBL 
and the two controls can be observed; there is a small increase in r²/a in the NIPBL 
siRNA treated cells but this is not statistically significant (Figure 5.7). 
There is no evidence of any significant change in the compaction of 11q13 upon 
SMC1 knockdown.  In the first replicate, this region appears to be decompacted, as 
measured by both r² and r²/a, however this is not significant, and there does not 
appear to be any change in the second replicate (Figure 5.8). 
In the first CTCF knockdown experiment, the mock transfected cells have 
significantly smaller r² measurements compared to CTCF and non-coding siRNA 
treatment, perhaps due to an effect of the treatment itself on the compaction of the 
nucleus generally, as this effect is erased in the r²/a datasets.  In the second replicate, 
the non-coding siRNA results in a significant change in r², but not in r²/a compared 
to both CTCF siRNA and mock transfection, whilst mock transfection gives a 
significant change in r²/a, but not in r² compared to both CTCF and non-coding 
siRNA (Figure 5.9). 
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Figure 5.7 – Chromatin compaction at 11q13 after NIPBL siRNA.  
A, Boxplots showing the interphase separation squared (r²) and the interphase separation squared 
normalised to nuclear area (r²/a), as Figure 3.2.  This experiment was repeated twice.  B, tables of 
statistics, showing the mean and median of each dataset, and the results of pair-wise Mann-Whitney 













Exp1 r² Exp2 r²
NIPBL Non-coding Mock NIPBL Non-coding Mock
mean (µm²) 1.22 1.03 1.09 mean (µm²) 1.42 1.18 1.10
median (µm²) 1.20 0.97 1.05 median (µm²) 1.22 1.13 0.96
Compared to NIPBL MW 1 0.047 0.210 Compared to NIPBL MW 1 0.057 0.006
Tukey's CI yes yes Tukey's CI yes yes
Non-coding MW 0.047 1 0.313 Non-coding MW 0.057 1 0.530
Tukey's CI yes yes Tukey's CI yes yes
Mock MW 0.210 0.313 1 Mock MW 0.006 0.530 1
Tukey's CI yes yes Tukey's CI yes yes
Exp1 r²/a Exp2 r²/a
NIPBL Non-coding Mock NIPBL Non-coding Mock
mean 0.0057 0.0047 0.0039 mean 0.0063 0.0048 0.0047
median 0.0038 0.0030 0.0030 median 0.0035 0.0028 0.0028
Compared to NIPBL MW 1 0.303 0.063 Compared to NIPBL MW 1 0.129 0.176
Tukey's CI yes yes Tukey's CI yes yes
Non-coding MW 0.303 1 0.546 Non-coding MW 0.129 1 0.793
Tukey's CI yes yes Tukey's CI yes yes
Mock MW 0.063 0.546 1 Mock MW 0.176 0.793 1













Figure 5.8 – Chromatin compaction at 11q13 after SMC1 siRNA.  
A, Boxplots showing the interphase separation squared (r²) and the interphase separation squared 
normalised to nuclear area (r²/a), as Figure 3.2.  This experiment was repeated twice.  B, tables of 
statistics, showing the mean and median of each dataset, and the results of pair-wise Mann-Whitney 
U-tests and if the Tukey’s confidence interval overlap.  Significant differences are highlighted in grey.
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Exp1 r² Exp2 r²
SMC1 Non-coding Mock SMC1 Non-coding Mock
mean (µm²) 2.57 2.08 1.48 mean (µm²) 1.16 1.03 1.05
median (µm²) 1.12 1.16 0.99 median (µm²) 0.92 0.95 0.94
Compared to SMC1 MW 1 0.657 0.216 Compared to SMC1 MW 1 0.253 0.260
Tukey's CI yes yes Tukey's CI yes yes
Non-coding MW 0.657 1 0.375 Non-coding MW 0.253 1 0.976
Tukey's CI yes yes Tukey's CI yes yes
Mock MW 0.216 0.375 1 Mock MW 0.260 0.976 1
Tukey's CI yes yes Tukey's CI yes yes
Exp1 r²/a Exp2 r²/a
SMC1 Non-coding Mock SMC1 Non-coding Mock
mean 0.0062 0.0035 0.0036 mean 0.0040 0.0041 0.0042
median 0.0027 0.0020 0.0020 median 0.0020 0.0024 0.0024
Compared to SMC1 MW 1 0.075 0.276 Compared to SMC1 MW 1 0.817 0.874
Tukey's CI yes yes Tukey's CI yes yes
Non-coding MW 0.075 1 0.363 Non-coding MW 0.817 1 0.686
Tukey's CI yes yes Tukey's CI yes yes
Mock MW 0.276 0.363 1 Mock MW 0.874 0.686 1
Tukey's CI yes yes Tukey's CI yes yes
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B
Figure 5.9 – Chromatin compaction at 11q13 after CTCF siRNA.  
A, Boxplots showing the interphase separation squared (r²) and the interphase separation squared 
normalised to nuclear area (r²/a), as Figure 3.2.  This experiment was repeated twice.  B, tables of 
statistics, showing the mean and median of each dataset, and the results of pair-wise Mann-Whitney 
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Exp1 r² Exp2 r²
CTCF Non-coding Mock CTCF Non-coding Mock
mean (µm²) 2.43 2.14 1.08 mean (µm²) 2.53 2.85 1.93
median (µm²) 1.09 1.06 0.57 median (µm²) 1.63 1.34 1.00
Compared to CTCF MW 1 0.675 0.000 Compared to CTCF MW 1 0.009 0.096
Tukey's CI yes no Tukey's CI yes yes
Non-coding MW 0.675 1 0.000 Non-coding MW 0.009 1 0.403
Tukey's CI yes yes Tukey's CI yes yes
Mock MW 0.000 0.000 1 Mock MW 0.096 0.403 1
Tukey's CI no yes Tukey's CI yes yes
Exp1 r²/a Exp2 r²/a
CTCF Non-coding Mock CTCF Non-coding Mock
mean 0.0078 0.0076 0.0052 mean 0.0053 0.0060 0.0041
median 0.0040 0.0040 0.0029 median 0.0040 0.0029 0.0020
Compared to CTCF MW 1 0.989 0.104 Compared to CTCF MW 1 0.391 0.047
Tukey's CI yes yes Tukey's CI yes yes
Non-coding MW 0.989 1 0.055 Non-coding MW 0.391 1 0.226
Tukey's CI yes yes Tukey's CI yes yes
Mock MW 0.104 0.055 1 Mock MW 0.047 0.226 1
Tukey's CI yes yes Tukey's CI yes yes
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5.3.2 NIPBL and SMC1 knockdown decompact chromatin at a 
CTCF-poor region, but CTCF knockdown does not 
In the previous chapter, I demonstrated that there was no decompaction of the 
chromatin at 18q22 in CdLS compared to wildtype, indeed in some CdLS cells, the 
region appears more compact than wildtype, probably due to relative chromatin 
decompaction at other genomic regions in NIPBL mutants.  This region is a gene 
desert, and is CTCF- and cohesin-binding poor (Barski et al, 2007; Liu et al, 2009; 
Figure 5.6B).  The flanking genes, CDH7 and CDH19, are not misregulated upon 
non-coding siRNA transfection in HT0180s (Tagami et al, 2008). 
In all experiments, r² and r²/a measurements were lower at 18q22 compared to 
11q13, as expected from a gene-poor region compared to a ridge. 
Surprisingly, given effects at 18q22 in CdLS cells, NIPBL knockdown results in 
a decompaction of 18q22 compared to the two controls; this effect is significant in 
both the r² and the r²/a datasets in both experiments, so the decompaction at this 
region is over and above the gross decompaction of the nucleus (Figure 5.10). 
 Like NIPBL knockdown, SMC1 knockdown also decompacts chromatin at 
18q22.  This effect can be seen in the first experiment but is only significant in the r² 
dataset comparing NIPBL knockdown to non-coding siRNA treatment.   This effect 
is significant in both the r² and r²/a datasets in the second experiment (Figure 5.11).  
There is no evidence that CTCF knockdown affects the compaction of chromatin 
at 18q22 compared to the two controls.  It appears that this region is compacted in 
the non-coding control compared to the mock transfection and the CTCF knockdown 
in both experiments, however this is only significant in the second experiment 
compared to CTCF knockdown (Figure 5.12).  The lack of effect is unsurprising 
given the absence of CTCF-binding at this region. 
 
5.4 Discussion 
In the previous chapter I showed that in some CdLS LCLs the 11q13 region is 
decompacted compared to wildtype, whereas the 18q22 region remained compact, 




Figure 5.10 – Knockdown of NIPBL decompacts chromatin at 18q22. 
A, Boxplots showing the interphase separation squared (r²) and the interphase separation 
squared normalised to nuclear area (r²/a), as Figure 3.2.  This experiment was repeated 
twice.  B, tables of statistics, showing the mean and median of each dataset, and the 
results of pair-wise Mann-Whitney U-tests and if the Tukey’s confidence interval overlap.  






Experiment 1 Experiment 2
r²
/a
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Exp1 r² Exp2 r²
NIPBL Non-coding Mock NIPBL Non-coding Mock
mean (µm²) 0.87 0.47 0.45 mean (µm²) 0.77 0.61 0.56
median (µm²) 0.67 0.38 0.35 median (µm²) 0.67 0.40 0.31
Compared to NIPBL MW 1 0.000 0.000 Compared to NIPBL MW 1 0.000 0.000
Tukey's CI no no Tukey's CI no no
Non-coding MW 0.000 1 0.509 Non-coding MW 0.000 1 0.047
Tukey's CI no yes Tukey's CI no yes
Mock MW 0.000 0.509 1 Mock MW 0.000 0.047 1
Tukey's CI no yes Tukey's CI no yes
Exp1 r²/a Exp2 r²/a
NIPBL Non-coding Mock NIPBL Non-coding Mock
mean 0.0038 0.0007 0.0009 mean 0.0019 0.0029 0.0039
median 0.0009 0.0003 0.0003 median 0.0009 0.0004 0.0003
Compared to NIPBL MW 1 0.000 0.000 Compared to NIPBL MW 1 0.003 0.000
Tukey's CI no no Tukey's CI no no
Non-coding MW 0.000 1 0.278 Non-coding MW 0.003 1 0.303
Tukey's CI no yes Tukey's CI no yes
Mock MW 0.000 0.278 1 Mock MW 0.000 0.303 1




Figure 5.11 – Knockdown of SMC1 decompacts chromatin at 18q22.    
A, Boxplots showing the interphase separation squared (r²) and the interphase separation squared 
normalised to nuclear area (r²/a), as Figure 3.2.  This experiment was repeated twice.  B, tables of 
statistics, showing the mean and median of each dataset, and the results of pair-wise Mann-
Whitney U-tests and if the Tukey’s confidence interval overlap.  Significant differences are 
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Exp1 r² Exp2 r²
SMC1 Non-coding Mock SMC1 Non-coding Mock
mean (µm²) 0.75 0.42 0.46 mean (µm²) 0.67 0.43 0.73
median (µm²) 0.22 0.11 0.17 median (µm²) 0.45 0.29 0.26
Compared to SMC1 MW 1 0.001 0.085 Compared to SMC1 MW 1 0.000 0.001
Tukey's CI no yes Tukey's CI no no
Non-coding MW 0.001 1 0.258 Non-coding MW 0.000 1 0.799
Tukey's CI yes Tukey's CI no yes
Mock MW 0.085 0.258 1 Mock MW 0.001 0.799 1
Tukey's CI yes yes Tukey's CI no yes
Exp1 r²/a Exp2 r²/a
SMC1 Non-coding Mock SMC1 Non-coding Mock
mean 0.0015 0.0010 0.0015 mean 0.0019 0.0010 0.0104
median 0.0004 0.0003 0.0005 median 0.0005 0.0003 0.0002
Compared to SMC1 MW 1 0.187 0.544 Compared to SMC1 MW 1 0.000 0.007
Tukey's CI yes yes Tukey's CI no no
Non-coding MW 0.187 1 0.089 Non-coding MW 0.000 1 0.603
Tukey's CI yes yes Tukey's CI no yes
Mock MW 0.544 0.089 1 Mock MW 0.007 0.603 1




Figure 5.12 – Knockdown of CTCF does not affect chromatin compaction at 18q22.   
A, Boxplots showing the interphase separation squared (r²) and the interphase separation squared 
normalised to nuclear area (r²/a), as Figure 3.2.  This experiment was repeated twice.  B, tables of 
statistics, showing the mean and median of each dataset, and the results of pair-wise Mann-
Whitney U-tests and if the Tukey’s confidence interval overlap.  Significant differences are 
highlighted in grey. 
Exp1 r² Exp2 r²
CTCF Non-coding Mock CTCF Non-coding Mock
mean (µm²) 0.75 1.39 1.07 mean (µm²) 0.91 1.01 1.80
median (µm²) 0.19 0.11 0.14 median (µm²) 0.25 0.12 0.15
Compared to CTCF MW 1 0.089 0.303 Compared to CTCF MW 1 0.009 0.096
Tukey's CI yes yes Tukey's CI yes yes
Non-coding MW 0.089 1 0.625 Non-coding MW 0.009 1 0.403
Tukey's CI yes yes Tukey's CI yes yes
Mock MW 0.303 0.625 1 Mock MW 0.096 0.403 1
Tukey's CI yes yes Tukey's CI yes yes
Exp1 r²/a Exp2 r²/a
CTCF Non-coding Mock CTCF Non-coding Mock
mean 0.0030 0.0051 0.0046 mean 0.0019 0.0024 0.0051
median 0.0007 0.0004 0.0005 median 0.0005 0.0003 0.0004
Compared to CTCF MW 1 0.167 0.288 Compared to CTCF MW 1 0.011 0.432
Tukey's CI yes yes Tukey's CI yes yes
Non-coding MW 0.167 1 0.890 Non-coding MW 0.011 1 0.086
Tukey's CI yes yes Tukey's CI yes yes
Mock MW 0.288 0.890 1 Mock MW 0.432 0.086 1
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contrast, I have found that NIPBL and SMC1 knockdown in HT1080 decompacts 
chromatin at 18q22 to a greater extent than at 11q13. 
This apparent paradox can be explained in that the experiments used two 
different cell types, the B-lymphocyte derived LCLs and the fibroblast derived 
HT1080s.  There will be many differences between the two cell types, including gene 
expression and chromatin landscape.  In the LCLs, the 11q13 region may be tightly 
regulated by cohesin and NIPBL, and as such is disrupted in CdLS, whilst in the 
HT1080 cells this region may not be so tightly regulated so is not altered upon SMC1 
and NIPBL knockdown, vice versa for the 18q22 region. This suggests that loss of 
cohesin or NIPBL in CdLS or by RNAi knockdown does decompact chromatin at 
specific regions, but these regions vary by cell type.  Indeed, Liu et al (2009) studied 
gene expression changes in human CdLS LCLs and found genes misregulated at 
11q13 but none at 18q22, but there is no data for gene expression in fibroblast-
derived CdLS cell lines, which may give the reverse effect.  Also, although Liu et al, 
(2009) found no cohesin binding in this region in LCLs, this does not mean that the 
region is not bound by cohesin in fibroblast-derived cell lines, and it would be 
interesting to determine this. 
CTCF, however, does not decompact chromatin at either of the regions studied.  
This suggests that the decompaction of chromatin in CdLS is unrelated to the 
interaction between CTCF and cohesin.  Indeed, recent evidence suggests that CTCF 
may not regulate many tissue specific genes, and cohesin interacts with mediator and 
tissue specific transcription factors to regulate these genes (Kagey et al, 2010; 
Schmidt et al, 2010; Kernohan et al, 2010).  Given the sparseness of CTCF binding 
at 18q22, it is unsurprising that CTCF does not affect compaction at this region, but 
11q13 compaction is not affected by CTCF either, despite the dense CTCF binding at 
this region (Barski et al, 2007).  However this CTCF binding was studied in T-cells, 
different cell types from the LCLs in which I originally studied CdLS chromatin 
compaction and from the HT1080 cell lines in which I knocked down CTCF, so may 
not reflect the chromatin landscape of the cells I have been studying. 
It is also possible that the knockdown of NIPBL gives a different phenotype to 
CdLS due to the level of NIPBL mRNA loss.  In CdLS cells, there is only 30% loss 
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of NIPBL mRNA (Liu et al, 2009), however I achieved 90% knockdown of NIPBL 
mRNA, which may give a different phenotype.  Given that complete heterozygous 
knockout of NIPBL gives a different clinical phenotype to CdLS (Reeves et al, in 
preparation), it is entirely possible that a 90% decrease in NIPBL mRNA levels 
should give a different phenotype to a 30% decrease.  
There is no evidence that the genes adjacent to the region studied at 18q22, 
CDH7 and CDH19 have any particular difference in levels of expression between 
HT1080 fibrosarcoma-derived cells, or in LCLs (Cheung et al, 2005; Lehnhardt et al, 
2005), however the data available for the two cell lines is not very comparable.  The 
two genes, CDH7 and CDH19, are cadherin genes, involved in cell adhesion (Kools 
et al, 2000) and it seems logical to consider that these genes would be more highly 
expressed in HT1080s, which grow in an adhesive monolayer, than in LCLs, which 





6 Bioinformatic analysis of genome-
wide expression data in CdLS 
 
The genome-wide effect of NIPBL mutation on gene expression has been 
examined in LCLs derived from human CdLS patients (Liu et al, 2009), in two cell 
lines from a Nipbl knockout mouse model of CdLS (Kawauchi et al, 2009), in mouse 
ES cells with NIPBL and SMC1 knockdown (Kagey et al, 2010), and in Drosophila 
cell lines with Nipped-B knockdown (Schaaf et al, 2009).  In all four studies they 
found that CdLS or knockdowns that mimic CdLS cause low-level changes (<3-fold) 
in the expression of a large number of genes rather than a large change of expression 
of a few genes.  In three of the studies they identify candidate genes that may be 
responsible for the phenotypes observed in CdLS. 
I was interested in these studies because I wanted to find regions of the human 
genome where many genes were misexpressed in CdLS compared to wildtype, 
perhaps even a gene cluster, as this might be indicative of loss of long-range 
interaction and changes in chromatin compaction.  I was particularly interested in 
regions that might have genes misexpressed in CdLS in all three species, as these 
would be regions that were robustly misregulated in a number of biological systems.  
Such regions would then provide a good focus for further investigation of chromatin 
structure. 
All four studies use microarrays to study gene expression in CdLS in the different 
species.  In humans, gene expression analysis was carried out on 16 LCLs obtained 
from different CdLS probands, and compared to 17 healthy controls, and 1501 genes 
were identified that are misregulated with a false discovery rate <0.05 (Liu et al, 
2009). 
A mouse model of CdLS was made by gene-trapping Nipbl.  This resulted in a 
25-30% loss of Nipbl protein in heterozygous animals, similar to the level of NIPBL 
reduction in CdLS.  The phenotype of the mice was similar to that of CdLS, with 




Gene expression was analysed in ten Nipbl
+/-
 E13.5 brains compared to 11 wildtype 
from two litters: 978 misexpressed genes were identified in the mutants with a false 
discovery rate <0.05.  In ten Nipbl
+/-
 E15.5 MEF lines compared to nine wildtype, 
from three litters, 81 genes were misexpressed in mutants, with a false discovery rate 
<0.05 (Kawauchi et al, 2009). 
A second cellular murine model was created by knocking down Nipbl (75% 
knockdown) and SMC1 (90% knockdown) in ES cells.  It was found that upon Nipbl 
knockdown 257 genes were downregulated with a log2 fold change ≤-0.5 and 439 
genes upregulated with a log2 fold change ≥0.5 and upon Smc1 knockdown 818 
genes were upregulated and 1310 genes downregulated.  These included reduced 
expression of a number of pluripotency associated markers and increased expression 
of developmental transcription factors (Kagey et al, 2010). 
CdLS was modelled in Drosophila cell lines by knockdown of Nipped-B by 
RNAi in the central nervous system (CNS) derived BG3 cell line, and studied after 
three, four and six days of incubation; 653 genes were found to be misexpressed after 
three days, 1455 after four days and 1933 after six days siRNA incubation compared 
to a mock transfection with a log2 fold change ≤-0.5 or ≥0.5 (Schaaf et al, 2009). 
 
6.1 There is no correlation between the genes 
misregulated in human CdLS cells and the CdLS 
animal models 
In order to find genes that were consistently misregulated in CdLS cells, I asked 
Dr. Philippe Gautier, in the Bioinformatics department at the MRC Human Genetics 
Unit to identify orthologous genes that were misregulated in human CdLS and in 
animal cells which replicate CdLS, from the published data (Liu et al, 2009; 







6.1.1 Comparing human CdLS to the mouse model 
Only 67 genes were identified that were misregulated in both the mouse gene-
trap model (either the brains, or the MEFs; Kawauchi et al, 2009) and in the human 
LCLs (1501; Liu et al, 2009).  This low number compared to the total number of 
genes identified in each study (978 in mice and 1501 in humans) suggests that the 
coincidence of these genes is little more than random.  Comparing the mouse ES-cell 
knockdown data, 142 genes were found in common between human CdLS and Smc1 
knockdown, and only 36 in common between human CdLS and Nipbl knockdown 
(257), with a log2 ratio of fold change <-0.5 or >0.5 (Liu et al, 2009; Kagey et al, 
2010).  A higher proportion of the genes misregulated in each of the knockdowns 
were also misregulated in human CdLS LCLs, 32.3% and 14.0% of the genes 
misregulated upon Smc1 and Nipbl knockdown respectively, compared to the mouse 
gene-trap, however this is still probably random.  The level of misexpression relative 
to wildtype was compared between the two species, and the Spearman’s rank 
correlation coefficient calculated.  No correlation was found between the level of 
increase or decrease in gene expression in the human CdLS LCL data and either the 
Nipbl knockdown ES cell data, Smc1 knockdown ES cells or the mouse Nipbl gene-
trap (ρ=0.390, ρ=0.324, ρ=0.067; Figure 6.1). 
Rather than suggesting that the mouse model is not an accurate model of CdLS, 
this difference between the human and mouse cell lines may represent a difference in 
cell lines, as the human lymphocyte-derived LCLs came from a very different 
developmental environment to the fibroblast-derived MEFs and the mouse brain 
cells, or the pluripotent ES cells, where different genes may be regulated by cohesin.  
Indeed, in wildtype human LCLs and in mouse ES cells, cohesin is preferentially 
found near to transcription start sites of genes that are misregulated in CdLS or upon 
Nipbl knockdown respectively (Liu et al, 2009; Kagey et al, 2010), suggesting that if 
cohesin is differentially bound to the genome in different cell lines, then different 





Figure 6.1 - Lack of correlation between the genes misexpressed in CdLS and mouse 
models of CdLS.
The log2 fold change in expression of genes that are misexpressed in human CdLS LCLs (Liu 
et al, 2009) is plotted against their fold-change in mouse CdLS models (Kawauchi et al, 2009; 
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6.1.2 Comparing human CdLS to the Drosophila model 
There were 320 orthologous genes that were misexpressed in both the human 
LCLs (Liu et al, 2009) and the fly Nipped-B knockdown BG3 cells (Schaaf et al, 
2009).  This is less than 20% of the genes misexpressed in the Drosophila cells 
(1933) and less than 25% of the genes misexpressed in human CdLS cells (1501).  
Comparison of the level of misexpression in both species by Spearman’s rank 
correlation found that there was no correlation in the level of increase or decrease in 
gene expression at ρ=0.466 after three days incubation, ρ=0.385 after four days and 
ρ=0.208 after six days, compared to human LCLs (Figure 6.2).  Again we can 
consider that this is a difference between cell lines, and not necessarily a failure to 
produce an accurate animal model of CdLS. 
 
6.1.3 There is no correlation in changes in gene expression in 
different tissues of the CdLS mouse 
To determine if the lack of correlation between species I observed was due to 
differences between cell lines, or differences between species, I asked Dr. Philippe 
Gautier to compare the two gene-trap mouse samples, the E13.5 brains and the E15.5 
MEFs from gene-trap heterozygotes (Kawauchi et al, 2009) and the two mouse ES 
cell knockdown datasets (Kagey et al, 2010). 
Only 13 genes were found that are misexpressed in both cell types from the gene-
trap mice, however there is a strong correlation (ρ=0.850) between the levels of 
misexpression in both (Figure 6.3A).  24 genes were misexpressed with a log2 fold 
change <-0.5 or >0.5 in both the Nipbl and Smc1 knockdown ES cells and there is a 
strong correlation (ρ=0.721) between the misexpression levels (Figure 6.3B).  There 
is no correlation between the levels of misexpression upon Nipbl and Smc1 
knockdown in ES cells and either the Nipbl gene-trap MEFs (ρ=0.067 and ρ=0.038 
respectively) or the Nipbl gene-trap brains at (ρ=0.019 and ρ=-0.142 respectively; 
Figure 6.3C; Figure 6.3D). 
The small number of correlated genes suggests that the developmental 
background of the cells has a huge effect on the genes that may be misexpressed in 
CdLS.  That the misexpression is correlated suggests that genomic context is 
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Figure 6.2 - Lack of correlation between the genes 
misexpressed in CdLS and Drosophila CdLS models.
The log2 fold change in expression of genes that are 
misexpressed in human CdLS LCLs (Liu et al, 2009) is plotted 
against their log2 fold-change in Drosophila CNS cell lines 



































Figure 6.3 - Correlation between misexpression of genes in CdLS mouse models.
The log2 fold change in expression of genes that are misexpressed in different mouse CdLS models.  A, 
Comparison of gene expression between MEFs and brain cells from the same Nipbl gene-trap 
(Kawauchi et al, 2009).  A line of best fit is shown with the equation of the line, calculated on Microsoft 
Excel.  B, Comparison of gene expression between SMC1 and Nipbl knockdown in ES cells (Kagey et 
al, 2010).   A line of best fit is shown with the equation of the line, calculated on Microsoft Excel.  C, 
Comparison of gene expression between the Nipbl gene-trap mouse brain (Kawauchi et al, 2009) and 
SMC1 and Nipbl ES-cell knockdown (Kagey et al, 2010).  D, Comparison of gene expression between 
the Nipbl gene-trap MEFs (Kawauchi et al, 2009) and SMC1 and Nipbl ES-cell knockdown (Kagey et al, 
2010).  
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important in cohesin-mediated gene regulation, however the small number of genes 
involved suggests that developmental programming may also have a significant 
effect.  These data are similar to those reported by Kagey et al (2010) who suggest 
that cohesin occupies different sites in the genome, and therefore regulates different 
genes, depending on the tissue.  If this is the case, it will have a huge impact on 
studies on CdLS, cohesin and chromosome topology, which tend to only focus on a 
single cell line or tissue. 
 
6.2 The protocadherin cluster as a candidate region 
for chromatin misregulation 
Analysis of the three species produced no stand-out candidate region for analysis 
by FISH.  However I decided to look at the protocadherin cluster on human 
chromosome 5, as many genes in the protocadherin-β cluster were misregulated in 
the mouse brain CdLS model (Kawauchi et al, 2009), and protocadherin-γ C3 was 
also downregulated in human CdLS LCLs (Liu et al, 2009; Figure 6.4A).  
Protocadherins are expressed in neurons and provide adhesion between neurons at 
the synapses.  The three protocadherin clusters, protocadherin-α, protocadherin-β and 
protocadherin-γ, consist of a tandem array of differentially spliced exons and a 
constant region with a set of constant exons.  It is thought that the diversity achieved 
through the different splicing variants leads to synaptic specificity (Yagi, 2008).  
There is a putative enhancer of protocadherin-α in between protocadherin-α and the 
protocadherin-β cluster (Ribich et al, 2006).  A SNP variant within this enhancer is 
thought to be associated with schizophrenia and bipolar disorder (Pedrosa et al, 
2008). 
In the human genome this region has sparse CTCF and cohesin binding over the 
protocadherin-α and protocadherin-β clusters, but dense binding of both over the 
protocadherin-γ cluster in human T-cells and LCLs respectively (Figure 6.4A; Liu et 
al, 2009; Barski et al, 2009).  In mouse ES cells, there is also more cohesin binding 
over the protocadherin-γ than over the protocadherin-α and protocadherin-β clusters 
(Kagey et al, 2010; Figure 6.4).  Using the UCSC browser I selected two fosmid 
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Figure 6.4 - The protocadherin cluster in human and mouse.
UCSC track of the protocadherin region in human (chr5:139,900,000-141,100,000; GRCh37/h19 assembly) 
and mouse (chr18:36,750,000-38,600,000; NCBI37/mm9 assembly; Kent et al, 2002; 
http://genome.ucsc.edu/).  Human, CTCF binding across the region is indicated as a bar chart in black at 
the top of the track (Barski et al, 2007).  Cohesin binding across the region is indicated below in black (Liu 
et al, 2009).  The positions of the FISH probes used are indicated below, the reference probe is indicated in 
green and the different distance probes are indicated in red.  The genes in the region are in blue, however 
those that are upregulated in CdLS LCLs compared to wildtype are highlighted in green, and those 
downregulated in red (Liu et al, 2009).  Mouse, cohesin binding sites found by ChIP are shown in black 











probes 752kb apart that spanned all three clusters: WI2-920O6, labelled in DIG-11-
dUTP and WI2-812D24, labelled in biotin-16-dUTP (Figure 6.4).  I measured 
chromatin compaction by 2D FISH at this region in the CdLS cell lines studied in 
previous chapters, CN1, CN2, CP1, CP2, CP3 and CdL 223P, compared to the 
wildtype lines, W1, WP1, WP2 and WP3, as in Chapter 4. 
I found that some CdLS cell lines appeared to be compacted at this region 
compared to wildtype, whilst others appeared to be decompacted (Figure 6.5A).  I 
compared the r² and r²/a datasets pair-wise for each cell line and although I found 
some pairs of cell lines had significantly different datasets to one another, there was 
no apparent pattern differentiating CdLS cell lines from wildtype cell lines (Figure 
6.4B).   From this I conclude that there is no evidence to suggest that the 
protocadherin region is decompacted in CdLS cell lines compared to wildtype. 
Whilst an enhancer has been determined for protocadherin-α, there is not yet 
evidence of an enhancer of protocadherin-β or protocadherin-γ, which are 
misregulated in the CdLS mouse model and CdLS respectively.  We can speculate 
that these two clusters have enhancers, and it is the interactions between these 
enhancers and the promoters of the protocadherin-β and protocadherin-γ genes that 
are disrupted in CdLS.  However, without knowing where these enhancers are, we 
cannot accurately predict what changes might occur in the compaction of this region.  
Therefore, it is still likely that the chromatin landscape is altered around the 
protocadherin cluster in LCLs, but my assay was not able to detect this and a more 
focussed approach may be necessary. 
 
6.3 Discussion 
Authors of papers looking at gene expression in CdLS, be it genome-wide (Liu et 
al, 2009; Kawauchi et al, 2009; Schaaf et al, 2009) or looking at a specific region 
(Zhao et al, 2006; Kurukuti et al, 2006; Splinter et al, 2006; Nativio et al, 2006; 
Degner et al, 2009; Hadjur et al, 2009; Mishiro et al, 2009; Hou et al, 2010) are keen 
to identify specific genes which may be linked to one or more of the phenotypes of 
CdLS.  However, in the small number of cell lines in which genome-wide gene 











Figure 6.5 - Chromatin compaction does not change at the protocadherin cluster in CdLS. 
A, Boxplot showing the interphase separation squared normalised to nuclear area (r²/a), as Figure 
3.2.    Wildtype cell lines are highlighted in black.  B, tables of statistics, showing the mean and 
median of each dataset, and the results of pair-wise Mann-Whitney U-tests and Tukey’s confidence 
interval overlaps.  Wildtype cell lines are highlighted in black and significant differences are 
highlighted in grey.
r²
W1 WP1 WP2 WP3 CN1 CN2 CP1 CP2 CP3 CP4
mean (µm²) 0.73 0.99 1.19 0.76 0.57 1.00 1.33 1.53 0.70 0.91
median (µm²) 0.28 0.47 0.46 0.39 0.30 0.49 0.70 0.62 0.37 0.63
Compared to W1 MW 1 0.0611 0.0035 0.5455 0.8184 0.0298 0.0002 0.0008 0.4132 0.0046
Tukey's CI yes yes yes yes yes no yes yes yes
WP1 MW 0.0611 1 0.4111 0.1871 0.0497 0.8839 0.0563 0.46 0.2162 0.4315
Tukey's CI yes yes yes yes yes yes yes yes yes
WP2 MW 0.0035 0.4111 1 0.0346 0.0032 0.4397 0.2618 0.6013 0.0278 0.8656
Tukey's CI yes yes yes yes yes yes yes yes yes
WP3 MW 0.5455 0.1871 0.0346 1 0.576 0.1468 0.0021 0.0058 0.8758 0.0357
Tukey's CI yes yes yes yes yes no yes yes yes
CN1 MW 0.8184 0.0497 0.0032 0.576 1 0.0414 0.0001 0.0008 0.5116 0.0047
Tukey's CI yes yes yes yes yes no no yes yes
CN2 MW 0.0298 0.8839 0.4397 0.1468 0.0414 1 0.0794 0.1749 0.194 0.396
Tukey's CI yes yes yes yes yes yes yes yes yes
CP1 MW 0.0002 0.0563 0.2618 0.0021 0.0001 0.0794 1 0.8075 0.0025 0.3656
Tukey's CI no yes yes no no yes yes yes yes
CP2 MW 0.0008 0.46 0.6013 0.0058 0.0008 0.1749 0.8075 1 0.0066 0.4132
Tukey's CI yes yes yes yes yes yes yes yes yes
CP3 MW 0.4132 0.2162 0.0278 0.8758 0.5116 0.194 0.0025 0.0066 1 0.0406
Tukey's CI yes yes yes yes yes yes yes yes yes
CP4 MW 0.0046 0.4315 0.8656 0.0357 0.0047 0.396 0.3656 0.4132 0.0406 1
Tukey's CI yes yes yes yes yes yes yes yes yes
r²/a
W1 WP1 WP2 WP3 CN1 CN2 CP1 CP2 CP3 CP4
mean 0.0030 0.0049 0.0043 0.0040 0.0027 0.0046 0.0053 0.0079 0.0033 0.0046
median 0.0013 0.0022 0.0022 0.0016 0.0012 0.0022 0.0033608028249W110.0030 0.0018 0.0027
Compared to W1 MW 1 0.0514 0.0078 0.1406 0.5425 0.0021 0 0 0.261 0.0011
Tukey's CI yes yes yes yes yes no no yes no
WP1 MW 0.0514 1 0.5814 0.6385 0.1323 0.2964 0.0274 0.089 0.3359 0.2425
Tukey's CI yes yes yes yes yes yes yes yes yes
WP2 MW 0.0078 0.5814 1 0.2925 0.0207 0.6334 0.0729 0.0747 0.1462 0.3796
Tukey's CI yes yes yes yes yes yes yes yes yes
WP3 MW 0.1406 0.6385 0.2925 1 0.3289 0.105 0.0092 0.0063 0.71 0.9043
Tukey's CI yes yes yes yes yes yes yes yes yes
CN1 MW 0.5425 0.1323 0.0207 0.3289 1 0.0055 0.0001 0.0001 0.5487 0.003
Tukey's CI yes yes yes yes yes no no yes yes
CN2 MW 0.0021 0.2964 0.6334 0.105 0.0055 1 0.2077 0.2293 0.0418 0.7782
Tukey's CI yes yes yes yes yes yes yes yes yes
CP1 MW 0 0.0274 0.0729 0.0092 0.0001 0.2077 1 0.9016 0.0019 0.3276
Tukey's CI no yes yes no yes yes yes yes yes
CP2 MW 0 0.089 0.0747 0.0063 0.0001 0.2293 0.9016 1 0.0015 0.2555
Tukey's CI no yes yes no yes yes yes yes yes
CP3 MW 0.261 0.3359 0.1462 0.71 0.5487 0.0418 0.0019 0.0015 1 0.0312
Tukey's CI yes yes yes yes yes yes yes yes yes
CP4 MW 0.0011 0.2425 0.3796 0.9043 0.003 0.7782 0.3276 0.2555 0.0312 1




significantly misregulated and I have shown that there is a huge variation in which 
genes are misregulated and to what extent between the different species and cell lines 
or tissues studied.  I consider it likely that almost all genes in the genome may be 
misregulated in CdLS, in one tissue or another.  Given this variation, it can only be 
of interest if one particular gene is highly misregulated in CdLS in the tissue in 
which it is normally active, for example the loss of expression of pluripotency-
associated genes in ES cells upon Nipbl knockdown (Kagey et al, 2010), or loss of 
expression of protocadherins in the developing brain (Kawauchi et al, 2009).  
Otherwise, we can consider that CdLS is caused by small alterations in the 






In this thesis I have discussed the effects of CdLS on chromatin by studying 
compaction at various regions in CdLS LCLs and by RNAi of proteins involved in 
CdLS, the cohesin complex and chromatin architecture.  I found that at the scale of 
chromosome territories, chromatin organisation tends towards a homogenisation in 
CdLS, with smaller than average CTs increasing in size and larger than average CTs 
decreasing (Section 4.1), and regions usually internal to the CT moving closer to the 
periphery and external regions moving into the CT (Section 4.2).  On a smaller scale, 
changes in chromatin compaction in CdLS will depend upon the particular 
interactions of cohesin at that region (Section 4.3); however the extent of these 
changes may depend upon the CdLS mutation, with more severe protein truncations 
tending to give a weaker cellular phenotype than mild truncations (Section 4.6).  
Though not seen in all cell lines to a statistically significant level, gene-rich regions 
with dense cohesin and CTCF binding tend to decompact in CdLS, whereas gene-
poor regions do not. (Section 4.3; Section 4.6).  The phenotypes of CdLS vary 
between tissues: there is misexpression of different genes in different tissues (Section 
6.1.3) and the effects on chromatin compaction differ between CdLS LCLs and 
RNAi knockdown HT1080s (Section 5.3).  
 
7.1 Cohesin regulates gene expression independently 
of CTCF 
CTCF is not the only partner of cohesin-mediated DNA interactions as CTCF 
knockdown does not give the same chromatin phenotype as NIPBL and SMC1 
knockdown (Section 5.3).  
It has been found that CTCF interacts with cohesin at 79% of genomic loci 
(Wendt et al, 2008; Parelho et al, 2008; Stedman et al, 2008).  These interactions 
result in the looping of chromatin in ACHs (active chromatin hubs) detected by 3C, 




(Nativio et al, 2006; Degner et al, 2009; Hadjur et al, 2009; Mishiro et al, 2009; Hou 
et al, 2010). 
However I have found that chromatin at 18q22 is decompacted upon knockdown 
of NIPBL and SMC1 in fibroblast derived cells, but not upon CTCF knockdown 
(Section 5.3).  Thus I conclude that changes in chromatin structure mediated by 
cohesin are independent of CTCF.  This can be added to growing body of data that 
suggests that cohesin is able to regulate gene expression through chromatin topology 
by interacting with proteins other than CTCF such as Mediator, and some tissue 
specific proteins, such as ATRX, ER, HNF4A and CEBPA (Kagey et al, 2010; 
Kernohan et al, 2010; Schmidt et al, 2010).  It has also been shown that NIPBL only 
associates with cohesin-binding sites where CTCF does not also interact, suggesting 
that CTCF-mediated interactions may not be altered in CdLS (Kagey et al, 2010).  It 
is likely that there are a number of other tissue specific transcription factors that are 
able to bring about intrachromosome interactions that can be tethered by cohesin to 
regulate gene expression (Figure 7.1). 
To identify other proteins that can mediate interactions with cohesin it may be 
necessary to carry out immuno-precipitations with the cohesin proteins in a variety of 
tissues, and to then determine co-occupation of DNA loci by these proteins by ChIP, 
and determine any intrachromosome interactions between these loci by 3C or 5C.  
These data lead me to ask: how important is CTCF in regulating chromosome 
topology with cohesin?  At a number of regions it has been demonstrated that CTCF 
and cohesin cooperate to form chromosome loops that regulate gene expression 
(Nativio et al, 2006; Degner et al, 2009; Hadjur et al, 2009; Mishiro et al, 2009; Hou 
et al, 2010) so we cannot exclude CTCF-cohesin interaction as a method of gene 
regulation.  However CTCF association and NIPBL association at cohesin binding 
sites are mutually exclusive (Kagey et al, 2010), suggesting that while CTCF can 
regulate intra-chromosome interactions with cohesin, it is not these interactions that 
are perturbed in CdLS.  Indeed, cohesin co-localises with NIPBL and Mediator 
together, although this relationship has not been shown with the tissue specific 
transcription factors, so it is the intra-chromosome interactions mediated by this trio 



























































































































































































































































































































7.2 NIPBL mutations have dominant negative effects 
My data suggest that there may be a stronger effect on chromatin compaction in 
cell lines where the NIPBL mutation has a smaller effect on the resulting protein, i.e. 
C-terminal mutations may have a larger cellular phenotypic effect than N-terminal 
mutations (Chapter 4).  This suggests a negative correlation between severity of the 
mutation and the severity of the cellular phenotype.  Clinical studies found that 
patients who present with mild CdLS phenotypes are more likely to have mild 
NIPBL mutations, such as missense mutations, and patients with severe CdLS often 
have truncating NIPBL mutations, such as frameshift and nonsense mutations, 
however this correlation is not absolute (Gillis et al, 2004; Bhuiyan et al, 2006; 
Selicorni et al, 2007).  These studies, however, did not look at the severity of the 
truncations within this category, and all of the CdLS LCLs I studied had a truncating 
mutation (Figure 3.1).  It is possible that missense mutations give a mild phenotype 
because they give an almost functional NIPBL protein which is able to load cohesin 
onto chromatin at near-wildtype efficiency.  C-terminal truncating mutations should 
produce much larger, though probably non-functional, NIPBL proteins which could 
interfere with the activity of wildtype protein, either preventing loading of cohesin 
onto chromatin or loading cohesin onto different loci; it is conceivable that a larger 
non-functional protein could have a stronger negative effect than a smaller non-
functional protein (Figure 7.2). 
NIPBL is a large protein of unknown structure, however it contains two domains 
of interest: a PxVxL domain which can interact with chromoshadow domains 
(Lechner et al, 2005), and HEAT repeats which act as a protein binding scaffold 
(Neuwald and Hirano, 2000; Figure 3.1).  The mutated proteins produced in CN1 and 
CN2 cell lines, which both showed a strong effect on chromatin compaction, are both 
large proteins that retain both the PxVxL domains and the HEAT repeats, although 
CN1 has an in-frame skipped exon in between the second and third HEAT repeats.  
CP1, CP2 and CP3, however, all produce short NIPBL peptides which lack both the 
PxVxL domain and the HEAT repeats, whilst CP4 produces no peptide at all, and 
these four cell lines had a smaller difference in chromatin compaction to wildtype 
(Figure 3.1).  If these two domains are present they may allow the mutant NIPBL to 







Figure 7.2 - How NIPBL mutations might have a dominant negative effect.
























or enzymatic activity, thus mutant NIPBL may be able to block access of wildtype 
NIPBL to partner proteins, having a dominant negative effect.  Smaller truncated 
proteins, without the PxVxL domain and the HEAT repeats, will not be able to 
interact with so many proteins, so the dominant negative effect may be reduced. 
These data suggest that NIPBL mutations might have a dominant negative effect, 
as opposed to a haploinsufficient effect as previously suggested (Krantz et al, 2004; 
Tonkin et al, 2004).  A dominant negative effect of NIPBL mutation is also 
suggested by the non-CdLS phenotype recently observed in a patient with a complete 
NIPBL deletion (Reese et al, in preparation); since this patient possessed none of the 
facial phenotypes observed in CdLS, it is likely that these phenotypes are caused by a 
dominant negative effect of mutant NIPBL, and not a haploinsufficient effect. 
In the case of the knockdown I carried out with NIPBL, this would not give a 
dominant negative effect, as only the quantity of protein was reduced.  However I 
achieved over 90% knockdown of NIPBL mRNA upon RNAi treatment, compared 
to the only ~30% loss observed in CdLS cell lines (Liu et al, 2009).  This suggests 
that NIPBL mutation may have both dominant negative and haploinsufficient effects, 
that loss of a high proportion of the endogenous protein results in decompaction of 
chromatin, as does interference of non-functional protein with functional protein, but 
that loss of only a small proportion of the endogenous protein is not sufficient to 
produce a similar effect. 
It would be interesting if the interacting partners of mutated NIPBL proteins 
could be determined by immuno-precipitation with tagged mutant and wildtype 
proteins, to discover which of the different mutants are able to interact with different 
NIPBL protein partners.  After this, the dominant negative effect on 
intrachromosome interactions could be assayed by 5C, comparing interactions at a 
region known to be disrupted in CdLS.  Chromosome interactions could be compared 
between different CdLS cell lines, with a variety of NIPBL mutations, including 
missense, truncating mutations giving a large protein, truncating mutations giving a 
small protein and complete deletion.  Quantitative analysis could identify the 
frequency of interactions in the different mutants compared to wildtype and 




Searching the literature, I have been unable to identify another dominant 
negative genetic disorder where a large non-functional protein would have a stronger 
effect than a small non-functional protein.  However, this does not mean this idea is 
not plausible. 
 
7.3 FISH as an assay to study CdLS 
Throughout my PhD I have used the 2D FISH assay to study chromatin 
compaction in CdLS.  Although I have found some effects of CdLS on chromatin 
compaction, I have not been able to identify the specific interactions that take place 
at the regions studied and therefore found the effects at some of the regions studied 
difficult to interpret. 
I think that to study chromatin in CdLS further it would be important to study it 
at a molecular level, and the most useful assay may be by the C methods (Figure 
1.7).  I think that 5C is the best method for studying interactions of known genomic 
regions as it is a higher throughput method than 3C, which has already been used in a 
number of studies identifying CTCF or Mediator and cohesin mediated interactions 
(Nativio et al, 2006; Degner et al, 2009; Hadjur et al, 2009; Mishiro et al, 2009; Hou 
et al, 2010; Kagey et al, 2010).  Hi-C, however, is a developing technology that is 
able to detect genome wide interactions, but has not yet been used to study 
interactions at such high resolution as 5C (Lieberman-Aiden et al, 2009).  Once the 
technology has been developed to increase resolution, and with sufficient 
bioinformatic ability, Hi-C would be an ideal method to identify chromatin 
interactions in that were disrupted in CdLS cells compared to wildtype. 
This data would be well complemented by data on cohesin and NIPBL genome 
interactions.  It would be worthwhile to carry out ChIP or DamID experiments with 
cohesin and NIPBL, and to compare their genomic localisation with regions where 
chromatin interactions were disrupted in CdLS. 
Previous studied have found that cohesin tends to localise near to the 
transcription start sites of genes misregulated in CdLS or upon NIPBL or SMC1 




complement to interaction and localisation data would be studies of genes 
misregulated in CdLS in that tissue. 
It would be important to carry out these studies in a number of cell lines and 
tissues, as it is likely that different interactions would occur and be affected 
differently in different tissues.  If we were able to identify tissue-specific proteins 
that interact with cohesin, it would be interesting to compare all of these data 
 
7.4 Conclusions 
Without a consistent cellular phenotype between CdLS cell lines, it is difficult to 
make firm conclusions about the compaction of chromatin in CdLS.  However, the 
fact that chromatin is decompacted in some CdLS cell lines and upon SMC1 and 
NIPBL knockdown, suggests that NIPBL and SMC1 do influence chromatin 
compaction, probably by altering chromosome topology.  It is also likely that this 
occurs independently of CTCF, and differs between cell lines.  It is likely this loss of 
cohesin-mediated intra-chromosome interactions that causes aberrant gene 
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